This regulatory network was inferred from the input dataset. The miRNAs and mRNAs are
presented as round and rectangle nodes respectively. The numerical value popped up upon mouse over the gene node is the log2 transformed fold-change of the gene expression between the two groups. All of the nodes are clickable, and the detailed information of the miRNAs/mRNAs and related cancer pathway will be displayed in another window. The edges between nodes are supported by both interactions (predicted or experimentally verified) and correlations learnt from cancer dataset. The numerical value popped up upon mouse over the edge is the correlation beat value (effect size) between the two nodes. The experimental evidences of the edges reported in previous cancer studies are highlighted by red/orange color. All of these information can be accessed by the "mouse-over" action. This network shows a full map of the miRNA-mRNA regulation of the input gene list(s), and the hub miRNAs (with the high network degree/betweenness centrality) would be the potential cancer drivers or tumor suppressors. The full result table can be accessed in the "Regulations" tab.
"miRNACancerMAP" is also a network visualization tool for users to draw their regulatory network by personal customization. Users can set the complexity of the network by limiting the number of nodes or edges. And the color of the nodes can be defined by different categories of the mRNAs and miRNAs, such as Gene-Ontology, pathway, and expression status. Users can also select to use network degree or network betweenness centrality to define the node size. And edges can be black or colored by the correlation. Purple edge means negative correlation (mostly found between miRNA and mRNA), and blue edge means positive correlation (found in PPI or miRNA-miRNA sponge effect). We can also add the protein-protein interactions (PPI) into the network. This result will show the cluster of genes regulated by some specific miRNAs. Additionally, miRNA-miRNA edges can be added by the "miRNA sponge" button, presenting some clusters of miRNAs that have the interactions via sponge effect.
Num | microRNA | Gene | miRNA log2FC | miRNA pvalue | Gene log2FC | Gene pvalue | Interaction | Correlation beta | Correlation P-value | PMID | Reported in cancer studies |
---|---|---|---|---|---|---|---|---|---|---|---|
1 | hsa-let-7a-3p | APC | 0.1 | 0.42376 | -0.55 | 0 | mirMAP | -0.18 | 2.0E-5 | NA | |
2 | hsa-miR-125a-5p | APC | 0.22 | 0.11955 | -0.55 | 0 | miRanda | -0.24 | 0 | NA | |
3 | hsa-miR-135b-5p | APC | 1.56 | 0 | -0.55 | 0 | miRTarBase; MirTarget | -0.1 | 1.0E-5 | 24735923; 18632633; 23328512 | We show that miR-135b overexpression is triggered in mice and humans by APC loss PTEN/PI3K pathway deregulation and SRC overexpression and promotes tumor transformation and progression;Regulation of the adenomatous polyposis coli gene by the miR 135 family in colorectal cancer;Real-time quantitative PCR and Western blot were used to explore the relationship between miR-135b and adenomatous polyposis coli APC; MiR-135b promoted gastric cancer cell proliferation inhibited its apoptosis and directly regulated the expression of APC in gastric cancer cell |
4 | hsa-miR-182-5p | APC | 1.15 | 0 | -0.55 | 0 | MirTarget | -0.11 | 0.00011 | NA | |
5 | hsa-miR-186-5p | APC | 0.35 | 0.00015 | -0.55 | 0 | miRNAWalker2 validate | -0.29 | 0 | NA | |
6 | hsa-miR-193a-3p | APC | 0.22 | 0.11183 | -0.55 | 0 | miRanda | -0.16 | 2.0E-5 | NA | |
7 | hsa-miR-21-5p | APC | 1.62 | 0 | -0.55 | 0 | miRNAWalker2 validate | -0.28 | 0 | 23773491; 24832083 | The prognostic significance of APC gene mutation and miR 21 expression in advanced stage colorectal cancer; The aim of this study was to analyse the association of APC gene mutation and miR-21 expression with clinical outcome in CRC patients; APC gene mutation and expression of APC and miR-21 were analysed by direct DNA sequencing and real-time reverse transcription polymerase chain reaction; APC gene expression was low in CRC and negatively correlated with miR-21 expression and gene mutation; In Taiwan downregulation of the APC gene in CRC correlated with gene mutation and miR-21 upregulation; APC mutation and miR-21 expression could be used to predict the clinical outcome of CRC especially in patients with advanced disease;MicroRNA 21 promotes tumour malignancy via increased nuclear translocation of β catenin and predicts poor outcome in APC mutated but not in APC wild type colorectal cancer; However in our preliminary data the prognostic value of miR-21 levels was observed only in adenomatous polyposis coli APC-mutated tumours not in APC-wild-type tumours; We enrolled 165 colorectal tumour to determine APC mutation miR-21 levels and nuclear β-catenin expression by direct sequencing real-time PCR and immunohistochemistry |
8 | hsa-miR-320a | APC | 0.8 | 0 | -0.55 | 0 | miRanda | -0.17 | 1.0E-5 | NA | |
9 | hsa-miR-338-3p | APC | -0.95 | 0 | -0.55 | 0 | miRanda | -0.16 | 0 | NA | |
10 | hsa-miR-374b-5p | APC | -0.29 | 0.00415 | -0.55 | 0 | mirMAP | -0.26 | 0 | NA | |
11 | hsa-miR-450b-5p | APC | 1.26 | 0 | -0.55 | 0 | miRNATAP | -0.18 | 0 | NA | |
12 | hsa-miR-501-3p | APC | 0.82 | 0 | -0.55 | 0 | TargetScan | -0.24 | 0 | NA | |
13 | hsa-miR-589-3p | APC | 1.6 | 0 | -0.55 | 0 | MirTarget | -0.15 | 0 | NA | |
14 | hsa-miR-655-3p | APC | -1.15 | 0 | -0.55 | 0 | MirTarget | -0.11 | 1.0E-5 | NA | |
15 | hsa-let-7a-5p | APC2 | -0.44 | 3.0E-5 | 1.4 | 0 | TargetScan | -0.38 | 0.00058 | NA | |
16 | hsa-let-7a-3p | AXIN2 | 0.1 | 0.42376 | -0.65 | 0.00118 | miRNATAP | -0.35 | 0 | NA | |
17 | hsa-miR-103a-3p | AXIN2 | 0.56 | 0 | -0.65 | 0.00118 | miRNAWalker2 validate; MirTarget; miRNATAP | -0.33 | 0.00063 | NA | |
18 | hsa-miR-15a-5p | AXIN2 | 0.78 | 0 | -0.65 | 0.00118 | MirTarget; miRNATAP | -0.57 | 0 | 26252081 | The combination of miR-15a and AXIN2 significantly improved the diagnostic accuracy |
19 | hsa-miR-15b-5p | AXIN2 | 0.85 | 0 | -0.65 | 0.00118 | miRTarBase; MirTarget; miRNATAP | -0.35 | 0 | NA | |
20 | hsa-miR-16-2-3p | AXIN2 | 1.16 | 0 | -0.65 | 0.00118 | mirMAP | -0.49 | 0 | NA | |
21 | hsa-miR-16-5p | AXIN2 | 0.52 | 0 | -0.65 | 0.00118 | miRNAWalker2 validate; miRTarBase; MirTarget; miRNATAP | -0.52 | 0 | NA | |
22 | hsa-miR-205-5p | AXIN2 | 1.51 | 0 | -0.65 | 0.00118 | miRNATAP | -0.4 | 0 | NA | |
23 | hsa-miR-221-3p | AXIN2 | 0.41 | 0.00074 | -0.65 | 0.00118 | miRNATAP | -0.38 | 0 | NA | |
24 | hsa-miR-222-3p | AXIN2 | 1.08 | 0 | -0.65 | 0.00118 | miRNATAP | -0.45 | 0 | NA | |
25 | hsa-miR-26b-3p | AXIN2 | 0.42 | 0.00223 | -0.65 | 0.00118 | MirTarget | -0.2 | 0.00225 | NA | |
26 | hsa-miR-29a-5p | AXIN2 | 0.32 | 0.03704 | -0.65 | 0.00118 | MirTarget | -0.26 | 1.0E-5 | NA | |
27 | hsa-miR-34a-5p | AXIN2 | -0.12 | 0.364 | -0.65 | 0.00118 | miRNAWalker2 validate; miRTarBase | -0.18 | 0.00764 | 23624843 | p53 regulates nuclear GSK 3 levels through miR 34 mediated Axin2 suppression in colorectal cancer cells; Exogenous miR-34a decreases Axin2 UTR-reporter activity through multiple binding sites within the 5' and 3' UTR of Axin2; Further RNA transcripts of miR-34 target were correlated with Axin2 in clinical data set of colorectal cancer patients |
28 | hsa-miR-3614-5p | AXIN2 | 0.96 | 3.0E-5 | -0.65 | 0.00118 | MirTarget; miRNATAP | -0.19 | 0 | NA | |
29 | hsa-miR-429 | AXIN2 | 0.56 | 0.00564 | -0.65 | 0.00118 | miRanda | -0.16 | 0.00016 | NA | |
30 | hsa-miR-582-5p | AXIN2 | -0.04 | 0.82183 | -0.65 | 0.00118 | miRNATAP | -0.27 | 0 | NA | |
31 | hsa-miR-590-3p | AXIN2 | 0.22 | 0.09659 | -0.65 | 0.00118 | MirTarget; PITA; miRanda; miRNATAP | -0.27 | 4.0E-5 | NA | |
32 | hsa-miR-944 | AXIN2 | 1.47 | 0 | -0.65 | 0.00118 | MirTarget; PITA; miRNATAP | -0.18 | 2.0E-5 | NA | |
33 | hsa-miR-103a-3p | BTRC | 0.56 | 0 | -0.38 | 0 | MirTarget; miRNATAP | -0.2 | 0 | NA | |
34 | hsa-miR-130b-3p | BTRC | 1.45 | 0 | -0.38 | 0 | mirMAP | -0.14 | 0 | NA | |
35 | hsa-miR-130b-5p | BTRC | 1.77 | 0 | -0.38 | 0 | mirMAP | -0.13 | 0 | NA | |
36 | hsa-miR-15a-5p | BTRC | 0.78 | 0 | -0.38 | 0 | miRNAWalker2 validate; MirTarget; miRNATAP | -0.17 | 0 | NA | |
37 | hsa-miR-15b-5p | BTRC | 0.85 | 0 | -0.38 | 0 | MirTarget; miRNATAP | -0.17 | 0 | NA | |
38 | hsa-miR-16-1-3p | BTRC | 0.96 | 0 | -0.38 | 0 | mirMAP | -0.12 | 0 | NA | |
39 | hsa-miR-16-5p | BTRC | 0.52 | 0 | -0.38 | 0 | miRNAWalker2 validate; MirTarget; miRNATAP | -0.14 | 1.0E-5 | NA | |
40 | hsa-miR-28-5p | BTRC | -0.03 | 0.73305 | -0.38 | 0 | miRanda | -0.23 | 0 | NA | |
41 | hsa-miR-320a | BTRC | 0.8 | 0 | -0.38 | 0 | miRNAWalker2 validate; PITA | -0.14 | 0 | NA | |
42 | hsa-miR-342-3p | BTRC | 1 | 0 | -0.38 | 0 | mirMAP | -0.1 | 0 | NA | |
43 | hsa-miR-3913-5p | BTRC | 0.49 | 0.00112 | -0.38 | 0 | mirMAP | -0.14 | 0 | NA | |
44 | hsa-miR-505-3p | BTRC | 0.91 | 0 | -0.38 | 0 | MirTarget | -0.14 | 0 | NA | |
45 | hsa-miR-92a-3p | BTRC | 0.99 | 0 | -0.38 | 0 | miRNAWalker2 validate | -0.13 | 0 | NA | |
46 | hsa-miR-93-3p | BTRC | 1.69 | 0 | -0.38 | 0 | mirMAP | -0.12 | 0 | NA | |
47 | hsa-miR-10a-5p | CAMK2A | -0.32 | 0.14809 | -1.03 | 0.00875 | mirMAP | -0.25 | 0.00169 | NA | |
48 | hsa-miR-129-5p | CAMK2A | -0.25 | 0.43645 | -1.03 | 0.00875 | MirTarget; miRanda | -0.14 | 0.00933 | NA | |
49 | hsa-miR-130b-5p | CAMK2A | 1.77 | 0 | -1.03 | 0.00875 | mirMAP | -0.72 | 0 | NA | |
50 | hsa-miR-138-5p | CAMK2A | 0.7 | 0.00825 | -1.03 | 0.00875 | MirTarget | -0.33 | 0 | NA | |
51 | hsa-miR-148a-3p | CAMK2A | -0.43 | 0.00954 | -1.03 | 0.00875 | miRNATAP | -0.66 | 0 | NA | |
52 | hsa-miR-148b-5p | CAMK2A | 1.15 | 0 | -1.03 | 0.00875 | mirMAP | -0.36 | 0.00066 | NA | |
53 | hsa-miR-15b-3p | CAMK2A | 1.05 | 0 | -1.03 | 0.00875 | mirMAP | -0.95 | 0 | NA | |
54 | hsa-miR-19b-1-5p | CAMK2A | 0.76 | 0 | -1.03 | 0.00875 | mirMAP | -0.69 | 0 | NA | |
55 | hsa-miR-205-5p | CAMK2A | 1.51 | 0 | -1.03 | 0.00875 | mirMAP | -0.5 | 0 | NA | |
56 | hsa-miR-25-3p | CAMK2A | 0.77 | 0 | -1.03 | 0.00875 | MirTarget | -0.91 | 0 | NA | |
57 | hsa-miR-27b-3p | CAMK2A | -0.73 | 0 | -1.03 | 0.00875 | mirMAP; miRNATAP | -0.48 | 0.00049 | NA | |
58 | hsa-miR-30d-5p | CAMK2A | -0.38 | 0.00017 | -1.03 | 0.00875 | mirMAP | -0.68 | 5.0E-5 | NA | |
59 | hsa-miR-30e-5p | CAMK2A | -1.02 | 0 | -1.03 | 0.00875 | mirMAP | -0.55 | 6.0E-5 | NA | |
60 | hsa-miR-32-5p | CAMK2A | -0.32 | 0.01025 | -1.03 | 0.00875 | MirTarget | -0.4 | 0.00436 | NA | |
61 | hsa-miR-331-3p | CAMK2A | 0.91 | 0 | -1.03 | 0.00875 | MirTarget | -0.45 | 0.00029 | NA | |
62 | hsa-miR-363-3p | CAMK2A | -0.61 | 0.01861 | -1.03 | 0.00875 | MirTarget | -0.38 | 0 | NA | |
63 | hsa-miR-429 | CAMK2A | 0.56 | 0.00564 | -1.03 | 0.00875 | miRNATAP | -0.83 | 0 | NA | |
64 | hsa-miR-582-3p | CAMK2A | -0.25 | 0.1438 | -1.03 | 0.00875 | mirMAP | -0.4 | 7.0E-5 | NA | |
65 | hsa-miR-7-1-3p | CAMK2A | 1.14 | 0 | -1.03 | 0.00875 | MirTarget | -0.62 | 0 | NA | |
66 | hsa-miR-92a-3p | CAMK2A | 0.99 | 0 | -1.03 | 0.00875 | MirTarget | -1.07 | 0 | NA | |
67 | hsa-miR-92b-3p | CAMK2A | 0.87 | 0 | -1.03 | 0.00875 | MirTarget | -0.83 | 0 | NA | |
68 | hsa-miR-939-5p | CAMK2A | 1 | 0 | -1.03 | 0.00875 | MirTarget | -0.35 | 0.001 | NA | |
69 | hsa-miR-182-5p | CAMK2B | 1.15 | 0 | -2.54 | 0 | mirMAP | -0.4 | 0 | NA | |
70 | hsa-miR-18a-5p | CAMK2B | 1.65 | 0 | -2.54 | 0 | mirMAP | -0.33 | 0.00019 | NA | |
71 | hsa-miR-193b-3p | CAMK2B | 1.73 | 0 | -2.54 | 0 | mirMAP | -0.31 | 0.00032 | NA | |
72 | hsa-miR-205-5p | CAMK2B | 1.51 | 0 | -2.54 | 0 | mirMAP | -0.62 | 0 | NA | |
73 | hsa-miR-2355-5p | CAMK2B | 1.47 | 0 | -2.54 | 0 | mirMAP | -0.38 | 9.0E-5 | NA | |
74 | hsa-miR-589-3p | CAMK2B | 1.6 | 0 | -2.54 | 0 | MirTarget | -0.4 | 0 | NA | |
75 | hsa-miR-940 | CAMK2B | 1.25 | 0 | -2.54 | 0 | PITA; miRNATAP | -0.28 | 0.00105 | NA | |
76 | hsa-miR-96-5p | CAMK2B | 1.42 | 0 | -2.54 | 0 | mirMAP | -0.42 | 0 | NA | |
77 | hsa-miR-17-3p | CAMK2D | -0.01 | 0.90956 | -0.03 | 0.80371 | miRNATAP | -0.13 | 0.00291 | NA | |
78 | hsa-miR-200b-3p | CAMK2D | 0.07 | 0.68286 | -0.03 | 0.80371 | TargetScan; mirMAP | -0.11 | 5.0E-5 | NA | |
79 | hsa-miR-28-5p | CAMK2D | -0.03 | 0.73305 | -0.03 | 0.80371 | miRanda | -0.26 | 4.0E-5 | NA | |
80 | hsa-miR-29b-2-5p | CAMK2D | -0.5 | 0.00073 | -0.03 | 0.80371 | mirMAP | -0.15 | 0 | NA | |
81 | hsa-miR-30b-5p | CAMK2D | -0.4 | 0.00347 | -0.03 | 0.80371 | miRNATAP | -0.15 | 2.0E-5 | NA | |
82 | hsa-miR-30c-5p | CAMK2D | 0.02 | 0.88637 | -0.03 | 0.80371 | miRNATAP | -0.14 | 2.0E-5 | NA | |
83 | hsa-miR-30d-5p | CAMK2D | -0.38 | 0.00017 | -0.03 | 0.80371 | miRNATAP | -0.17 | 0.00024 | NA | |
84 | hsa-miR-30e-5p | CAMK2D | -1.02 | 0 | -0.03 | 0.80371 | miRNATAP | -0.16 | 2.0E-5 | NA | |
85 | hsa-miR-320a | CAMK2D | 0.8 | 0 | -0.03 | 0.80371 | miRanda | -0.13 | 0.00012 | NA | |
86 | hsa-miR-342-3p | CAMK2D | 1 | 0 | -0.03 | 0.80371 | miRanda | -0.15 | 0 | NA | |
87 | hsa-miR-374a-3p | CAMK2D | -0.3 | 0.00683 | -0.03 | 0.80371 | miRNATAP | -0.18 | 6.0E-5 | NA | |
88 | hsa-miR-582-5p | CAMK2D | -0.04 | 0.82183 | -0.03 | 0.80371 | mirMAP | -0.2 | 0 | NA | |
89 | hsa-miR-590-3p | CAMK2D | 0.22 | 0.09659 | -0.03 | 0.80371 | miRanda; mirMAP | -0.12 | 0.00056 | NA | |
90 | hsa-miR-7-1-3p | CAMK2D | 1.14 | 0 | -0.03 | 0.80371 | mirMAP | -0.15 | 0 | NA | |
91 | hsa-miR-181a-5p | CAMK2G | 0.82 | 0 | -0.24 | 0.0014 | miRNATAP | -0.11 | 0.00031 | NA | |
92 | hsa-miR-181b-5p | CAMK2G | 0.97 | 0 | -0.24 | 0.0014 | miRNATAP | -0.1 | 0.00014 | NA | |
93 | hsa-let-7g-5p | CCND1 | -0.25 | 0.0094 | -0.01 | 0.95947 | miRNATAP | -0.42 | 1.0E-5 | NA | |
94 | hsa-miR-106a-5p | CCND1 | 0.68 | 0.00222 | -0.01 | 0.95947 | MirTarget; miRNATAP | -0.29 | 0 | NA | |
95 | hsa-miR-1266-5p | CCND1 | -0.6 | 0.02013 | -0.01 | 0.95947 | MirTarget | -0.14 | 0.00019 | NA | |
96 | hsa-miR-142-3p | CCND1 | 1.13 | 0 | -0.01 | 0.95947 | miRanda | -0.21 | 0 | 23619912 | Transfection of miR-142-3p mimics in colon cancer cells downregulated cyclin D1 expression induced G1 phase cell cycle arrest and elevated the sensitivity of the cells to 5-fluorouracil |
97 | hsa-miR-142-5p | CCND1 | 0.29 | 0.09 | -0.01 | 0.95947 | PITA | -0.19 | 0.00053 | NA | |
98 | hsa-miR-150-5p | CCND1 | -0.24 | 0.33155 | -0.01 | 0.95947 | mirMAP | -0.18 | 0 | NA | |
99 | hsa-miR-155-5p | CCND1 | 0.53 | 0.00249 | -0.01 | 0.95947 | miRNAWalker2 validate | -0.21 | 0.0001 | 26955820 | MicroRNA 155 expression inversely correlates with pathologic stage of gastric cancer and it inhibits gastric cancer cell growth by targeting cyclin D1 |
100 | hsa-miR-15a-5p | CCND1 | 0.78 | 0 | -0.01 | 0.95947 | miRNAWalker2 validate; miRTarBase; MirTarget; miRNATAP | -0.32 | 5.0E-5 | 22922827 | CCND1 has been found to be a target of miR-15a and miR-16-1 through analysis of complementary sequences between microRNAs and CCND1 mRNA; Moreover the transcription of CCND1 is suppressed by miR-15a and miR-16-1 via direct binding to the CCND1 3'-untranslated region 3'-UTR |
101 | hsa-miR-15b-5p | CCND1 | 0.85 | 0 | -0.01 | 0.95947 | miRNAWalker2 validate; miRTarBase; MirTarget; miRNATAP | -0.2 | 0.00913 | NA | |
102 | hsa-miR-16-1-3p | CCND1 | 0.96 | 0 | -0.01 | 0.95947 | miRNAWalker2 validate; miRTarBase | -0.3 | 0 | 22922827; 18483394 | CCND1 has been found to be a target of miR-15a and miR-16-1 through analysis of complementary sequences between microRNAs and CCND1 mRNA; Moreover the transcription of CCND1 is suppressed by miR-15a and miR-16-1 via direct binding to the CCND1 3'-untranslated region 3'-UTR;Truncation in CCND1 mRNA alters miR 16 1 regulation in mantle cell lymphoma; Furthermore we demonstrated that this truncation alters miR-16-1 binding sites and through the use of reporter constructs we were able to show that miR-16-1 regulates CCND1 mRNA expression; This study introduces the role of miR-16-1 in the regulation of CCND1 in MCL |
103 | hsa-miR-16-5p | CCND1 | 0.52 | 0 | -0.01 | 0.95947 | miRNAWalker2 validate; miRTarBase; MirTarget; miRNATAP | -0.36 | 3.0E-5 | 23991964; 22922827; 18483394 | At the molecular level our results further revealed that cyclin D1 expression was negatively regulated by miR-16;CCND1 has been found to be a target of miR-15a and miR-16-1 through analysis of complementary sequences between microRNAs and CCND1 mRNA; Moreover the transcription of CCND1 is suppressed by miR-15a and miR-16-1 via direct binding to the CCND1 3'-untranslated region 3'-UTR;Truncation in CCND1 mRNA alters miR 16 1 regulation in mantle cell lymphoma; Furthermore we demonstrated that this truncation alters miR-16-1 binding sites and through the use of reporter constructs we were able to show that miR-16-1 regulates CCND1 mRNA expression; This study introduces the role of miR-16-1 in the regulation of CCND1 in MCL |
104 | hsa-miR-19a-3p | CCND1 | 1.36 | 0 | -0.01 | 0.95947 | miRNAWalker2 validate; miRTarBase; miRNATAP | -0.13 | 0.00806 | 25985117 | Moreover miR-19a might play inhibitory roles in HCC malignancy via regulating Cyclin D1 expression |
105 | hsa-miR-19b-1-5p | CCND1 | 0.76 | 0 | -0.01 | 0.95947 | miRNAWalker2 validate; miRTarBase | -0.2 | 0.00133 | NA | |
106 | hsa-miR-19b-3p | CCND1 | 0.54 | 0.00062 | -0.01 | 0.95947 | miRNATAP | -0.23 | 0.0001 | NA | |
107 | hsa-miR-20a-5p | CCND1 | 1.15 | 0 | -0.01 | 0.95947 | miRNAWalker2 validate; miRTarBase; MirTarget; miRNATAP | -0.15 | 0.0057 | NA | |
108 | hsa-miR-20b-5p | CCND1 | 0.35 | 0.23201 | -0.01 | 0.95947 | MirTarget; miRNATAP | -0.25 | 0 | NA | |
109 | hsa-miR-29b-3p | CCND1 | -0.11 | 0.51126 | -0.01 | 0.95947 | mirMAP | -0.18 | 0.00109 | NA | |
110 | hsa-miR-29c-3p | CCND1 | -2.08 | 0 | -0.01 | 0.95947 | mirMAP | -0.16 | 0.00015 | NA | |
111 | hsa-miR-33a-3p | CCND1 | 0.2 | 0.21234 | -0.01 | 0.95947 | MirTarget | -0.2 | 0.00047 | NA | |
112 | hsa-miR-34a-5p | CCND1 | -0.12 | 0.364 | -0.01 | 0.95947 | miRNAWalker2 validate; miRTarBase; miRNATAP | -0.31 | 2.0E-5 | 25792709; 21399894 | This inhibition of proliferation was associated with a decrease in cyclin D1 levels orchestrated principally by HNF-4α a target of miR-34a considered to act as a tumour suppressor in the liver;Quantitative PCR and western analysis confirmed decreased expression of two genes BCL-2 and CCND1 in docetaxel-resistant cells which are both targeted by miR-34a |
113 | hsa-miR-425-5p | CCND1 | 0.93 | 0 | -0.01 | 0.95947 | miRNAWalker2 validate | -0.15 | 0.00573 | NA | |
114 | hsa-miR-497-5p | CCND1 | -0.97 | 0 | -0.01 | 0.95947 | MirTarget; miRNATAP | -0.27 | 5.0E-5 | 21350001 | Raf-1 and Ccnd1 were identified as novel direct targets of miR-195 and miR-497 miR-195/497 expression levels in clinical specimens were found to be correlated inversely with malignancy of breast cancer |
115 | hsa-miR-590-3p | CCND1 | 0.22 | 0.09659 | -0.01 | 0.95947 | mirMAP | -0.24 | 0.00077 | NA | |
116 | hsa-miR-7-1-3p | CCND1 | 1.14 | 0 | -0.01 | 0.95947 | mirMAP | -0.22 | 0.00036 | NA | |
117 | hsa-miR-9-5p | CCND1 | 1.66 | 2.0E-5 | -0.01 | 0.95947 | miRNAWalker2 validate | -0.14 | 0 | NA | |
118 | hsa-miR-92a-3p | CCND1 | 0.99 | 0 | -0.01 | 0.95947 | miRNAWalker2 validate | -0.24 | 0.002 | NA | |
119 | hsa-miR-942-5p | CCND1 | 0.68 | 0 | -0.01 | 0.95947 | MirTarget | -0.23 | 0.00111 | NA | |
120 | hsa-miR-224-3p | CCND2 | 0.5 | 0.00811 | 0.15 | 0.53242 | mirMAP | -0.31 | 0 | NA | |
121 | hsa-miR-27b-3p | CCND3 | -0.73 | 0 | -0.05 | 0.63156 | miRNAWalker2 validate | -0.13 | 0.00016 | NA | |
122 | hsa-miR-140-5p | CHD8 | -0.41 | 0.00014 | 0.1 | 0.23186 | miRanda | -0.11 | 0.00071 | NA | |
123 | hsa-let-7a-3p | CREBBP | 0.1 | 0.42376 | 0.02 | 0.83362 | miRNATAP | -0.14 | 9.0E-5 | NA | |
124 | hsa-miR-186-5p | CREBBP | 0.35 | 0.00015 | 0.02 | 0.83362 | mirMAP; miRNATAP | -0.27 | 0 | NA | |
125 | hsa-miR-26b-5p | CREBBP | -0.25 | 0.02852 | 0.02 | 0.83362 | miRNATAP | -0.21 | 0 | NA | |
126 | hsa-miR-30d-3p | CREBBP | -0.58 | 0 | 0.02 | 0.83362 | MirTarget; miRNATAP | -0.13 | 0.00047 | NA | |
127 | hsa-miR-590-3p | CREBBP | 0.22 | 0.09659 | 0.02 | 0.83362 | PITA; miRanda; mirMAP; miRNATAP | -0.1 | 0.00208 | NA | |
128 | hsa-miR-130b-5p | CSNK1A1 | 1.77 | 0 | -0.07 | 0.47768 | mirMAP | -0.2 | 0 | NA | |
129 | hsa-miR-186-5p | CSNK1A1 | 0.35 | 0.00015 | -0.07 | 0.47768 | miRNAWalker2 validate; miRNATAP | -0.13 | 0.00354 | NA | |
130 | hsa-miR-30a-5p | CSNK1A1 | -1.8 | 0 | -0.07 | 0.47768 | MirTarget; miRNATAP | -0.15 | 0 | NA | |
131 | hsa-miR-30b-5p | CSNK1A1 | -0.4 | 0.00347 | -0.07 | 0.47768 | MirTarget; mirMAP; miRNATAP | -0.15 | 0 | NA | |
132 | hsa-miR-30c-5p | CSNK1A1 | 0.02 | 0.88637 | -0.07 | 0.47768 | MirTarget; mirMAP; miRNATAP | -0.11 | 5.0E-5 | NA | |
133 | hsa-miR-30d-5p | CSNK1A1 | -0.38 | 0.00017 | -0.07 | 0.47768 | MirTarget; miRNATAP | -0.16 | 7.0E-5 | NA | |
134 | hsa-miR-30e-5p | CSNK1A1 | -1.02 | 0 | -0.07 | 0.47768 | MirTarget | -0.1 | 0.00229 | NA | |
135 | hsa-miR-320a | CSNK1A1 | 0.8 | 0 | -0.07 | 0.47768 | mirMAP | -0.18 | 0 | NA | |
136 | hsa-miR-320b | CSNK1A1 | 1.23 | 0 | -0.07 | 0.47768 | mirMAP | -0.13 | 0 | NA | |
137 | hsa-miR-324-3p | CSNK1A1 | 0.87 | 0 | -0.07 | 0.47768 | miRNAWalker2 validate | -0.11 | 0.00024 | NA | |
138 | hsa-miR-335-3p | CSNK1A1 | 0.34 | 0.05424 | -0.07 | 0.47768 | mirMAP | -0.19 | 0 | NA | |
139 | hsa-miR-340-5p | CSNK1A1 | -0.61 | 4.0E-5 | -0.07 | 0.47768 | mirMAP | -0.15 | 0 | NA | |
140 | hsa-miR-491-5p | CSNK1A1 | -0.54 | 0.00136 | -0.07 | 0.47768 | miRanda | -0.12 | 0 | NA | |
141 | hsa-miR-501-3p | CSNK1A1 | 0.82 | 0 | -0.07 | 0.47768 | TargetScan; miRNATAP | -0.12 | 3.0E-5 | NA | |
142 | hsa-miR-502-3p | CSNK1A1 | -0.17 | 0.10688 | -0.07 | 0.47768 | miRNATAP | -0.12 | 0.00325 | NA | |
143 | hsa-miR-664a-3p | CSNK1A1 | -0.26 | 0.05132 | -0.07 | 0.47768 | mirMAP | -0.19 | 0 | NA | |
144 | hsa-miR-664a-5p | CSNK1A1 | -0.87 | 0 | -0.07 | 0.47768 | MirTarget | -0.19 | 0 | NA | |
145 | hsa-miR-9-5p | CSNK1A1 | 1.66 | 2.0E-5 | -0.07 | 0.47768 | miRNATAP | -0.1 | 0 | NA | |
146 | hsa-miR-28-3p | CSNK1A1L | 0.46 | 0 | -0.21 | 0.11447 | PITA | -0.3 | 0 | NA | |
147 | hsa-miR-491-5p | CSNK1A1L | -0.54 | 0.00136 | -0.21 | 0.11447 | PITA; miRanda | -0.11 | 0.00301 | NA | |
148 | hsa-miR-590-3p | CSNK1A1L | 0.22 | 0.09659 | -0.21 | 0.11447 | mirMAP | -0.12 | 0.00543 | NA | |
149 | hsa-miR-148a-5p | CSNK1E | -1 | 0 | 0.55 | 0 | miRNATAP | -0.12 | 0 | NA | |
150 | hsa-miR-126-5p | CSNK2A2 | -0.95 | 0 | 0.12 | 0.11406 | mirMAP | -0.1 | 8.0E-5 | NA |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | WNT SIGNALING PATHWAY | 69 | 351 | 4.995e-96 | 2.324e-92 |
2 | CANONICAL WNT SIGNALING PATHWAY | 35 | 95 | 5.843e-57 | 1.359e-53 |
3 | NON CANONICAL WNT SIGNALING PATHWAY | 34 | 140 | 4.477e-48 | 6.944e-45 |
4 | REGULATION OF WNT SIGNALING PATHWAY | 41 | 310 | 1.168e-46 | 1.358e-43 |
5 | NEGATIVE REGULATION OF WNT SIGNALING PATHWAY | 31 | 197 | 2.265e-37 | 2.108e-34 |
6 | REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS | 51 | 1021 | 2.759e-37 | 2.14e-34 |
7 | REGULATION OF CANONICAL WNT SIGNALING PATHWAY | 32 | 236 | 2.013e-36 | 1.338e-33 |
8 | REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT | 56 | 1672 | 3.022e-32 | 1.758e-29 |
9 | POSITIVE REGULATION OF RESPONSE TO STIMULUS | 59 | 1929 | 3.604e-32 | 1.864e-29 |
10 | POSITIVE REGULATION OF GENE EXPRESSION | 55 | 1733 | 2.308e-30 | 9.761e-28 |
11 | POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS | 52 | 1492 | 2.205e-30 | 9.761e-28 |
12 | NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY | 25 | 162 | 7.169e-30 | 2.78e-27 |
13 | REGULATION OF ORGAN MORPHOGENESIS | 28 | 242 | 8.245e-30 | 2.951e-27 |
14 | EPITHELIUM DEVELOPMENT | 42 | 945 | 4.895e-28 | 1.627e-25 |
15 | TISSUE DEVELOPMENT | 50 | 1518 | 6.726e-28 | 2.086e-25 |
16 | POSITIVE REGULATION OF CELL COMMUNICATION | 50 | 1532 | 1.028e-27 | 2.99e-25 |
17 | MORPHOGENESIS OF AN EPITHELIUM | 31 | 400 | 1.334e-27 | 3.651e-25 |
18 | TISSUE MORPHOGENESIS | 34 | 533 | 1.611e-27 | 4.164e-25 |
19 | WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY | 16 | 39 | 4.757e-27 | 1.165e-24 |
20 | REGULATION OF PROTEIN MODIFICATION PROCESS | 51 | 1710 | 1.611e-26 | 3.747e-24 |
21 | REGULATION OF CELL DIFFERENTIATION | 48 | 1492 | 3.562e-26 | 7.893e-24 |
22 | REGULATION OF ESTABLISHMENT OF PLANAR POLARITY | 20 | 110 | 1.693e-25 | 3.58e-23 |
23 | NEGATIVE REGULATION OF CELL COMMUNICATION | 43 | 1192 | 4.129e-25 | 8.354e-23 |
24 | TUBE MORPHOGENESIS | 27 | 323 | 6.905e-25 | 1.339e-22 |
25 | NEGATIVE REGULATION OF RESPONSE TO STIMULUS | 45 | 1360 | 7.632e-25 | 1.42e-22 |
26 | REGULATION OF PHOSPHORUS METABOLIC PROCESS | 48 | 1618 | 1.25e-24 | 2.237e-22 |
27 | TUBE DEVELOPMENT | 32 | 552 | 1.452e-24 | 2.503e-22 |
28 | POSITIVE REGULATION OF BIOSYNTHETIC PROCESS | 50 | 1805 | 1.845e-24 | 3.066e-22 |
29 | ORGAN MORPHOGENESIS | 37 | 841 | 2.508e-24 | 4.024e-22 |
30 | POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS | 41 | 1135 | 7.314e-24 | 1.134e-21 |
31 | CARDIOVASCULAR SYSTEM DEVELOPMENT | 35 | 788 | 4.376e-23 | 6.362e-21 |
32 | CIRCULATORY SYSTEM DEVELOPMENT | 35 | 788 | 4.376e-23 | 6.362e-21 |
33 | POSITIVE REGULATION OF DEVELOPMENTAL PROCESS | 40 | 1142 | 9.673e-23 | 1.364e-20 |
34 | NEURON DIFFERENTIATION | 36 | 874 | 1.137e-22 | 1.556e-20 |
35 | POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS | 38 | 1036 | 3.171e-22 | 4.098e-20 |
36 | POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS | 38 | 1036 | 3.171e-22 | 4.098e-20 |
37 | POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS | 42 | 1395 | 1.849e-21 | 2.326e-19 |
38 | POSITIVE REGULATION OF CELL DIFFERENTIATION | 34 | 823 | 2.124e-21 | 2.601e-19 |
39 | NEUROGENESIS | 42 | 1402 | 2.235e-21 | 2.667e-19 |
40 | EMBRYONIC MORPHOGENESIS | 29 | 539 | 2.528e-21 | 2.94e-19 |
41 | EMBRYO DEVELOPMENT | 35 | 894 | 2.701e-21 | 3.065e-19 |
42 | EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING | 29 | 554 | 5.4e-21 | 5.983e-19 |
43 | POSITIVE REGULATION OF MOLECULAR FUNCTION | 46 | 1791 | 6.86e-21 | 7.423e-19 |
44 | CELL FATE COMMITMENT | 21 | 227 | 2.351e-20 | 2.486e-18 |
45 | REGULATION OF EMBRYONIC DEVELOPMENT | 17 | 114 | 3.116e-20 | 3.222e-18 |
46 | BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY | 11 | 22 | 4.07e-20 | 4.116e-18 |
47 | PATTERN SPECIFICATION PROCESS | 25 | 418 | 1.708e-19 | 1.691e-17 |
48 | ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS | 34 | 957 | 2.408e-19 | 2.334e-17 |
49 | REGULATION OF CELLULAR PROTEIN LOCALIZATION | 27 | 552 | 8.629e-19 | 8.194e-17 |
50 | POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION | 36 | 1152 | 1.03e-18 | 9.583e-17 |
51 | REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 42 | 1656 | 1.123e-18 | 1.024e-16 |
52 | HEART DEVELOPMENT | 25 | 466 | 2.303e-18 | 2.06e-16 |
53 | REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION | 22 | 337 | 5.16e-18 | 4.53e-16 |
54 | INTRACELLULAR SIGNAL TRANSDUCTION | 40 | 1572 | 9.271e-18 | 7.843e-16 |
55 | CELLULAR RESPONSE TO ORGANIC SUBSTANCE | 43 | 1848 | 9.164e-18 | 7.843e-16 |
56 | CELL PROLIFERATION | 28 | 672 | 1.163e-17 | 9.66e-16 |
57 | REGULATION OF CELL CYCLE | 32 | 949 | 1.625e-17 | 1.303e-15 |
58 | REGIONALIZATION | 21 | 311 | 1.605e-17 | 1.303e-15 |
59 | MORPHOGENESIS OF EMBRYONIC EPITHELIUM | 16 | 134 | 1.704e-17 | 1.344e-15 |
60 | CELL DEVELOPMENT | 38 | 1426 | 1.785e-17 | 1.384e-15 |
61 | REGULATION OF CELLULAR RESPONSE TO STRESS | 28 | 691 | 2.393e-17 | 1.825e-15 |
62 | REGULATION OF BINDING | 20 | 283 | 4.192e-17 | 3.146e-15 |
63 | REGULATION OF RESPONSE TO STRESS | 38 | 1468 | 4.688e-17 | 3.462e-15 |
64 | REGULATION OF CELL DEATH | 38 | 1472 | 5.131e-17 | 3.73e-15 |
65 | SENSORY ORGAN DEVELOPMENT | 24 | 493 | 1.097e-16 | 7.855e-15 |
66 | NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS | 29 | 801 | 1.147e-16 | 8.084e-15 |
67 | REGULATION OF CELL MORPHOGENESIS | 25 | 552 | 1.245e-16 | 8.649e-15 |
68 | POSITIVE REGULATION OF WNT SIGNALING PATHWAY | 16 | 152 | 1.328e-16 | 9.09e-15 |
69 | POSITIVE REGULATION OF CATALYTIC ACTIVITY | 38 | 1518 | 1.42e-16 | 9.573e-15 |
70 | REGULATION OF PROTEIN LOCALIZATION | 31 | 950 | 1.464e-16 | 9.734e-15 |
71 | CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION | 24 | 513 | 2.686e-16 | 1.761e-14 |
72 | ANTERIOR POSTERIOR PATTERN SPECIFICATION | 17 | 194 | 3.174e-16 | 2.051e-14 |
73 | REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY | 21 | 365 | 4.104e-16 | 2.616e-14 |
74 | POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 31 | 1004 | 6.78e-16 | 4.263e-14 |
75 | REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 40 | 1784 | 7.31e-16 | 4.535e-14 |
76 | STEM CELL DIFFERENTIATION | 16 | 190 | 4.74e-15 | 2.902e-13 |
77 | NEGATIVE REGULATION OF NITROGEN COMPOUND METABOLIC PROCESS | 36 | 1517 | 6.165e-15 | 3.725e-13 |
78 | REGULATION OF JNK CASCADE | 15 | 159 | 6.58e-15 | 3.925e-13 |
79 | EPITHELIAL TO MESENCHYMAL TRANSITION | 11 | 56 | 7.393e-15 | 4.354e-13 |
80 | TUBE FORMATION | 14 | 129 | 7.682e-15 | 4.468e-13 |
81 | PROTEIN PHOSPHORYLATION | 29 | 944 | 8.289e-15 | 4.761e-13 |
82 | REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE | 16 | 197 | 8.4e-15 | 4.767e-13 |
83 | REGULATION OF TRANSFERASE ACTIVITY | 29 | 946 | 8.752e-15 | 4.907e-13 |
84 | POSITIVE REGULATION OF CELL DEATH | 24 | 605 | 1.051e-14 | 5.824e-13 |
85 | REGULATION OF CELLULAR LOCALIZATION | 33 | 1277 | 1.065e-14 | 5.831e-13 |
86 | NEGATIVE REGULATION OF GENE EXPRESSION | 35 | 1493 | 2.402e-14 | 1.3e-12 |
87 | REGULATION OF CELL DEVELOPMENT | 27 | 836 | 2.56e-14 | 1.354e-12 |
88 | REGULATION OF CELL PROLIFERATION | 35 | 1496 | 2.55e-14 | 1.354e-12 |
89 | EMBRYONIC ORGAN DEVELOPMENT | 20 | 406 | 4.212e-14 | 2.202e-12 |
90 | CELLULAR RESPONSE TO RETINOIC ACID | 11 | 65 | 4.271e-14 | 2.208e-12 |
91 | NEURAL TUBE DEVELOPMENT | 14 | 149 | 5.86e-14 | 2.996e-12 |
92 | DORSAL VENTRAL AXIS SPECIFICATION | 8 | 20 | 6.142e-14 | 3.106e-12 |
93 | POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY | 13 | 119 | 6.784e-14 | 3.394e-12 |
94 | REGULATION OF MAPK CASCADE | 24 | 660 | 7.043e-14 | 3.486e-12 |
95 | RESPONSE TO GROWTH FACTOR | 21 | 475 | 7.51e-14 | 3.679e-12 |
96 | POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 27 | 876 | 7.854e-14 | 3.807e-12 |
97 | MESENCHYME DEVELOPMENT | 15 | 190 | 9.325e-14 | 4.473e-12 |
98 | NEURAL TUBE FORMATION | 12 | 94 | 9.682e-14 | 4.597e-12 |
99 | RESPONSE TO OXYGEN CONTAINING COMPOUND | 33 | 1381 | 9.783e-14 | 4.598e-12 |
100 | IMMUNE RESPONSE REGULATING CELL SURFACE RECEPTOR SIGNALING PATHWAY | 18 | 323 | 1.103e-13 | 5.13e-12 |
101 | REGULATION OF INTRACELLULAR PROTEIN TRANSPORT | 19 | 381 | 1.568e-13 | 7.223e-12 |
102 | NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS | 28 | 983 | 1.716e-13 | 7.826e-12 |
103 | POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION | 14 | 162 | 1.881e-13 | 8.498e-12 |
104 | CELL ACTIVATION | 22 | 568 | 2.568e-13 | 1.149e-11 |
105 | REGULATION OF KINASE ACTIVITY | 25 | 776 | 2.938e-13 | 1.302e-11 |
106 | REGULATION OF ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE | 7 | 14 | 3.421e-13 | 1.488e-11 |
107 | CONVERGENT EXTENSION | 7 | 14 | 3.421e-13 | 1.488e-11 |
108 | SOMITE DEVELOPMENT | 11 | 78 | 3.505e-13 | 1.51e-11 |
109 | CELLULAR RESPONSE TO LIPID | 20 | 457 | 3.821e-13 | 1.631e-11 |
110 | NEGATIVE REGULATION OF CELL DEATH | 26 | 872 | 5.323e-13 | 2.252e-11 |
111 | CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND | 25 | 799 | 5.614e-13 | 2.353e-11 |
112 | VASCULATURE DEVELOPMENT | 20 | 469 | 6.166e-13 | 2.562e-11 |
113 | REGULATION OF PROTEIN TARGETING | 17 | 307 | 6.267e-13 | 2.58e-11 |
114 | REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY | 20 | 470 | 6.413e-13 | 2.618e-11 |
115 | FC EPSILON RECEPTOR SIGNALING PATHWAY | 13 | 142 | 6.833e-13 | 2.765e-11 |
116 | REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT | 15 | 220 | 7.987e-13 | 3.204e-11 |
117 | RESPONSE TO LIPID | 26 | 888 | 8.058e-13 | 3.205e-11 |
118 | RESPONSE TO TRANSFORMING GROWTH FACTOR BETA | 13 | 144 | 8.19e-13 | 3.23e-11 |
119 | REGULATION OF STEM CELL DIFFERENTIATION | 12 | 113 | 9.214e-13 | 3.603e-11 |
120 | REGULATION OF CYTOPLASMIC TRANSPORT | 20 | 481 | 9.816e-13 | 3.806e-11 |
121 | CELL CYCLE | 31 | 1316 | 9.911e-13 | 3.811e-11 |
122 | NEGATIVE REGULATION OF CELL DIFFERENTIATION | 22 | 609 | 1.032e-12 | 3.934e-11 |
123 | SOMITOGENESIS | 10 | 62 | 1.066e-12 | 4.033e-11 |
124 | CELLULAR COMPONENT MORPHOGENESIS | 26 | 900 | 1.093e-12 | 4.103e-11 |
125 | DOPAMINERGIC NEURON DIFFERENTIATION | 8 | 28 | 1.463e-12 | 5.446e-11 |
126 | SEGMENTATION | 11 | 89 | 1.567e-12 | 5.788e-11 |
127 | NEGATIVE REGULATION OF MOLECULAR FUNCTION | 28 | 1079 | 1.644e-12 | 6.023e-11 |
128 | CELL CYCLE PROCESS | 28 | 1081 | 1.719e-12 | 6.248e-11 |
129 | AXIS SPECIFICATION | 11 | 90 | 1.778e-12 | 6.412e-11 |
130 | EMBRYONIC ORGAN MORPHOGENESIS | 16 | 279 | 1.862e-12 | 6.663e-11 |
131 | REGULATION OF CELLULAR COMPONENT MOVEMENT | 24 | 771 | 1.979e-12 | 7.029e-11 |
132 | GASTRULATION | 13 | 155 | 2.116e-12 | 7.46e-11 |
133 | REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION | 10 | 67 | 2.405e-12 | 8.415e-11 |
134 | SENSORY ORGAN MORPHOGENESIS | 15 | 239 | 2.65e-12 | 9.203e-11 |
135 | DIGESTIVE TRACT MORPHOGENESIS | 9 | 48 | 3.593e-12 | 1.238e-10 |
136 | RHYTHMIC PROCESS | 16 | 298 | 5.062e-12 | 1.732e-10 |
137 | POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS | 18 | 406 | 5.241e-12 | 1.78e-10 |
138 | MORPHOGENESIS OF A BRANCHING STRUCTURE | 13 | 167 | 5.499e-12 | 1.854e-10 |
139 | REPRODUCTIVE SYSTEM DEVELOPMENT | 18 | 408 | 5.688e-12 | 1.904e-10 |
140 | REGULATION OF PROTEIN BINDING | 13 | 168 | 5.934e-12 | 1.967e-10 |
141 | REGULATION OF TRANSPORT | 35 | 1804 | 5.959e-12 | 1.967e-10 |
142 | PHOSPHORYLATION | 29 | 1228 | 6.11e-12 | 2.002e-10 |
143 | NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 23 | 740 | 6.369e-12 | 2.072e-10 |
144 | POSITIVE REGULATION OF CELL DEVELOPMENT | 19 | 472 | 6.81e-12 | 2.201e-10 |
145 | REGULATION OF HYDROLASE ACTIVITY | 30 | 1327 | 7.179e-12 | 2.288e-10 |
146 | MESENCHYMAL CELL DIFFERENTIATION | 12 | 134 | 7.162e-12 | 2.288e-10 |
147 | HEART MORPHOGENESIS | 14 | 212 | 7.508e-12 | 2.376e-10 |
148 | POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE | 12 | 135 | 7.826e-12 | 2.46e-10 |
149 | POSITIVE REGULATION OF TRANSFERASE ACTIVITY | 21 | 616 | 1.082e-11 | 3.378e-10 |
150 | CELL DEATH | 26 | 1001 | 1.195e-11 | 3.707e-10 |
151 | RESPONSE TO RETINOIC ACID | 11 | 107 | 1.228e-11 | 3.784e-10 |
152 | REGULATION OF INTRACELLULAR TRANSPORT | 21 | 621 | 1.259e-11 | 3.853e-10 |
153 | REGULATION OF ORGANELLE ORGANIZATION | 28 | 1178 | 1.33e-11 | 4.043e-10 |
154 | REGULATION OF CELL CYCLE PROCESS | 20 | 558 | 1.46e-11 | 4.412e-10 |
155 | PHOSPHATE CONTAINING COMPOUND METABOLIC PROCESS | 36 | 1977 | 1.668e-11 | 5.008e-10 |
156 | REGULATION OF JUN KINASE ACTIVITY | 10 | 81 | 1.713e-11 | 5.108e-10 |
157 | REGULATION OF PROTEIN IMPORT | 13 | 183 | 1.758e-11 | 5.209e-10 |
158 | EYE DEVELOPMENT | 16 | 326 | 1.955e-11 | 5.757e-10 |
159 | HEAD DEVELOPMENT | 22 | 709 | 2.033e-11 | 5.951e-10 |
160 | POSITIVE REGULATION OF ORGANELLE ORGANIZATION | 20 | 573 | 2.351e-11 | 6.836e-10 |
161 | POSITIVE REGULATION OF CELL CYCLE | 16 | 332 | 2.568e-11 | 7.421e-10 |
162 | DEVELOPMENTAL GROWTH | 16 | 333 | 2.686e-11 | 7.714e-10 |
163 | REGULATION OF PROTEIN CATABOLIC PROCESS | 17 | 393 | 3.183e-11 | 9.087e-10 |
164 | NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION | 11 | 117 | 3.29e-11 | 9.335e-10 |
165 | GLAND DEVELOPMENT | 17 | 395 | 3.447e-11 | 9.72e-10 |
166 | POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY | 15 | 289 | 3.985e-11 | 1.117e-09 |
167 | MIDBRAIN DEVELOPMENT | 10 | 90 | 5.012e-11 | 1.396e-09 |
168 | DORSAL VENTRAL PATTERN FORMATION | 10 | 91 | 5.606e-11 | 1.553e-09 |
169 | POSITIVE REGULATION OF MAPK CASCADE | 18 | 470 | 5.853e-11 | 1.611e-09 |
170 | NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT | 7 | 26 | 6.221e-11 | 1.703e-09 |
171 | BETA CATENIN TCF COMPLEX ASSEMBLY | 8 | 43 | 6.388e-11 | 1.738e-09 |
172 | UROGENITAL SYSTEM DEVELOPMENT | 15 | 299 | 6.436e-11 | 1.741e-09 |
173 | FC RECEPTOR SIGNALING PATHWAY | 13 | 206 | 7.781e-11 | 2.093e-09 |
174 | POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION | 16 | 360 | 8.551e-11 | 2.287e-09 |
175 | POSITIVE REGULATION OF KINASE ACTIVITY | 18 | 482 | 8.824e-11 | 2.346e-09 |
176 | MITOTIC CELL CYCLE | 22 | 766 | 8.994e-11 | 2.378e-09 |
177 | REGULATION OF CELLULAR COMPONENT BIOGENESIS | 22 | 767 | 9.221e-11 | 2.424e-09 |
178 | POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT | 14 | 258 | 1.039e-10 | 2.716e-09 |
179 | NEGATIVE REGULATION OF BINDING | 11 | 131 | 1.131e-10 | 2.924e-09 |
180 | BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE | 11 | 131 | 1.131e-10 | 2.924e-09 |
181 | LOCOMOTION | 26 | 1114 | 1.256e-10 | 3.229e-09 |
182 | POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS | 14 | 263 | 1.339e-10 | 3.405e-09 |
183 | RESPONSE TO DRUG | 17 | 431 | 1.339e-10 | 3.405e-09 |
184 | REGULATION OF IMMUNE SYSTEM PROCESS | 29 | 1403 | 1.506e-10 | 3.807e-09 |
185 | REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS | 13 | 218 | 1.575e-10 | 3.961e-09 |
186 | CELLULAR RESPONSE TO ACID CHEMICAL | 12 | 175 | 1.662e-10 | 4.157e-09 |
187 | NEGATIVE REGULATION OF CELL PROLIFERATION | 20 | 643 | 1.816e-10 | 4.519e-09 |
188 | POSITIVE REGULATION OF STEM CELL DIFFERENTIATION | 8 | 50 | 2.293e-10 | 5.676e-09 |
189 | POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION | 18 | 514 | 2.496e-10 | 6.144e-09 |
190 | REGULATION OF CATABOLIC PROCESS | 21 | 731 | 2.559e-10 | 6.267e-09 |
191 | SKELETAL SYSTEM DEVELOPMENT | 17 | 455 | 3.084e-10 | 7.513e-09 |
192 | RESPONSE TO ENDOGENOUS STIMULUS | 29 | 1450 | 3.271e-10 | 7.927e-09 |
193 | POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT | 14 | 282 | 3.352e-10 | 8.08e-09 |
194 | SINGLE ORGANISM CELL ADHESION | 17 | 459 | 3.527e-10 | 8.459e-09 |
195 | NEGATIVE REGULATION OF PROTEIN BINDING | 9 | 79 | 3.845e-10 | 9.174e-09 |
196 | REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 21 | 750 | 4.078e-10 | 9.68e-09 |
197 | PEPTIDYL SERINE MODIFICATION | 11 | 148 | 4.224e-10 | 9.927e-09 |
198 | DIGESTIVE SYSTEM DEVELOPMENT | 11 | 148 | 4.224e-10 | 9.927e-09 |
199 | REGULATION OF MITOTIC CELL CYCLE | 17 | 468 | 4.746e-10 | 1.11e-08 |
200 | POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION | 7 | 34 | 4.912e-10 | 1.143e-08 |
201 | KIDNEY MORPHOGENESIS | 9 | 82 | 5.402e-10 | 1.251e-08 |
202 | GROWTH | 16 | 410 | 5.748e-10 | 1.324e-08 |
203 | RESPONSE TO ABIOTIC STIMULUS | 24 | 1024 | 6.89e-10 | 1.579e-08 |
204 | REGULATION OF IMMUNE RESPONSE | 22 | 858 | 7.653e-10 | 1.746e-08 |
205 | EMBRYONIC PATTERN SPECIFICATION | 8 | 58 | 7.904e-10 | 1.794e-08 |
206 | POSITIVE REGULATION OF PROTEOLYSIS | 15 | 363 | 9.518e-10 | 2.15e-08 |
207 | POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT | 10 | 121 | 9.664e-10 | 2.172e-08 |
208 | REGULATION OF GROWTH | 19 | 633 | 9.932e-10 | 2.222e-08 |
209 | CENTRAL NERVOUS SYSTEM DEVELOPMENT | 22 | 872 | 1.035e-09 | 2.303e-08 |
210 | REGULATION OF PROTEOLYSIS | 20 | 711 | 1.045e-09 | 2.315e-08 |
211 | LEUKOCYTE CELL CELL ADHESION | 13 | 255 | 1.084e-09 | 2.39e-08 |
212 | PROTEIN COMPLEX SUBUNIT ORGANIZATION | 29 | 1527 | 1.09e-09 | 2.393e-08 |
213 | EPITHELIAL CELL DIFFERENTIATION | 17 | 495 | 1.114e-09 | 2.433e-08 |
214 | POSITIVE REGULATION OF INTRACELLULAR TRANSPORT | 15 | 370 | 1.236e-09 | 2.688e-08 |
215 | MESONEPHROS DEVELOPMENT | 9 | 90 | 1.257e-09 | 2.72e-08 |
216 | KIDNEY EPITHELIUM DEVELOPMENT | 10 | 125 | 1.331e-09 | 2.867e-08 |
217 | POSITIVE REGULATION OF JUN KINASE ACTIVITY | 8 | 63 | 1.562e-09 | 3.35e-08 |
218 | CELLULAR RESPONSE TO ABIOTIC STIMULUS | 13 | 263 | 1.579e-09 | 3.37e-08 |
219 | CELLULAR RESPONSE TO EXTERNAL STIMULUS | 13 | 264 | 1.653e-09 | 3.512e-08 |
220 | REGULATION OF MAP KINASE ACTIVITY | 14 | 319 | 1.664e-09 | 3.519e-08 |
221 | APPENDAGE DEVELOPMENT | 11 | 169 | 1.739e-09 | 3.645e-08 |
222 | LIMB DEVELOPMENT | 11 | 169 | 1.739e-09 | 3.645e-08 |
223 | NEGATIVE REGULATION OF CELL GROWTH | 11 | 170 | 1.851e-09 | 3.863e-08 |
224 | CELLULAR RESPONSE TO STRESS | 29 | 1565 | 1.92e-09 | 3.988e-08 |
225 | PROTEASOMAL PROTEIN CATABOLIC PROCESS | 13 | 271 | 2.27e-09 | 4.695e-08 |
226 | LENS DEVELOPMENT IN CAMERA TYPE EYE | 8 | 66 | 2.286e-09 | 4.707e-08 |
227 | REGULATION OF CELL GROWTH | 15 | 391 | 2.622e-09 | 5.375e-08 |
228 | CELLULAR RESPONSE TO ENDOGENOUS STIMULUS | 23 | 1008 | 2.787e-09 | 5.688e-08 |
229 | DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION | 18 | 602 | 3.071e-09 | 6.24e-08 |
230 | POSITIVE REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY | 12 | 228 | 3.446e-09 | 6.972e-08 |
231 | MACROMOLECULAR COMPLEX DISASSEMBLY | 11 | 182 | 3.801e-09 | 7.656e-08 |
232 | REGULATION OF EPITHELIAL CELL PROLIFERATION | 13 | 285 | 4.169e-09 | 8.362e-08 |
233 | DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS | 9 | 104 | 4.595e-09 | 9.177e-08 |
234 | NEGATIVE REGULATION OF GROWTH | 12 | 236 | 5.083e-09 | 1.011e-07 |
235 | DEVELOPMENTAL INDUCTION | 6 | 27 | 5.499e-09 | 1.08e-07 |
236 | REGULATION OF CATENIN IMPORT INTO NUCLEUS | 6 | 27 | 5.499e-09 | 1.08e-07 |
237 | AXIS ELONGATION | 6 | 27 | 5.499e-09 | 1.08e-07 |
238 | REGULATION OF CELL ADHESION | 18 | 629 | 6.088e-09 | 1.19e-07 |
239 | IMMUNE SYSTEM PROCESS | 32 | 1984 | 6.731e-09 | 1.31e-07 |
240 | REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY | 8 | 77 | 7.98e-09 | 1.547e-07 |
241 | RESPIRATORY SYSTEM DEVELOPMENT | 11 | 197 | 8.706e-09 | 1.674e-07 |
242 | REGULATION OF APOPTOTIC SIGNALING PATHWAY | 14 | 363 | 8.676e-09 | 1.674e-07 |
243 | REGULATION OF OSTEOBLAST DIFFERENTIATION | 9 | 112 | 8.871e-09 | 1.699e-07 |
244 | BLOOD VESSEL MORPHOGENESIS | 14 | 364 | 8.983e-09 | 1.713e-07 |
245 | MUSCLE STRUCTURE DEVELOPMENT | 15 | 432 | 1.004e-08 | 1.907e-07 |
246 | POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION | 10 | 154 | 1.013e-08 | 1.915e-07 |
247 | POSITIVE REGULATION OF CELL PROLIFERATION | 20 | 814 | 1.042e-08 | 1.964e-07 |
248 | POSITIVE REGULATION OF HYDROLASE ACTIVITY | 21 | 905 | 1.146e-08 | 2.15e-07 |
249 | MAMMARY GLAND EPITHELIUM DEVELOPMENT | 7 | 53 | 1.295e-08 | 2.42e-07 |
250 | RESPONSE TO EXTERNAL STIMULUS | 30 | 1821 | 1.441e-08 | 2.682e-07 |
251 | CELLULAR COMPONENT DISASSEMBLY | 16 | 515 | 1.486e-08 | 2.754e-07 |
252 | REPRODUCTION | 25 | 1297 | 1.513e-08 | 2.794e-07 |
253 | RESPONSE TO ACID CHEMICAL | 13 | 319 | 1.601e-08 | 2.944e-07 |
254 | PARAXIAL MESODERM DEVELOPMENT | 5 | 16 | 1.662e-08 | 3.045e-07 |
255 | PALATE DEVELOPMENT | 8 | 85 | 1.762e-08 | 3.215e-07 |
256 | OUTFLOW TRACT MORPHOGENESIS | 7 | 56 | 1.923e-08 | 3.495e-07 |
257 | EMBRYONIC AXIS SPECIFICATION | 6 | 33 | 2.005e-08 | 3.629e-07 |
258 | POSITIVE REGULATION OF TRANSPORT | 21 | 936 | 2.053e-08 | 3.702e-07 |
259 | NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION | 18 | 684 | 2.214e-08 | 3.978e-07 |
260 | BIOLOGICAL ADHESION | 22 | 1032 | 2.231e-08 | 3.993e-07 |
261 | CELL CELL SIGNALING | 19 | 767 | 2.251e-08 | 4.013e-07 |
262 | REGULATION OF STEM CELL PROLIFERATION | 8 | 88 | 2.322e-08 | 4.124e-07 |
263 | REGULATION OF MESENCHYMAL CELL PROLIFERATION | 6 | 34 | 2.424e-08 | 4.272e-07 |
264 | BRAIN MORPHOGENESIS | 6 | 34 | 2.424e-08 | 4.272e-07 |
265 | POSITIVE REGULATION OF CATABOLIC PROCESS | 14 | 395 | 2.512e-08 | 4.41e-07 |
266 | REGULATION OF CELL SUBSTRATE ADHESION | 10 | 173 | 3.081e-08 | 5.389e-07 |
267 | SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION | 14 | 404 | 3.327e-08 | 5.798e-07 |
268 | EMBRYONIC DIGIT MORPHOGENESIS | 7 | 61 | 3.539e-08 | 6.144e-07 |
269 | LYMPHOCYTE ACTIVATION | 13 | 342 | 3.637e-08 | 6.29e-07 |
270 | REGULATION OF OSSIFICATION | 10 | 178 | 4.037e-08 | 6.957e-07 |
271 | REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS | 11 | 229 | 4.12e-08 | 7.074e-07 |
272 | RESPONSE TO CYTOKINE | 18 | 714 | 4.251e-08 | 7.272e-07 |
273 | REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY | 5 | 19 | 4.37e-08 | 7.447e-07 |
274 | REGULATION OF MUSCLE ADAPTATION | 7 | 63 | 4.449e-08 | 7.555e-07 |
275 | LEUKOCYTE ACTIVATION | 14 | 414 | 4.509e-08 | 7.628e-07 |
276 | REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS | 10 | 181 | 4.729e-08 | 7.973e-07 |
277 | EYE MORPHOGENESIS | 9 | 136 | 4.86e-08 | 8.163e-07 |
278 | MESENCHYME MORPHOGENESIS | 6 | 38 | 4.889e-08 | 8.184e-07 |
279 | POSITIVE REGULATION OF CELL MATRIX ADHESION | 6 | 40 | 6.739e-08 | 1.124e-06 |
280 | CAMERA TYPE EYE MORPHOGENESIS | 8 | 101 | 6.895e-08 | 1.146e-06 |
281 | RESPONSE TO ALCOHOL | 13 | 362 | 7.061e-08 | 1.169e-06 |
282 | POSITIVE REGULATION OF ADHERENS JUNCTION ORGANIZATION | 5 | 21 | 7.582e-08 | 1.247e-06 |
283 | COCHLEA MORPHOGENESIS | 5 | 21 | 7.582e-08 | 1.247e-06 |
284 | REGULATION OF CELL JUNCTION ASSEMBLY | 7 | 68 | 7.627e-08 | 1.25e-06 |
285 | NEGATIVE REGULATION OF CELL DEVELOPMENT | 12 | 303 | 8.084e-08 | 1.306e-06 |
286 | IMMUNE SYSTEM DEVELOPMENT | 16 | 582 | 8.065e-08 | 1.306e-06 |
287 | REGULATION OF CIRCADIAN RHYTHM | 8 | 103 | 8.04e-08 | 1.306e-06 |
288 | STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE | 8 | 103 | 8.04e-08 | 1.306e-06 |
289 | POSITIVE REGULATION OF CELL CYCLE PROCESS | 11 | 247 | 8.905e-08 | 1.434e-06 |
290 | CONNECTIVE TISSUE DEVELOPMENT | 10 | 194 | 9.089e-08 | 1.458e-06 |
291 | REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 9 | 148 | 1.009e-07 | 1.607e-06 |
292 | FAT CELL DIFFERENTIATION | 8 | 106 | 1.006e-07 | 1.607e-06 |
293 | MORPHOGENESIS OF AN EPITHELIAL SHEET | 6 | 43 | 1.057e-07 | 1.678e-06 |
294 | IN UTERO EMBRYONIC DEVELOPMENT | 12 | 311 | 1.073e-07 | 1.698e-06 |
295 | REGULATION OF ACTIN FILAMENT BASED PROCESS | 12 | 312 | 1.111e-07 | 1.752e-06 |
296 | NEGATIVE REGULATION OF MITOTIC CELL CYCLE | 10 | 199 | 1.154e-07 | 1.813e-06 |
297 | FORMATION OF PRIMARY GERM LAYER | 8 | 110 | 1.343e-07 | 2.105e-06 |
298 | CELL CELL ADHESION | 16 | 608 | 1.462e-07 | 2.282e-06 |
299 | REGULATION OF CELL CYCLE PHASE TRANSITION | 12 | 321 | 1.511e-07 | 2.351e-06 |
300 | POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY | 5 | 24 | 1.564e-07 | 2.425e-06 |
301 | PEPTIDYL THREONINE MODIFICATION | 6 | 46 | 1.602e-07 | 2.477e-06 |
302 | REGULATION OF CELLULAR RESPONSE TO HEAT | 7 | 76 | 1.661e-07 | 2.559e-06 |
303 | POSITIVE REGULATION OF MAP KINASE ACTIVITY | 10 | 207 | 1.666e-07 | 2.559e-06 |
304 | SEX DIFFERENTIATION | 11 | 266 | 1.88e-07 | 2.878e-06 |
305 | NEPHRON DEVELOPMENT | 8 | 115 | 1.897e-07 | 2.894e-06 |
306 | RENAL TUBULE DEVELOPMENT | 7 | 78 | 1.989e-07 | 3.017e-06 |
307 | SKIN DEVELOPMENT | 10 | 211 | 1.991e-07 | 3.017e-06 |
308 | ANTERIOR POSTERIOR AXIS SPECIFICATION | 6 | 48 | 2.081e-07 | 3.134e-06 |
309 | POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY | 6 | 48 | 2.081e-07 | 3.134e-06 |
310 | MOVEMENT OF CELL OR SUBCELLULAR COMPONENT | 23 | 1275 | 2.117e-07 | 3.178e-06 |
311 | WOUND HEALING | 14 | 470 | 2.138e-07 | 3.199e-06 |
312 | MAMMARY GLAND DEVELOPMENT | 8 | 117 | 2.168e-07 | 3.233e-06 |
313 | MESODERM DEVELOPMENT | 8 | 118 | 2.316e-07 | 3.442e-06 |
314 | POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY | 4 | 11 | 2.482e-07 | 3.679e-06 |
315 | REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS | 11 | 274 | 2.53e-07 | 3.737e-06 |
316 | NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS | 21 | 1087 | 2.569e-07 | 3.782e-06 |
317 | REGULATION OF FIBROBLAST PROLIFERATION | 7 | 81 | 2.584e-07 | 3.793e-06 |
318 | REGULATION OF ADHERENS JUNCTION ORGANIZATION | 6 | 50 | 2.672e-07 | 3.909e-06 |
319 | REGULATION OF PROTEIN STABILITY | 10 | 221 | 3.056e-07 | 4.458e-06 |
320 | RESPONSE TO WOUNDING | 15 | 563 | 3.183e-07 | 4.628e-06 |
321 | POSITIVE REGULATION OF OSSIFICATION | 7 | 84 | 3.322e-07 | 4.816e-06 |
322 | POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY | 9 | 171 | 3.459e-07 | 4.999e-06 |
323 | RESPONSE TO ORGANIC CYCLIC COMPOUND | 19 | 917 | 3.64e-07 | 5.244e-06 |
324 | MESONEPHRIC TUBULE MORPHOGENESIS | 6 | 53 | 3.81e-07 | 5.472e-06 |
325 | RESPONSE TO UV | 8 | 126 | 3.838e-07 | 5.495e-06 |
326 | POSITIVE REGULATION OF LOCOMOTION | 13 | 420 | 3.89e-07 | 5.553e-06 |
327 | CELL MOTILITY | 18 | 835 | 4.346e-07 | 6.165e-06 |
328 | LOCALIZATION OF CELL | 18 | 835 | 4.346e-07 | 6.165e-06 |
329 | FOREBRAIN DEVELOPMENT | 12 | 357 | 4.713e-07 | 6.666e-06 |
330 | REGULATION OF CYTOSKELETON ORGANIZATION | 14 | 502 | 4.729e-07 | 6.668e-06 |
331 | PEPTIDYL AMINO ACID MODIFICATION | 18 | 841 | 4.823e-07 | 6.779e-06 |
332 | ANGIOGENESIS | 11 | 293 | 4.928e-07 | 6.907e-06 |
333 | EPITHELIAL CELL PROLIFERATION | 7 | 89 | 4.945e-07 | 6.909e-06 |
334 | REGULATION OF VASCULATURE DEVELOPMENT | 10 | 233 | 4.971e-07 | 6.926e-06 |
335 | REGULATION OF CELL MATRIX ADHESION | 7 | 90 | 5.338e-07 | 7.414e-06 |
336 | NEGATIVE REGULATION OF CELL CYCLE | 13 | 433 | 5.491e-07 | 7.604e-06 |
337 | INNER EAR MORPHOGENESIS | 7 | 92 | 6.205e-07 | 8.567e-06 |
338 | PROTEIN LOCALIZATION | 27 | 1805 | 6.468e-07 | 8.904e-06 |
339 | NEPHRON EPITHELIUM DEVELOPMENT | 7 | 93 | 6.68e-07 | 9.169e-06 |
340 | RESPONSE TO EXTRACELLULAR STIMULUS | 13 | 441 | 6.747e-07 | 9.233e-06 |
341 | POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION | 11 | 303 | 6.863e-07 | 9.365e-06 |
342 | EPITHELIAL CELL DEVELOPMENT | 9 | 186 | 7.022e-07 | 9.553e-06 |
343 | CELLULAR RESPONSE TO RADIATION | 8 | 137 | 7.276e-07 | 9.871e-06 |
344 | POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS | 18 | 867 | 7.492e-07 | 1.013e-05 |
345 | TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY | 7 | 95 | 7.724e-07 | 1.042e-05 |
346 | STEM CELL PROLIFERATION | 6 | 60 | 8.061e-07 | 1.084e-05 |
347 | POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT | 5 | 33 | 8.403e-07 | 1.127e-05 |
348 | POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS | 9 | 192 | 9.157e-07 | 1.224e-05 |
349 | POSITIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS | 7 | 98 | 9.544e-07 | 1.272e-05 |
350 | PROTEIN DESTABILIZATION | 5 | 34 | 9.81e-07 | 1.304e-05 |
351 | NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS | 15 | 616 | 9.882e-07 | 1.31e-05 |
352 | CARDIAC CHAMBER DEVELOPMENT | 8 | 144 | 1.062e-06 | 1.404e-05 |
353 | REGULATION OF CARTILAGE DEVELOPMENT | 6 | 63 | 1.08e-06 | 1.423e-05 |
354 | REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION | 7 | 100 | 1.095e-06 | 1.439e-05 |
355 | CELL CYCLE PHASE TRANSITION | 10 | 255 | 1.131e-06 | 1.482e-05 |
356 | NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS | 14 | 541 | 1.15e-06 | 1.499e-05 |
357 | NEGATIVE REGULATION OF PHOSPHATE METABOLIC PROCESS | 14 | 541 | 1.15e-06 | 1.499e-05 |
358 | CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND | 13 | 465 | 1.22e-06 | 1.585e-05 |
359 | CARTILAGE DEVELOPMENT | 8 | 147 | 1.241e-06 | 1.609e-05 |
360 | NEURON PROJECTION DEVELOPMENT | 14 | 545 | 1.255e-06 | 1.622e-05 |
361 | MALE SEX DIFFERENTIATION | 8 | 148 | 1.306e-06 | 1.684e-05 |
362 | SKELETAL SYSTEM MORPHOGENESIS | 9 | 201 | 1.341e-06 | 1.723e-05 |
363 | CELLULAR RESPONSE TO UV | 6 | 66 | 1.425e-06 | 1.815e-05 |
364 | CARDIAC CHAMBER MORPHOGENESIS | 7 | 104 | 1.428e-06 | 1.815e-05 |
365 | MESODERM MORPHOGENESIS | 6 | 66 | 1.425e-06 | 1.815e-05 |
366 | POSITIVE REGULATION OF PROTEIN IMPORT | 7 | 104 | 1.428e-06 | 1.815e-05 |
367 | NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 10 | 262 | 1.444e-06 | 1.831e-05 |
368 | TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 16 | 724 | 1.485e-06 | 1.877e-05 |
369 | NEGATIVE REGULATION OF LOCOMOTION | 10 | 263 | 1.495e-06 | 1.885e-05 |
370 | REGULATION OF NEURON DIFFERENTIATION | 14 | 554 | 1.521e-06 | 1.912e-05 |
371 | REGULATION OF FAT CELL DIFFERENTIATION | 7 | 106 | 1.623e-06 | 2.031e-05 |
372 | INNATE IMMUNE RESPONSE ACTIVATING CELL SURFACE RECEPTOR SIGNALING PATHWAY | 7 | 106 | 1.623e-06 | 2.031e-05 |
373 | REGULATION OF CELL PROJECTION ORGANIZATION | 14 | 558 | 1.654e-06 | 2.064e-05 |
374 | RESPONSE TO INORGANIC SUBSTANCE | 13 | 479 | 1.695e-06 | 2.108e-05 |
375 | RESPONSE TO METAL ION | 11 | 333 | 1.726e-06 | 2.142e-05 |
376 | REGULATION OF CHROMATIN BINDING | 4 | 17 | 1.747e-06 | 2.15e-05 |
377 | ESTABLISHMENT OF TISSUE POLARITY | 4 | 17 | 1.747e-06 | 2.15e-05 |
378 | REGULATION OF PRI MIRNA TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 4 | 17 | 1.747e-06 | 2.15e-05 |
379 | REGULATION OF CYTOKINE PRODUCTION | 14 | 563 | 1.836e-06 | 2.255e-05 |
380 | REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION | 7 | 108 | 1.841e-06 | 2.255e-05 |
381 | COCHLEA DEVELOPMENT | 5 | 39 | 1.987e-06 | 2.427e-05 |
382 | PROTEIN COMPLEX BIOGENESIS | 20 | 1132 | 2.076e-06 | 2.522e-05 |
383 | PROTEIN COMPLEX ASSEMBLY | 20 | 1132 | 2.076e-06 | 2.522e-05 |
384 | RESPONSE TO RADIATION | 12 | 413 | 2.169e-06 | 2.628e-05 |
385 | PERICARDIUM DEVELOPMENT | 4 | 18 | 2.236e-06 | 2.689e-05 |
386 | POST ANAL TAIL MORPHOGENESIS | 4 | 18 | 2.236e-06 | 2.689e-05 |
387 | INOSITOL PHOSPHATE MEDIATED SIGNALING | 4 | 18 | 2.236e-06 | 2.689e-05 |
388 | EAR MORPHOGENESIS | 7 | 112 | 2.351e-06 | 2.819e-05 |
389 | REGULATION OF CHROMOSOME ORGANIZATION | 10 | 278 | 2.459e-06 | 2.941e-05 |
390 | EMBRYONIC HEART TUBE DEVELOPMENT | 6 | 73 | 2.591e-06 | 3.091e-05 |
391 | CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION | 8 | 166 | 3.087e-06 | 3.674e-05 |
392 | REGULATION OF MUSCLE CELL APOPTOTIC PROCESS | 5 | 43 | 3.266e-06 | 3.877e-05 |
393 | REGULATION OF DEVELOPMENTAL GROWTH | 10 | 289 | 3.475e-06 | 4.103e-05 |
394 | APOPTOTIC SIGNALING PATHWAY | 10 | 289 | 3.475e-06 | 4.103e-05 |
395 | TRACHEA DEVELOPMENT | 4 | 20 | 3.512e-06 | 4.127e-05 |
396 | POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS | 4 | 20 | 3.512e-06 | 4.127e-05 |
397 | REGULATION OF BMP SIGNALING PATHWAY | 6 | 77 | 3.547e-06 | 4.157e-05 |
398 | LABYRINTHINE LAYER DEVELOPMENT | 5 | 44 | 3.669e-06 | 4.279e-05 |
399 | BRANCHING INVOLVED IN URETERIC BUD MORPHOGENESIS | 5 | 44 | 3.669e-06 | 4.279e-05 |
400 | NEURON DEVELOPMENT | 15 | 687 | 3.781e-06 | 4.398e-05 |
401 | LEUKOCYTE DIFFERENTIATION | 10 | 292 | 3.808e-06 | 4.419e-05 |
402 | POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 12 | 437 | 3.875e-06 | 4.486e-05 |
403 | NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS | 7 | 121 | 3.939e-06 | 4.548e-05 |
404 | THYMOCYTE AGGREGATION | 5 | 45 | 4.111e-06 | 4.723e-05 |
405 | T CELL DIFFERENTIATION IN THYMUS | 5 | 45 | 4.111e-06 | 4.723e-05 |
406 | REGULATION OF EPITHELIAL CELL DIFFERENTIATION | 7 | 122 | 4.161e-06 | 4.768e-05 |
407 | T CELL DIFFERENTIATION | 7 | 123 | 4.393e-06 | 5.022e-05 |
408 | CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION | 11 | 368 | 4.51e-06 | 5.144e-05 |
409 | POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION | 8 | 175 | 4.568e-06 | 5.197e-05 |
410 | POSITIVE REGULATION OF CYTOKINE PRODUCTION | 11 | 370 | 4.749e-06 | 5.39e-05 |
411 | RESPONSE TO HORMONE | 17 | 893 | 5.061e-06 | 5.73e-05 |
412 | MUSCLE CELL DIFFERENTIATION | 9 | 237 | 5.18e-06 | 5.85e-05 |
413 | SOMATIC STEM CELL DIVISION | 4 | 22 | 5.259e-06 | 5.925e-05 |
414 | POSITIVE REGULATION OF GROWTH | 9 | 238 | 5.359e-06 | 6.023e-05 |
415 | POSITIVE REGULATION OF CELL ADHESION | 11 | 376 | 5.533e-06 | 6.204e-05 |
416 | HEPATICOBILIARY SYSTEM DEVELOPMENT | 7 | 128 | 5.72e-06 | 6.397e-05 |
417 | CELL PROJECTION ORGANIZATION | 17 | 902 | 5.779e-06 | 6.448e-05 |
418 | POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS | 7 | 129 | 6.021e-06 | 6.703e-05 |
419 | CHROMATIN MODIFICATION | 13 | 539 | 6.14e-06 | 6.818e-05 |
420 | NEGATIVE REGULATION OF TRANSPORT | 12 | 458 | 6.246e-06 | 6.92e-05 |
421 | CARDIAC SEPTUM DEVELOPMENT | 6 | 85 | 6.32e-06 | 6.969e-05 |
422 | CARDIAC SEPTUM MORPHOGENESIS | 5 | 49 | 6.308e-06 | 6.969e-05 |
423 | CELL DIVISION | 12 | 460 | 6.528e-06 | 7.18e-05 |
424 | RESPONSE TO OXYGEN LEVELS | 10 | 311 | 6.639e-06 | 7.286e-05 |
425 | MAINTENANCE OF CELL NUMBER | 7 | 132 | 7.007e-06 | 7.672e-05 |
426 | TAXIS | 12 | 464 | 7.124e-06 | 7.781e-05 |
427 | POSITIVE REGULATION OF FAT CELL DIFFERENTIATION | 5 | 51 | 7.705e-06 | 8.396e-05 |
428 | CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS | 8 | 188 | 7.741e-06 | 8.415e-05 |
429 | NEGATIVE REGULATION OF CATALYTIC ACTIVITY | 16 | 829 | 8.35e-06 | 9.051e-05 |
430 | TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY | 8 | 190 | 8.364e-06 | 9.051e-05 |
431 | ENDOTHELIUM DEVELOPMENT | 6 | 90 | 8.805e-06 | 9.506e-05 |
432 | LENS FIBER CELL DIFFERENTIATION | 4 | 25 | 8.983e-06 | 9.675e-05 |
433 | REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE | 5 | 53 | 9.333e-06 | 0.0001003 |
434 | CELLULAR RESPONSE TO LIGHT STIMULUS | 6 | 91 | 9.386e-06 | 0.0001004 |
435 | PLACENTA DEVELOPMENT | 7 | 138 | 9.384e-06 | 0.0001004 |
436 | POSITIVE REGULATION OF IMMUNE RESPONSE | 13 | 563 | 9.789e-06 | 0.0001045 |
437 | MITOTIC CELL CYCLE CHECKPOINT | 7 | 139 | 9.839e-06 | 0.0001048 |
438 | NEURON PROJECTION MORPHOGENESIS | 11 | 402 | 1.039e-05 | 0.0001104 |
439 | ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY | 7 | 141 | 1.08e-05 | 0.0001145 |
440 | REGULATION OF KIDNEY DEVELOPMENT | 5 | 55 | 1.122e-05 | 0.0001186 |
441 | CHROMATIN ORGANIZATION | 14 | 663 | 1.194e-05 | 0.0001257 |
442 | REGULATION OF NEURON PROJECTION DEVELOPMENT | 11 | 408 | 1.193e-05 | 0.0001257 |
443 | REGULATION OF TRANSCRIPTION FACTOR IMPORT INTO NUCLEUS | 6 | 95 | 1.203e-05 | 0.0001263 |
444 | RESPONSE TO LITHIUM ION | 4 | 27 | 1.236e-05 | 0.0001292 |
445 | POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION | 4 | 27 | 1.236e-05 | 0.0001292 |
446 | NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION | 7 | 144 | 1.24e-05 | 0.0001293 |
447 | RESPONSE TO NITROGEN COMPOUND | 16 | 859 | 1.299e-05 | 0.0001349 |
448 | SYNAPSE ORGANIZATION | 7 | 145 | 1.297e-05 | 0.0001349 |
449 | PROTEIN CATABOLIC PROCESS | 13 | 579 | 1.318e-05 | 0.0001366 |
450 | REGULATION OF GTPASE ACTIVITY | 14 | 673 | 1.412e-05 | 0.000146 |
451 | REGULATION OF CELL CYCLE G1 S PHASE TRANSITION | 7 | 147 | 1.418e-05 | 0.0001463 |
452 | VENTRICULAR SEPTUM MORPHOGENESIS | 4 | 28 | 1.436e-05 | 0.0001472 |
453 | GASTRULATION WITH MOUTH FORMING SECOND | 4 | 28 | 1.436e-05 | 0.0001472 |
454 | MORPHOGENESIS OF A POLARIZED EPITHELIUM | 4 | 28 | 1.436e-05 | 0.0001472 |
455 | NEURON PROJECTION GUIDANCE | 8 | 205 | 1.454e-05 | 0.0001487 |
456 | POSITIVE REGULATION OF CELL SUBSTRATE ADHESION | 6 | 99 | 1.524e-05 | 0.0001555 |
457 | REGULATION OF CELL DIVISION | 9 | 272 | 1.564e-05 | 0.0001592 |
458 | VASCULOGENESIS | 5 | 59 | 1.587e-05 | 0.0001613 |
459 | COVALENT CHROMATIN MODIFICATION | 10 | 345 | 1.636e-05 | 0.0001654 |
460 | NEGATIVE REGULATION OF PHOSPHORYLATION | 11 | 422 | 1.633e-05 | 0.0001654 |
461 | STEM CELL DIVISION | 4 | 29 | 1.659e-05 | 0.0001674 |
462 | LYMPHOCYTE DIFFERENTIATION | 8 | 209 | 1.672e-05 | 0.0001684 |
463 | CHONDROCYTE DIFFERENTIATION | 5 | 60 | 1.724e-05 | 0.0001725 |
464 | REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY | 5 | 60 | 1.724e-05 | 0.0001725 |
465 | POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION | 5 | 60 | 1.724e-05 | 0.0001725 |
466 | RESPONSE TO MECHANICAL STIMULUS | 8 | 210 | 1.731e-05 | 0.0001728 |
467 | NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY | 6 | 102 | 1.808e-05 | 0.0001802 |
468 | ACTIVATION OF IMMUNE RESPONSE | 11 | 427 | 1.821e-05 | 0.000181 |
469 | PALLIUM DEVELOPMENT | 7 | 153 | 1.838e-05 | 0.0001823 |
470 | POSITIVE REGULATION OF STEM CELL PROLIFERATION | 5 | 61 | 1.87e-05 | 0.0001852 |
471 | REGULATION OF MUSCLE TISSUE DEVELOPMENT | 6 | 103 | 1.912e-05 | 0.0001881 |
472 | REGULATION OF MUSCLE ORGAN DEVELOPMENT | 6 | 103 | 1.912e-05 | 0.0001881 |
473 | RESPONSE TO X RAY | 4 | 30 | 1.906e-05 | 0.0001881 |
474 | AMEBOIDAL TYPE CELL MIGRATION | 7 | 154 | 1.917e-05 | 0.0001882 |
475 | RESPONSE TO LIGHT STIMULUS | 9 | 280 | 1.967e-05 | 0.0001927 |
476 | REGULATION OF SMOOTHENED SIGNALING PATHWAY | 5 | 62 | 2.026e-05 | 0.0001972 |
477 | EMBRYONIC HEART TUBE MORPHOGENESIS | 5 | 62 | 2.026e-05 | 0.0001972 |
478 | PROTEOLYSIS | 19 | 1208 | 2.022e-05 | 0.0001972 |
479 | DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS | 8 | 216 | 2.12e-05 | 0.0002059 |
480 | CEREBRAL CORTEX DEVELOPMENT | 6 | 105 | 2.133e-05 | 0.0002068 |
481 | REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION | 4 | 31 | 2.18e-05 | 0.0002109 |
482 | REGULATION OF EPIDERMIS DEVELOPMENT | 5 | 63 | 2.191e-05 | 0.0002115 |
483 | REGULATION OF ORGAN FORMATION | 4 | 32 | 2.481e-05 | 0.000238 |
484 | PATTERNING OF BLOOD VESSELS | 4 | 32 | 2.481e-05 | 0.000238 |
485 | EMBRYONIC FORELIMB MORPHOGENESIS | 4 | 32 | 2.481e-05 | 0.000238 |
486 | CELLULAR MACROMOLECULE LOCALIZATION | 19 | 1234 | 2.714e-05 | 0.0002598 |
487 | SOMATIC STEM CELL POPULATION MAINTENANCE | 5 | 66 | 2.751e-05 | 0.0002628 |
488 | CELLULAR RESPONSE TO BIOTIC STIMULUS | 7 | 163 | 2.764e-05 | 0.0002636 |
489 | CELLULAR RESPONSE TO DRUG | 5 | 67 | 2.96e-05 | 0.0002816 |
490 | TELENCEPHALON DEVELOPMENT | 8 | 228 | 3.12e-05 | 0.0002963 |
491 | POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION | 3 | 12 | 3.162e-05 | 0.0002973 |
492 | TRACHEA MORPHOGENESIS | 3 | 12 | 3.162e-05 | 0.0002973 |
493 | MAMMARY GLAND EPITHELIAL CELL PROLIFERATION | 3 | 12 | 3.162e-05 | 0.0002973 |
494 | REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY | 3 | 12 | 3.162e-05 | 0.0002973 |
495 | LENS FIBER CELL DEVELOPMENT | 3 | 12 | 3.162e-05 | 0.0002973 |
496 | REGULATION OF PROTEIN DEACETYLATION | 4 | 34 | 3.173e-05 | 0.0002977 |
497 | POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION | 7 | 167 | 3.229e-05 | 0.0003023 |
498 | REGULATION OF AXONOGENESIS | 7 | 168 | 3.355e-05 | 0.0003135 |
499 | SYNAPSE ASSEMBLY | 5 | 69 | 3.415e-05 | 0.0003185 |
500 | REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY | 8 | 232 | 3.531e-05 | 0.000328 |
501 | POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT | 8 | 232 | 3.531e-05 | 0.000328 |
502 | BONE REMODELING | 4 | 35 | 3.568e-05 | 0.0003298 |
503 | CELLULAR RESPONSE TO ALCOHOL | 6 | 115 | 3.572e-05 | 0.0003298 |
504 | RESPONSE TO CALCIUM ION | 6 | 115 | 3.572e-05 | 0.0003298 |
505 | NEURAL PRECURSOR CELL PROLIFERATION | 5 | 70 | 3.662e-05 | 0.0003374 |
506 | NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT | 5 | 71 | 3.923e-05 | 0.0003586 |
507 | SKIN EPIDERMIS DEVELOPMENT | 5 | 71 | 3.923e-05 | 0.0003586 |
508 | ENDODERM DEVELOPMENT | 5 | 71 | 3.923e-05 | 0.0003586 |
509 | CELL FATE SPECIFICATION | 5 | 71 | 3.923e-05 | 0.0003586 |
510 | SPECIFICATION OF SYMMETRY | 6 | 117 | 3.936e-05 | 0.0003591 |
511 | HEMATOPOIETIC STEM CELL PROLIFERATION | 3 | 13 | 4.095e-05 | 0.0003707 |
512 | REGULATION OF SKELETAL MUSCLE ADAPTATION | 3 | 13 | 4.095e-05 | 0.0003707 |
513 | REGULATION OF CELL FATE SPECIFICATION | 3 | 13 | 4.095e-05 | 0.0003707 |
514 | REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY | 3 | 13 | 4.095e-05 | 0.0003707 |
515 | ENDOTHELIAL CELL DIFFERENTIATION | 5 | 72 | 4.198e-05 | 0.0003793 |
516 | REGULATION OF MUSCLE HYPERTROPHY | 4 | 37 | 4.464e-05 | 0.0004025 |
517 | PANCREAS DEVELOPMENT | 5 | 73 | 4.488e-05 | 0.0004039 |
518 | MACROMOLECULAR COMPLEX ASSEMBLY | 20 | 1398 | 4.598e-05 | 0.000413 |
519 | EMBRYONIC SKELETAL SYSTEM DEVELOPMENT | 6 | 122 | 4.979e-05 | 0.0004464 |
520 | REGULATION OF HORMONE LEVELS | 11 | 478 | 5.095e-05 | 0.0004559 |
521 | NEURAL CREST CELL DIFFERENTIATION | 5 | 75 | 5.113e-05 | 0.0004567 |
522 | POSITIVE REGULATION OF MEIOTIC CELL CYCLE | 3 | 14 | 5.192e-05 | 0.000461 |
523 | CELL MIGRATION INVOLVED IN GASTRULATION | 3 | 14 | 5.192e-05 | 0.000461 |
524 | REGULATION OF MONOCYTE DIFFERENTIATION | 3 | 14 | 5.192e-05 | 0.000461 |
525 | POSITIVE REGULATION OF INNATE IMMUNE RESPONSE | 8 | 246 | 5.344e-05 | 0.0004736 |
526 | NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION | 4 | 39 | 5.514e-05 | 0.0004877 |
527 | REGULATION OF MYELOID CELL DIFFERENTIATION | 7 | 183 | 5.778e-05 | 0.0005102 |
528 | OSTEOBLAST DIFFERENTIATION | 6 | 126 | 5.963e-05 | 0.0005245 |
529 | NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY | 6 | 126 | 5.963e-05 | 0.0005245 |
530 | NEGATIVE REGULATION OF KINASE ACTIVITY | 8 | 250 | 5.985e-05 | 0.0005254 |
531 | FORELIMB MORPHOGENESIS | 4 | 40 | 6.101e-05 | 0.0005336 |
532 | REGULATION OF MEIOTIC CELL CYCLE | 4 | 40 | 6.101e-05 | 0.0005336 |
533 | OSSIFICATION | 8 | 251 | 6.155e-05 | 0.0005373 |
534 | CELL JUNCTION ORGANIZATION | 7 | 185 | 6.189e-05 | 0.0005393 |
535 | NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS | 3 | 15 | 6.464e-05 | 0.0005612 |
536 | REGULATION OF MESODERM DEVELOPMENT | 3 | 15 | 6.464e-05 | 0.0005612 |
537 | REGULATION OF PHOSPHATASE ACTIVITY | 6 | 128 | 6.51e-05 | 0.000562 |
538 | REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION | 6 | 128 | 6.51e-05 | 0.000562 |
539 | EPIDERMIS DEVELOPMENT | 8 | 253 | 6.507e-05 | 0.000562 |
540 | REGULATION OF REPRODUCTIVE PROCESS | 6 | 129 | 6.798e-05 | 0.0005858 |
541 | CELLULAR RESPONSE TO MECHANICAL STIMULUS | 5 | 80 | 6.973e-05 | 0.0005997 |
542 | REGULATION OF PEPTIDE TRANSPORT | 8 | 256 | 7.066e-05 | 0.0006066 |
543 | RESPONSE TO STEROID HORMONE | 11 | 497 | 7.223e-05 | 0.0006189 |
544 | PROTEIN DEPHOSPHORYLATION | 7 | 190 | 7.321e-05 | 0.0006262 |
545 | PROTEIN STABILIZATION | 6 | 131 | 7.405e-05 | 0.0006304 |
546 | NEGATIVE REGULATION OF BMP SIGNALING PATHWAY | 4 | 42 | 7.411e-05 | 0.0006304 |
547 | EPITHELIAL CELL MORPHOGENESIS | 4 | 42 | 7.411e-05 | 0.0006304 |
548 | NEGATIVE REGULATION OF NEURON DIFFERENTIATION | 7 | 191 | 7.566e-05 | 0.0006424 |
549 | PROTEIN AUTOPHOSPHORYLATION | 7 | 192 | 7.818e-05 | 0.0006626 |
550 | JNK CASCADE | 5 | 82 | 7.848e-05 | 0.0006639 |
551 | MORPHOGENESIS OF AN ENDOTHELIUM | 3 | 16 | 7.925e-05 | 0.0006656 |
552 | ORGAN INDUCTION | 3 | 16 | 7.925e-05 | 0.0006656 |
553 | APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS | 3 | 16 | 7.925e-05 | 0.0006656 |
554 | CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT | 3 | 16 | 7.925e-05 | 0.0006656 |
555 | NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION | 4 | 43 | 8.138e-05 | 0.000681 |
556 | REGULATION OF GLYCOPROTEIN METABOLIC PROCESS | 4 | 43 | 8.138e-05 | 0.000681 |
557 | HAIR CYCLE | 5 | 83 | 8.315e-05 | 0.0006921 |
558 | EMBRYONIC PLACENTA DEVELOPMENT | 5 | 83 | 8.315e-05 | 0.0006921 |
559 | MOLTING CYCLE | 5 | 83 | 8.315e-05 | 0.0006921 |
560 | CELL CYCLE CHECKPOINT | 7 | 194 | 8.343e-05 | 0.0006932 |
561 | ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY | 7 | 195 | 8.616e-05 | 0.0007121 |
562 | EAR DEVELOPMENT | 7 | 195 | 8.616e-05 | 0.0007121 |
563 | REGULATION OF MUSCLE SYSTEM PROCESS | 7 | 195 | 8.616e-05 | 0.0007121 |
564 | NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH | 5 | 84 | 8.804e-05 | 0.0007263 |
565 | REGULATION OF DNA METABOLIC PROCESS | 9 | 340 | 8.866e-05 | 0.0007302 |
566 | CHROMOSOME ORGANIZATION | 16 | 1009 | 8.995e-05 | 0.0007395 |
567 | REGULATION OF SECRETION | 13 | 699 | 9.175e-05 | 0.0007523 |
568 | POSITIVE REGULATION OF PROTEIN COMPLEX ASSEMBLY | 7 | 197 | 9.184e-05 | 0.0007523 |
569 | REGULATION OF NFAT PROTEIN IMPORT INTO NUCLEUS | 3 | 17 | 9.586e-05 | 0.0007811 |
570 | CELLULAR RESPONSE TO LITHIUM ION | 3 | 17 | 9.586e-05 | 0.0007811 |
571 | NEGATIVE REGULATION OF STEM CELL PROLIFERATION | 3 | 17 | 9.586e-05 | 0.0007811 |
572 | REGULATION OF CHONDROCYTE DIFFERENTIATION | 4 | 46 | 0.0001063 | 0.0008646 |
573 | REGULATION OF SYNAPTIC PLASTICITY | 6 | 140 | 0.0001069 | 0.0008683 |
574 | NEGATIVE REGULATION OF TRANSFERASE ACTIVITY | 9 | 351 | 0.0001129 | 0.000915 |
575 | ACTIVATION OF INNATE IMMUNE RESPONSE | 7 | 204 | 0.0001142 | 0.0009239 |
576 | UTERUS DEVELOPMENT | 3 | 18 | 0.0001146 | 0.000924 |
577 | SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION | 3 | 18 | 0.0001146 | 0.000924 |
578 | PLATELET ACTIVATION | 6 | 142 | 0.0001156 | 0.0009298 |
579 | POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS | 4 | 47 | 0.0001157 | 0.0009298 |
580 | RAS PROTEIN SIGNAL TRANSDUCTION | 6 | 143 | 0.0001202 | 0.0009639 |
581 | CALCIUM MEDIATED SIGNALING | 5 | 90 | 0.0001222 | 0.0009786 |
582 | REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY | 7 | 207 | 0.000125 | 0.0009994 |
583 | NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION | 7 | 209 | 0.0001327 | 0.001059 |
584 | RESPONSE TO ESTRADIOL | 6 | 146 | 0.0001346 | 0.001071 |
585 | NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION | 6 | 146 | 0.0001346 | 0.001071 |
586 | POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS | 3 | 19 | 0.0001355 | 0.001076 |
587 | REGULATION OF DNA BINDING | 5 | 93 | 0.0001427 | 0.001131 |
588 | POSITIVE REGULATION OF CELL GROWTH | 6 | 148 | 0.0001451 | 0.001148 |
589 | CELL PART MORPHOGENESIS | 12 | 633 | 0.0001455 | 0.001149 |
590 | POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION | 4 | 50 | 0.0001476 | 0.001162 |
591 | RHO PROTEIN SIGNAL TRANSDUCTION | 4 | 50 | 0.0001476 | 0.001162 |
592 | REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY | 7 | 213 | 0.0001492 | 0.001172 |
593 | NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT | 5 | 95 | 0.0001577 | 0.001238 |
594 | TONGUE DEVELOPMENT | 3 | 20 | 0.0001588 | 0.001242 |
595 | BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS | 3 | 20 | 0.0001588 | 0.001242 |
596 | POSITIVE REGULATION OF TRANSCRIPTION FACTOR IMPORT INTO NUCLEUS | 4 | 51 | 0.0001595 | 0.001245 |
597 | PROTEIN LOCALIZATION TO CELL PERIPHERY | 6 | 151 | 0.0001618 | 0.001261 |
598 | REGULATION OF MUSCLE CELL DIFFERENTIATION | 6 | 152 | 0.0001678 | 0.001303 |
599 | REGULATION OF CHROMATIN ORGANIZATION | 6 | 152 | 0.0001678 | 0.001303 |
600 | POSITIVE REGULATION OF REPRODUCTIVE PROCESS | 4 | 52 | 0.000172 | 0.00133 |
601 | REGULATION OF MITOCHONDRION ORGANIZATION | 7 | 218 | 0.0001721 | 0.00133 |
602 | RESPONSE TO ESTROGEN | 7 | 218 | 0.0001721 | 0.00133 |
603 | APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT | 3 | 21 | 0.0001846 | 0.001422 |
604 | BONE RESORPTION | 3 | 21 | 0.0001846 | 0.001422 |
605 | POSITIVE REGULATION OF FIBROBLAST PROLIFERATION | 4 | 53 | 0.0001853 | 0.001425 |
606 | G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 17 | 1193 | 0.0001935 | 0.001481 |
607 | POSITIVE REGULATION OF DEVELOPMENTAL GROWTH | 6 | 156 | 0.0001932 | 0.001481 |
608 | CELLULAR RESPONSE TO INORGANIC SUBSTANCE | 6 | 156 | 0.0001932 | 0.001481 |
609 | ENDOMEMBRANE SYSTEM ORGANIZATION | 10 | 465 | 0.0001969 | 0.001504 |
610 | VENTRICULAR SEPTUM DEVELOPMENT | 4 | 54 | 0.0001993 | 0.00152 |
611 | REGULATION OF DEPHOSPHORYLATION | 6 | 158 | 0.000207 | 0.001577 |
612 | MODULATION OF TRANSCRIPTION IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION | 3 | 22 | 0.0002129 | 0.001608 |
613 | POSITIVE REGULATION OF MUSCLE HYPERTROPHY | 3 | 22 | 0.0002129 | 0.001608 |
614 | POSITIVE REGULATION OF CARDIAC MUSCLE HYPERTROPHY | 3 | 22 | 0.0002129 | 0.001608 |
615 | REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS | 3 | 22 | 0.0002129 | 0.001608 |
616 | EMBRYONIC PLACENTA MORPHOGENESIS | 3 | 22 | 0.0002129 | 0.001608 |
617 | MODULATION OF SYNAPTIC TRANSMISSION | 8 | 301 | 0.0002154 | 0.001624 |
618 | SECOND MESSENGER MEDIATED SIGNALING | 6 | 160 | 0.0002216 | 0.001669 |
619 | REGULATION OF DNA REPLICATION | 6 | 161 | 0.0002292 | 0.001723 |
620 | SMAD PROTEIN SIGNAL TRANSDUCTION | 4 | 56 | 0.0002296 | 0.001723 |
621 | POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION | 5 | 103 | 0.0002304 | 0.001726 |
622 | MULTICELLULAR ORGANISM REPRODUCTION | 13 | 768 | 0.0002321 | 0.001736 |
623 | POSITIVE REGULATION OF NEURON DIFFERENTIATION | 8 | 306 | 0.0002408 | 0.001798 |
624 | NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION | 3 | 23 | 0.0002439 | 0.001813 |
625 | REGULATION OF OSTEOBLAST PROLIFERATION | 3 | 23 | 0.0002439 | 0.001813 |
626 | SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 3 | 23 | 0.0002439 | 0.001813 |
627 | APOPTOTIC MITOCHONDRIAL CHANGES | 4 | 57 | 0.0002459 | 0.001825 |
628 | REGULATION OF LEUKOCYTE DIFFERENTIATION | 7 | 232 | 0.0002518 | 0.001864 |
629 | ODONTOGENESIS | 5 | 105 | 0.000252 | 0.001864 |
630 | CELL SUBSTRATE ADHESION | 6 | 164 | 0.0002532 | 0.00187 |
631 | CARDIAC VENTRICLE DEVELOPMENT | 5 | 106 | 0.0002633 | 0.001942 |
632 | REGULATION OF EPITHELIAL CELL MIGRATION | 6 | 166 | 0.0002703 | 0.00199 |
633 | REGULATION OF HISTONE DEACETYLATION | 3 | 24 | 0.0002777 | 0.002028 |
634 | POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION | 3 | 24 | 0.0002777 | 0.002028 |
635 | EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS | 3 | 24 | 0.0002777 | 0.002028 |
636 | CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION | 3 | 24 | 0.0002777 | 0.002028 |
637 | REGULATION OF PROTEIN PHOSPHATASE TYPE 2A ACTIVITY | 3 | 24 | 0.0002777 | 0.002028 |
638 | RESPONSE TO CARBOHYDRATE | 6 | 168 | 0.0002883 | 0.002102 |
639 | NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS | 5 | 109 | 0.0002998 | 0.002179 |
640 | RESPONSE TO HYDROGEN PEROXIDE | 5 | 109 | 0.0002998 | 0.002179 |
641 | SINGLE ORGANISM CELLULAR LOCALIZATION | 14 | 898 | 0.000306 | 0.002221 |
642 | MEMBRANE ORGANIZATION | 14 | 899 | 0.0003095 | 0.002243 |
643 | REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION | 3 | 25 | 0.0003143 | 0.002271 |
644 | REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 3 | 25 | 0.0003143 | 0.002271 |
645 | ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY | 12 | 689 | 0.0003166 | 0.002284 |
646 | CELL CYCLE G1 S PHASE TRANSITION | 5 | 111 | 0.0003261 | 0.002341 |
647 | COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION | 5 | 111 | 0.0003261 | 0.002341 |
648 | G1 S TRANSITION OF MITOTIC CELL CYCLE | 5 | 111 | 0.0003261 | 0.002341 |
649 | SIGNAL RELEASE | 6 | 173 | 0.0003373 | 0.002418 |
650 | DEVELOPMENTAL PROGRAMMED CELL DEATH | 3 | 26 | 0.0003539 | 0.002526 |
651 | NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT | 3 | 26 | 0.0003539 | 0.002526 |
652 | REGULATION OF CELL FATE COMMITMENT | 3 | 26 | 0.0003539 | 0.002526 |
653 | NEUROEPITHELIAL CELL DIFFERENTIATION | 4 | 63 | 0.0003619 | 0.002578 |
654 | REGULATION OF ENDOTHELIAL CELL MIGRATION | 5 | 114 | 0.0003688 | 0.002624 |
655 | CELLULAR RESPONSE TO NITROGEN COMPOUND | 10 | 505 | 0.0003794 | 0.002695 |
656 | MITOCHONDRIAL TRANSPORT | 6 | 177 | 0.0003811 | 0.002703 |
657 | RESPONSE TO INTERLEUKIN 1 | 5 | 115 | 0.0003839 | 0.002719 |
658 | REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION | 3 | 27 | 0.0003966 | 0.0028 |
659 | NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION | 3 | 27 | 0.0003966 | 0.0028 |
660 | FEMALE SEX DIFFERENTIATION | 5 | 116 | 0.0003996 | 0.002817 |
661 | CELLULAR RESPONSE TO CYTOKINE STIMULUS | 11 | 606 | 0.0004027 | 0.002835 |
662 | NEGATIVE REGULATION OF AXONOGENESIS | 4 | 65 | 0.0004079 | 0.002867 |
663 | NEGATIVE REGULATION OF CYTOPLASMIC TRANSPORT | 5 | 117 | 0.0004156 | 0.002913 |
664 | CELLULAR RESPONSE TO STARVATION | 5 | 117 | 0.0004156 | 0.002913 |
665 | MACROMOLECULE CATABOLIC PROCESS | 14 | 926 | 0.0004167 | 0.002916 |
666 | PLACENTA BLOOD VESSEL DEVELOPMENT | 3 | 28 | 0.0004425 | 0.003073 |
667 | RESPONSE TO KETONE | 6 | 182 | 0.0004419 | 0.003073 |
668 | NEGATIVE REGULATION OF DENDRITE DEVELOPMENT | 3 | 28 | 0.0004425 | 0.003073 |
669 | MAMMARY GLAND DUCT MORPHOGENESIS | 3 | 28 | 0.0004425 | 0.003073 |
670 | METANEPHROS MORPHOGENESIS | 3 | 28 | 0.0004425 | 0.003073 |
671 | POSITIVE REGULATION OF NEURON DEATH | 4 | 67 | 0.0004581 | 0.003158 |
672 | POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION | 4 | 67 | 0.0004581 | 0.003158 |
673 | SYNAPTIC SIGNALING | 9 | 424 | 0.0004561 | 0.003158 |
674 | REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS | 4 | 67 | 0.0004581 | 0.003158 |
675 | REGULATION OF SISTER CHROMATID SEGREGATION | 4 | 67 | 0.0004581 | 0.003158 |
676 | REGULATION OF DENDRITE DEVELOPMENT | 5 | 120 | 0.0004668 | 0.003213 |
677 | POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION | 4 | 68 | 0.0004847 | 0.003331 |
678 | REGULATION OF MEIOTIC NUCLEAR DIVISION | 3 | 29 | 0.0004916 | 0.003369 |
679 | EMBRYONIC HINDLIMB MORPHOGENESIS | 3 | 29 | 0.0004916 | 0.003369 |
680 | CELLULAR RESPONSE TO INTERFERON GAMMA | 5 | 122 | 0.0005035 | 0.003445 |
681 | POSITIVE REGULATION OF AXONOGENESIS | 4 | 69 | 0.0005124 | 0.003501 |
682 | REGULATION OF HORMONE SECRETION | 7 | 262 | 0.0005232 | 0.00357 |
683 | ESTABLISHMENT OF PROTEIN LOCALIZATION | 18 | 1423 | 0.0005245 | 0.003573 |
684 | INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR | 3 | 30 | 0.0005441 | 0.003653 |
685 | ESTABLISHMENT OR MAINTENANCE OF EPITHELIAL CELL APICAL BASAL POLARITY | 3 | 30 | 0.0005441 | 0.003653 |
686 | SMOOTH MUSCLE CELL DIFFERENTIATION | 3 | 30 | 0.0005441 | 0.003653 |
687 | POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE | 3 | 30 | 0.0005441 | 0.003653 |
688 | NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS | 3 | 30 | 0.0005441 | 0.003653 |
689 | MUSCLE ORGAN MORPHOGENESIS | 4 | 70 | 0.0005413 | 0.003653 |
690 | INTERFERON GAMMA MEDIATED SIGNALING PATHWAY | 4 | 70 | 0.0005413 | 0.003653 |
691 | ESTABLISHMENT OF ENDOTHELIAL BARRIER | 3 | 30 | 0.0005441 | 0.003653 |
692 | MYELOID CELL DIFFERENTIATION | 6 | 189 | 0.0005394 | 0.003653 |
693 | REGULATION OF MEMBRANE PERMEABILITY | 4 | 70 | 0.0005413 | 0.003653 |
694 | INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE | 4 | 71 | 0.0005712 | 0.00383 |
695 | REGULATION OF NEURON APOPTOTIC PROCESS | 6 | 192 | 0.000586 | 0.003923 |
696 | SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION | 8 | 352 | 0.0006107 | 0.004077 |
697 | RESPONSE TO OXIDATIVE STRESS | 8 | 352 | 0.0006107 | 0.004077 |
698 | MUSCLE CELL DEVELOPMENT | 5 | 128 | 0.0006266 | 0.004177 |
699 | NEGATIVE REGULATION OF MAP KINASE ACTIVITY | 4 | 73 | 0.0006347 | 0.004213 |
700 | POSITIVE REGULATION OF PROTEIN BINDING | 4 | 73 | 0.0006347 | 0.004213 |
701 | G1 DNA DAMAGE CHECKPOINT | 4 | 73 | 0.0006347 | 0.004213 |
702 | PROTEIN ACETYLATION | 5 | 129 | 0.0006491 | 0.004296 |
703 | CELL JUNCTION ASSEMBLY | 5 | 129 | 0.0006491 | 0.004296 |
704 | REGULATION OF DENDRITE MORPHOGENESIS | 4 | 74 | 0.0006682 | 0.004404 |
705 | VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 4 | 74 | 0.0006682 | 0.004404 |
706 | CELL CELL JUNCTION ASSEMBLY | 4 | 74 | 0.0006682 | 0.004404 |
707 | REGULATION OF INNATE IMMUNE RESPONSE | 8 | 357 | 0.0006696 | 0.004407 |
708 | HOMEOSTATIC PROCESS | 17 | 1337 | 0.0007195 | 0.004729 |
709 | REGULATION OF PROTEIN EXPORT FROM NUCLEUS | 3 | 33 | 0.0007227 | 0.004736 |
710 | EMBRYONIC EYE MORPHOGENESIS | 3 | 33 | 0.0007227 | 0.004736 |
711 | CELLULAR RESPONSE TO HORMONE STIMULUS | 10 | 552 | 0.0007563 | 0.004949 |
712 | POSITIVE REGULATION OF DEFENSE RESPONSE | 8 | 364 | 0.0007597 | 0.004965 |
713 | REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL | 7 | 280 | 0.0007744 | 0.005054 |
714 | DIENCEPHALON DEVELOPMENT | 4 | 77 | 0.0007763 | 0.005059 |
715 | PLASMA MEMBRANE ORGANIZATION | 6 | 203 | 0.0007842 | 0.005103 |
716 | ORGAN FORMATION | 3 | 34 | 0.0007896 | 0.005124 |
717 | NEURAL TUBE PATTERNING | 3 | 34 | 0.0007896 | 0.005124 |
718 | NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION | 5 | 135 | 0.0007972 | 0.005166 |
719 | NEGATIVE REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY | 5 | 136 | 0.0008242 | 0.005333 |
720 | POSITIVE REGULATION OF SECRETION | 8 | 370 | 0.0008445 | 0.005457 |
721 | CIRCADIAN RHYTHM | 5 | 137 | 0.0008518 | 0.005489 |
722 | HINDBRAIN DEVELOPMENT | 5 | 137 | 0.0008518 | 0.005489 |
723 | REGULATION OF GASTRULATION | 3 | 35 | 0.0008603 | 0.005521 |
724 | RESPONSE TO MINERALOCORTICOID | 3 | 35 | 0.0008603 | 0.005521 |
725 | EMBRYONIC CAMERA TYPE EYE DEVELOPMENT | 3 | 35 | 0.0008603 | 0.005521 |
726 | DEPHOSPHORYLATION | 7 | 286 | 0.0008766 | 0.005618 |
727 | CELL CYCLE G2 M PHASE TRANSITION | 5 | 138 | 0.0008801 | 0.005633 |
728 | NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT | 4 | 80 | 0.0008962 | 0.005728 |
729 | REGULATION OF PEPTIDE SECRETION | 6 | 209 | 0.0009122 | 0.005822 |
730 | REGULATION OF PROTEIN COMPLEX ASSEMBLY | 8 | 375 | 0.0009208 | 0.005869 |
731 | T CELL PROLIFERATION | 3 | 36 | 0.0009349 | 0.005926 |
732 | POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 3 | 36 | 0.0009349 | 0.005926 |
733 | POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY | 3 | 36 | 0.0009349 | 0.005926 |
734 | HEAD MORPHOGENESIS | 3 | 36 | 0.0009349 | 0.005926 |
735 | METANEPHROS DEVELOPMENT | 4 | 81 | 0.0009389 | 0.005936 |
736 | POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION | 4 | 81 | 0.0009389 | 0.005936 |
737 | REGULATION OF CELL CELL ADHESION | 8 | 380 | 0.001003 | 0.006329 |
738 | HINDLIMB MORPHOGENESIS | 3 | 37 | 0.001013 | 0.006363 |
739 | NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION | 3 | 37 | 0.001013 | 0.006363 |
740 | ESTABLISHMENT OR MAINTENANCE OF APICAL BASAL CELL POLARITY | 3 | 37 | 0.001013 | 0.006363 |
741 | ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY | 3 | 37 | 0.001013 | 0.006363 |
742 | NEGATIVE REGULATION OF CELL CYCLE PROCESS | 6 | 214 | 0.001031 | 0.006447 |
743 | CELLULAR RESPONSE TO OXYGEN LEVELS | 5 | 143 | 0.001032 | 0.006447 |
744 | NIK NF KAPPAB SIGNALING | 4 | 83 | 0.001029 | 0.006447 |
745 | NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT | 5 | 143 | 0.001032 | 0.006447 |
746 | CATABOLIC PROCESS | 20 | 1773 | 0.001059 | 0.006606 |
747 | RESPONSE TO INTERFERON GAMMA | 5 | 144 | 0.001065 | 0.006633 |
748 | POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION | 4 | 84 | 0.001076 | 0.006691 |
749 | RESPONSE TO IONIZING RADIATION | 5 | 145 | 0.001098 | 0.006796 |
750 | NEGATIVE REGULATION OF MAPK CASCADE | 5 | 145 | 0.001098 | 0.006796 |
751 | SUBSTRATE ADHESION DEPENDENT CELL SPREADING | 3 | 38 | 0.001096 | 0.006796 |
752 | REGULATION OF MULTICELLULAR ORGANISMAL METABOLIC PROCESS | 3 | 38 | 0.001096 | 0.006796 |
753 | REGULATION OF CHROMOSOME SEGREGATION | 4 | 85 | 0.001124 | 0.006928 |
754 | EPHRIN RECEPTOR SIGNALING PATHWAY | 4 | 85 | 0.001124 | 0.006928 |
755 | POSITIVE REGULATION OF CHROMATIN MODIFICATION | 4 | 85 | 0.001124 | 0.006928 |
756 | T CELL RECEPTOR SIGNALING PATHWAY | 5 | 146 | 0.001132 | 0.006969 |
757 | CELLULAR RESPONSE TO STEROID HORMONE STIMULUS | 6 | 218 | 0.001134 | 0.006969 |
758 | REGULATION OF PROTEIN SECRETION | 8 | 389 | 0.001164 | 0.007147 |
759 | POSITIVE REGULATION OF VIRAL TRANSCRIPTION | 3 | 39 | 0.001183 | 0.007251 |
760 | TISSUE REMODELING | 4 | 87 | 0.001226 | 0.007505 |
761 | MAMMARY GLAND MORPHOGENESIS | 3 | 40 | 0.001274 | 0.007757 |
762 | APICAL JUNCTION ASSEMBLY | 3 | 40 | 0.001274 | 0.007757 |
763 | CALCIUM ION TRANSPORT | 6 | 223 | 0.001273 | 0.007757 |
764 | NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION | 3 | 40 | 0.001274 | 0.007757 |
765 | LEUKOCYTE PROLIFERATION | 4 | 88 | 0.001279 | 0.007769 |
766 | NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY | 4 | 88 | 0.001279 | 0.007769 |
767 | NEGATIVE REGULATION OF HYDROLASE ACTIVITY | 8 | 397 | 0.001325 | 0.008038 |
768 | REGULATION OF RESPONSE TO EXTERNAL STIMULUS | 13 | 926 | 0.001333 | 0.008078 |
769 | INTRINSIC APOPTOTIC SIGNALING PATHWAY | 5 | 152 | 0.001354 | 0.008195 |
770 | POSITIVE REGULATION OF KIDNEY DEVELOPMENT | 3 | 41 | 0.001369 | 0.00824 |
771 | NEGATIVE REGULATION OF STRESS ACTIVATED MAPK CASCADE | 3 | 41 | 0.001369 | 0.00824 |
772 | NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE | 3 | 41 | 0.001369 | 0.00824 |
773 | PROSTATE GLAND DEVELOPMENT | 3 | 41 | 0.001369 | 0.00824 |
774 | ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE | 4 | 90 | 0.00139 | 0.008356 |
775 | HEMOSTASIS | 7 | 311 | 0.001422 | 0.00854 |
776 | CELL CYCLE ARREST | 5 | 154 | 0.001435 | 0.008593 |
777 | RESPONSE TO STARVATION | 5 | 154 | 0.001435 | 0.008593 |
778 | PEPTIDYL LYSINE MODIFICATION | 7 | 312 | 0.001449 | 0.008665 |
779 | DENDRITE MORPHOGENESIS | 3 | 42 | 0.001469 | 0.008749 |
780 | REGULATION OF MITOPHAGY | 3 | 42 | 0.001469 | 0.008749 |
781 | GENITALIA DEVELOPMENT | 3 | 42 | 0.001469 | 0.008749 |
782 | PRIMITIVE STREAK FORMATION | 2 | 11 | 0.001511 | 0.008912 |
783 | ENDOCARDIUM DEVELOPMENT | 2 | 11 | 0.001511 | 0.008912 |
784 | NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 2 | 11 | 0.001511 | 0.008912 |
785 | MITOCHONDRIAL MEMBRANE ORGANIZATION | 4 | 92 | 0.001508 | 0.008912 |
786 | REGULATION OF HEMOPOIESIS | 7 | 314 | 0.001503 | 0.008912 |
787 | OLFACTORY BULB INTERNEURON DEVELOPMENT | 2 | 11 | 0.001511 | 0.008912 |
788 | ENDOTHELIAL TUBE MORPHOGENESIS | 2 | 11 | 0.001511 | 0.008912 |
789 | POSITIVE REGULATION OF NFAT PROTEIN IMPORT INTO NUCLEUS | 2 | 11 | 0.001511 | 0.008912 |
790 | PROTEIN LOCALIZATION TO NUCLEUS | 5 | 156 | 0.001519 | 0.008947 |
791 | POSITIVE REGULATION OF MULTI ORGANISM PROCESS | 5 | 157 | 0.001562 | 0.009191 |
792 | EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS | 4 | 93 | 0.001569 | 0.009216 |
793 | REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 3 | 43 | 0.001573 | 0.009216 |
794 | CEREBRAL CORTEX CELL MIGRATION | 3 | 43 | 0.001573 | 0.009216 |
795 | RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 6 | 233 | 0.001592 | 0.009306 |
796 | REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING | 6 | 233 | 0.001592 | 0.009306 |
797 | REGULATION OF SYSTEM PROCESS | 9 | 507 | 0.001604 | 0.009366 |
798 | REGULATION OF DNA BIOSYNTHETIC PROCESS | 4 | 94 | 0.001632 | 0.009516 |
799 | CELLULAR RESPONSE TO DNA DAMAGE STIMULUS | 11 | 720 | 0.001642 | 0.009562 |
800 | PROTEIN ACYLATION | 5 | 159 | 0.001652 | 0.009608 |
801 | BODY MORPHOGENESIS | 3 | 44 | 0.001681 | 0.009753 |
802 | NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION | 3 | 44 | 0.001681 | 0.009753 |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | FRIZZLED BINDING | 18 | 36 | 2.402e-32 | 2.231e-29 |
2 | BETA CATENIN BINDING | 18 | 84 | 2.054e-24 | 9.541e-22 |
3 | WNT ACTIVATED RECEPTOR ACTIVITY | 12 | 22 | 1.8e-22 | 5.573e-20 |
4 | WNT PROTEIN BINDING | 13 | 31 | 2.635e-22 | 6.12e-20 |
5 | G PROTEIN COUPLED RECEPTOR BINDING | 18 | 259 | 2.409e-15 | 4.476e-13 |
6 | ENZYME BINDING | 38 | 1737 | 1.137e-14 | 1.76e-12 |
7 | PROTEIN SERINE THREONINE KINASE ACTIVITY | 21 | 445 | 2.098e-14 | 2.785e-12 |
8 | TRANSCRIPTION FACTOR BINDING | 21 | 524 | 5.015e-13 | 5.824e-11 |
9 | RECEPTOR BINDING | 33 | 1476 | 6.254e-13 | 6.456e-11 |
10 | PROTEIN KINASE ACTIVITY | 22 | 640 | 2.753e-12 | 2.557e-10 |
11 | RECEPTOR AGONIST ACTIVITY | 6 | 16 | 1.56e-10 | 1.318e-08 |
12 | SIGNAL TRANSDUCER ACTIVITY | 32 | 1731 | 2.25e-10 | 1.742e-08 |
13 | KINASE ACTIVITY | 22 | 842 | 5.383e-10 | 3.847e-08 |
14 | REGULATORY REGION NUCLEIC ACID BINDING | 21 | 818 | 1.937e-09 | 1.285e-07 |
15 | KINASE BINDING | 18 | 606 | 3.406e-09 | 2.11e-07 |
16 | SMAD BINDING | 8 | 72 | 4.64e-09 | 2.536e-07 |
17 | RNA POLYMERASE II TRANSCRIPTION FACTOR BINDING | 9 | 104 | 4.595e-09 | 2.536e-07 |
18 | ARMADILLO REPEAT DOMAIN BINDING | 5 | 13 | 4.961e-09 | 2.561e-07 |
19 | PROTEIN DOMAIN SPECIFIC BINDING | 18 | 624 | 5.378e-09 | 2.629e-07 |
20 | CORE PROMOTER PROXIMAL REGION DNA BINDING | 14 | 371 | 1.143e-08 | 5.056e-07 |
21 | TRANSFERASE ACTIVITY TRANSFERRING PHOSPHORUS CONTAINING GROUPS | 22 | 992 | 1.098e-08 | 5.056e-07 |
22 | RECEPTOR ACTIVATOR ACTIVITY | 6 | 32 | 1.647e-08 | 6.956e-07 |
23 | UBIQUITIN LIKE PROTEIN LIGASE BINDING | 12 | 264 | 1.778e-08 | 7.183e-07 |
24 | MOLECULAR FUNCTION REGULATOR | 25 | 1353 | 3.479e-08 | 1.347e-06 |
25 | TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC BINDING | 12 | 315 | 1.232e-07 | 4.442e-06 |
26 | R SMAD BINDING | 5 | 23 | 1.243e-07 | 4.442e-06 |
27 | RECEPTOR REGULATOR ACTIVITY | 6 | 45 | 1.399e-07 | 4.815e-06 |
28 | RNA POLYMERASE II TRANSCRIPTION FACTOR ACTIVITY SEQUENCE SPECIFIC DNA BINDING | 16 | 629 | 2.311e-07 | 7.668e-06 |
29 | I SMAD BINDING | 4 | 11 | 2.482e-07 | 7.953e-06 |
30 | GAMMA CATENIN BINDING | 4 | 12 | 3.708e-07 | 1.148e-05 |
31 | PDZ DOMAIN BINDING | 7 | 90 | 5.338e-07 | 1.6e-05 |
32 | ACTIVATING TRANSCRIPTION FACTOR BINDING | 6 | 57 | 5.919e-07 | 1.718e-05 |
33 | MAP KINASE ACTIVITY | 4 | 14 | 7.438e-07 | 2.094e-05 |
34 | RNA POLYMERASE II ACTIVATING TRANSCRIPTION FACTOR BINDING | 5 | 36 | 1.318e-06 | 3.601e-05 |
35 | TRANSCRIPTION FACTOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING | 11 | 328 | 1.491e-06 | 3.956e-05 |
36 | PROTEIN DIMERIZATION ACTIVITY | 20 | 1149 | 2.605e-06 | 6.722e-05 |
37 | DOUBLE STRANDED DNA BINDING | 16 | 764 | 2.971e-06 | 7.439e-05 |
38 | TRANSCRIPTION FACTOR ACTIVITY PROTEIN BINDING | 14 | 588 | 3.043e-06 | 7.439e-05 |
39 | TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING | 9 | 226 | 3.518e-06 | 8.381e-05 |
40 | CHROMATIN BINDING | 12 | 435 | 3.698e-06 | 8.588e-05 |
41 | RHO GTPASE BINDING | 6 | 78 | 3.826e-06 | 8.608e-05 |
42 | RIBONUCLEOTIDE BINDING | 26 | 1860 | 3.892e-06 | 8.608e-05 |
43 | RECEPTOR SIGNALING PROTEIN ACTIVITY | 8 | 172 | 4.019e-06 | 8.666e-05 |
44 | ADENYL NUCLEOTIDE BINDING | 23 | 1514 | 4.104e-06 | 8.666e-05 |
45 | CALMODULIN DEPENDENT PROTEIN KINASE ACTIVITY | 4 | 28 | 1.436e-05 | 0.0002965 |
46 | NUCLEIC ACID BINDING TRANSCRIPTION FACTOR ACTIVITY | 19 | 1199 | 1.823e-05 | 0.0003681 |
47 | P53 BINDING | 5 | 67 | 2.96e-05 | 0.000585 |
48 | SEQUENCE SPECIFIC DNA BINDING | 17 | 1037 | 3.491e-05 | 0.0006756 |
49 | CALMODULIN BINDING | 7 | 179 | 5.024e-05 | 0.0009525 |
50 | PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR BINDING | 3 | 15 | 6.464e-05 | 0.001201 |
51 | RECEPTOR SIGNALING PROTEIN SERINE THREONINE KINASE ACTIVITY | 5 | 92 | 0.0001356 | 0.00247 |
52 | ENZYME REGULATOR ACTIVITY | 15 | 959 | 0.000177 | 0.003163 |
53 | PROTEIN PHOSPHATASE TYPE 2A REGULATOR ACTIVITY | 3 | 21 | 0.0001846 | 0.003236 |
54 | TRANSCRIPTION COACTIVATOR ACTIVITY | 8 | 296 | 0.0001922 | 0.003307 |
55 | PROTEIN HETERODIMERIZATION ACTIVITY | 10 | 468 | 0.0002073 | 0.003502 |
56 | PROTEIN SERINE THREONINE PHOSPHATASE ACTIVITY | 4 | 64 | 0.0003844 | 0.006377 |
57 | BHLH TRANSCRIPTION FACTOR BINDING | 3 | 28 | 0.0004425 | 0.006967 |
58 | CADHERIN BINDING | 3 | 28 | 0.0004425 | 0.006967 |
59 | MACROMOLECULAR COMPLEX BINDING | 18 | 1399 | 0.0004285 | 0.006967 |
60 | NF KAPPAB BINDING | 3 | 30 | 0.0005441 | 0.008425 |
61 | PHOSPHOLIPASE C ACTIVITY | 3 | 31 | 0.0006001 | 0.009139 |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | WNT SIGNALOSOME | 9 | 11 | 1.388e-19 | 8.105e-17 |
2 | BETA CATENIN DESTRUCTION COMPLEX | 8 | 14 | 1.503e-15 | 4.39e-13 |
3 | ENDOCYTIC VESICLE MEMBRANE | 13 | 152 | 1.646e-12 | 3.204e-10 |
4 | ENDOCYTIC VESICLE | 13 | 256 | 1.137e-09 | 1.66e-07 |
5 | EXTRACELLULAR MATRIX | 15 | 426 | 8.328e-09 | 5.517e-07 |
6 | PHOSPHATASE COMPLEX | 7 | 48 | 6.323e-09 | 5.517e-07 |
7 | TRANSCRIPTION FACTOR COMPLEX | 13 | 298 | 7.118e-09 | 5.517e-07 |
8 | PROTEINACEOUS EXTRACELLULAR MATRIX | 14 | 356 | 6.777e-09 | 5.517e-07 |
9 | LATERAL PLASMA MEMBRANE | 7 | 50 | 8.503e-09 | 5.517e-07 |
10 | CATALYTIC COMPLEX | 22 | 1038 | 2.474e-08 | 1.445e-06 |
11 | CHROMOSOME | 20 | 880 | 3.803e-08 | 2.019e-06 |
12 | NUCLEAR CHROMATIN | 12 | 291 | 5.201e-08 | 2.531e-06 |
13 | PROTEIN PHOSPHATASE TYPE 2A COMPLEX | 5 | 20 | 5.801e-08 | 2.606e-06 |
14 | CHROMATIN | 14 | 441 | 9.831e-08 | 4.101e-06 |
15 | NUCLEAR TRANSCRIPTION FACTOR COMPLEX | 8 | 127 | 4.078e-07 | 1.588e-05 |
16 | VESICLE MEMBRANE | 14 | 512 | 5.986e-07 | 2.185e-05 |
17 | INTRACELLULAR VESICLE | 22 | 1259 | 7.014e-07 | 2.41e-05 |
18 | SYNAPSE | 16 | 754 | 2.509e-06 | 8.115e-05 |
19 | CELL SURFACE | 16 | 757 | 2.64e-06 | 8.115e-05 |
20 | CYTOPLASMIC VESICLE PART | 14 | 601 | 3.916e-06 | 0.0001143 |
21 | CYTOSKELETAL PART | 22 | 1436 | 6.066e-06 | 0.0001687 |
22 | GOLGI LUMEN | 6 | 94 | 1.132e-05 | 0.0003004 |
23 | MICROTUBULE CYTOSKELETON | 18 | 1068 | 1.375e-05 | 0.0003491 |
24 | RNA POLYMERASE II TRANSCRIPTION FACTOR COMPLEX | 6 | 101 | 1.709e-05 | 0.0004159 |
25 | NUCLEAR CHROMOSOME | 12 | 523 | 2.345e-05 | 0.0005477 |
26 | CYTOSKELETON | 25 | 1967 | 3.208e-05 | 0.0007206 |
27 | LAMELLIPODIUM | 7 | 172 | 3.899e-05 | 0.0008433 |
28 | TRANSFERASE COMPLEX | 13 | 703 | 9.714e-05 | 0.002026 |
29 | SYNAPSE PART | 12 | 610 | 0.0001029 | 0.002073 |
30 | PROTEIN KINASE COMPLEX | 5 | 90 | 0.0001222 | 0.002363 |
31 | MICROTUBULE ORGANIZING CENTER | 12 | 623 | 0.0001254 | 0.002363 |
32 | NUCLEAR MEMBRANE | 8 | 280 | 0.0001315 | 0.0024 |
33 | CENTROSOME | 10 | 487 | 0.0002849 | 0.005041 |
34 | CHROMOSOME CENTROMERIC REGION | 6 | 174 | 0.0003479 | 0.005975 |
35 | NUCLEAR ENVELOPE | 9 | 416 | 0.0003974 | 0.006559 |
36 | NUCLEOPLASM PART | 12 | 708 | 0.0004044 | 0.006559 |
37 | CYCLIN DEPENDENT PROTEIN KINASE HOLOENZYME COMPLEX | 3 | 31 | 0.0006001 | 0.009471 |
38 | APICAL JUNCTION COMPLEX | 5 | 128 | 0.0006266 | 0.009629 |
39 | EXCITATORY SYNAPSE | 6 | 197 | 0.0006706 | 0.00979 |
40 | TRANSCRIPTIONAL REPRESSOR COMPLEX | 4 | 74 | 0.0006682 | 0.00979 |
Num | Pathway | Pathview | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|---|
1 | hsa04310_Wnt_signaling_pathway | 107 | 151 | 2.657e-250 | 4.783e-248 | |
2 | hsa04916_Melanogenesis | 39 | 101 | 1.115e-64 | 1.004e-62 | |
3 | hsa04390_Hippo_signaling_pathway | 43 | 154 | 2.352e-64 | 1.411e-62 | |
4 | hsa04340_Hedgehog_signaling_pathway | 20 | 56 | 3.789e-32 | 1.705e-30 | |
5 | hsa04720_Long.term_potentiation | 15 | 70 | 1.72e-20 | 6.193e-19 | |
6 | hsa04114_Oocyte_meiosis | 16 | 114 | 1.178e-18 | 3.534e-17 | |
7 | hsa04520_Adherens_junction | 14 | 73 | 1.859e-18 | 4.78e-17 | |
8 | hsa04912_GnRH_signaling_pathway | 15 | 101 | 6.202e-18 | 1.395e-16 | |
9 | hsa04350_TGF.beta_signaling_pathway | 13 | 85 | 7.45e-16 | 1.49e-14 | |
10 | hsa04010_MAPK_signaling_pathway | 18 | 268 | 4.377e-15 | 7.879e-14 | |
11 | hsa04510_Focal_adhesion | 16 | 200 | 1.066e-14 | 1.745e-13 | |
12 | hsa04012_ErbB_signaling_pathway | 12 | 87 | 3.709e-14 | 5.563e-13 | |
13 | hsa04722_Neurotrophin_signaling_pathway | 13 | 127 | 1.595e-13 | 2.209e-12 | |
14 | hsa04971_Gastric_acid_secretion | 11 | 74 | 1.917e-13 | 2.464e-12 | |
15 | hsa04662_B_cell_receptor_signaling_pathway | 11 | 75 | 2.236e-13 | 2.683e-12 | |
16 | hsa04110_Cell_cycle | 12 | 128 | 4.141e-12 | 4.659e-11 | |
17 | hsa04360_Axon_guidance | 12 | 130 | 4.986e-12 | 5.279e-11 | |
18 | hsa04370_VEGF_signaling_pathway | 10 | 76 | 8.897e-12 | 8.897e-11 | |
19 | hsa04020_Calcium_signaling_pathway | 13 | 177 | 1.152e-11 | 1.092e-10 | |
20 | hsa04660_T_cell_receptor_signaling_pathway | 11 | 108 | 1.361e-11 | 1.225e-10 | |
21 | hsa04062_Chemokine_signaling_pathway | 12 | 189 | 4.05e-10 | 3.471e-09 | |
22 | hsa04270_Vascular_smooth_muscle_contraction | 10 | 116 | 6.37e-10 | 5.212e-09 | |
23 | hsa04380_Osteoclast_differentiation | 10 | 128 | 1.68e-09 | 1.315e-08 | |
24 | hsa04650_Natural_killer_cell_mediated_cytotoxicity | 10 | 136 | 3.038e-09 | 2.279e-08 | |
25 | hsa04730_Long.term_depression | 8 | 70 | 3.692e-09 | 2.658e-08 | |
26 | hsa04151_PI3K_AKT_signaling_pathway | 13 | 351 | 4.929e-08 | 3.412e-07 | |
27 | hsa04670_Leukocyte_transendothelial_migration | 8 | 117 | 2.168e-07 | 1.397e-06 | |
28 | hsa04664_Fc_epsilon_RI_signaling_pathway | 7 | 79 | 2.173e-07 | 1.397e-06 | |
29 | hsa04970_Salivary_secretion | 7 | 89 | 4.945e-07 | 3.069e-06 | |
30 | hsa04540_Gap_junction | 7 | 90 | 5.338e-07 | 3.203e-06 | |
31 | hsa04530_Tight_junction | 8 | 133 | 5.805e-07 | 3.371e-06 | |
32 | hsa04972_Pancreatic_secretion | 7 | 101 | 1.171e-06 | 6.588e-06 | |
33 | hsa04014_Ras_signaling_pathway | 9 | 236 | 5.005e-06 | 2.709e-05 | |
34 | hsa04330_Notch_signaling_pathway | 5 | 47 | 5.117e-06 | 2.709e-05 | |
35 | hsa04710_Circadian_rhythm_._mammal | 4 | 23 | 6.34e-06 | 3.26e-05 | |
36 | hsa04620_Toll.like_receptor_signaling_pathway | 6 | 102 | 1.808e-05 | 9.041e-05 | |
37 | hsa04115_p53_signaling_pathway | 5 | 69 | 3.415e-05 | 0.0001661 | |
38 | hsa04070_Phosphatidylinositol_signaling_system | 5 | 78 | 6.175e-05 | 0.0002925 | |
39 | hsa03015_mRNA_surveillance_pathway | 5 | 83 | 8.315e-05 | 0.0003838 | |
40 | hsa04910_Insulin_signaling_pathway | 6 | 138 | 9.878e-05 | 0.0004445 | |
41 | hsa04914_Progesterone.mediated_oocyte_maturation | 5 | 87 | 0.000104 | 0.0004568 | |
42 | hsa04210_Apoptosis | 5 | 89 | 0.0001159 | 0.0004967 | |
43 | hsa04810_Regulation_of_actin_cytoskeleton | 7 | 214 | 0.0001535 | 0.0006428 | |
44 | hsa04630_Jak.STAT_signaling_pathway | 6 | 155 | 0.0001866 | 0.0007633 | |
45 | hsa04621_NOD.like_receptor_signaling_pathway | 4 | 59 | 0.000281 | 0.001124 | |
46 | hsa04622_RIG.I.like_receptor_signaling_pathway | 4 | 71 | 0.0005712 | 0.002235 | |
47 | hsa04666_Fc_gamma_R.mediated_phagocytosis | 4 | 95 | 0.001697 | 0.006499 | |
48 | hsa04742_Taste_transduction | 3 | 52 | 0.00272 | 0.0102 | |
49 | hsa00562_Inositol_phosphate_metabolism | 3 | 57 | 0.003532 | 0.01297 | |
50 | hsa04920_Adipocytokine_signaling_pathway | 3 | 68 | 0.005798 | 0.02087 | |
51 | hsa04120_Ubiquitin_mediated_proteolysis | 4 | 139 | 0.006638 | 0.02343 | |
52 | hsa04141_Protein_processing_in_endoplasmic_reticulum | 4 | 168 | 0.01269 | 0.04394 | |
53 | hsa04740_Olfactory_transduction | 6 | 388 | 0.01801 | 0.06117 | |
54 | hsa04960_Aldosterone.regulated_sodium_reabsorption | 2 | 42 | 0.02124 | 0.07081 | |
55 | hsa04962_Vasopressin.regulated_water_reabsorption | 2 | 44 | 0.02318 | 0.07451 | |
56 | hsa04973_Carbohydrate_digestion_and_absorption | 2 | 44 | 0.02318 | 0.07451 | |
57 | hsa04976_Bile_secretion | 2 | 71 | 0.05551 | 0.1753 | |
58 | hsa04144_Endocytosis | 3 | 203 | 0.09537 | 0.296 |
Num | lncRNA | miRNAs | miRNAs count | Gene | Sponge regulatory network | lncRNA log2FC | lncRNA pvalue | Gene log2FC | Gene pvalue | lncRNA-gene Pearson correlation |
---|---|---|---|---|---|---|---|---|---|---|
1 | MAGI2-AS3 |
hsa-miR-141-5p;hsa-miR-182-5p;hsa-miR-18a-5p;hsa-miR-193a-3p;hsa-miR-1976;hsa-miR-19b-3p;hsa-miR-205-5p;hsa-miR-339-5p;hsa-miR-429;hsa-miR-589-3p;hsa-miR-590-3p | 11 | DAAM2 | Sponge network | -0.939 | 4.0E-5 | -0.579 | 0.01161 | 0.796 |
2 | MAGI2-AS3 |
hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-let-7g-3p;hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-141-3p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-17-3p;hsa-miR-17-5p;hsa-miR-185-5p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-224-3p;hsa-miR-25-3p;hsa-miR-27a-3p;hsa-miR-301a-3p;hsa-miR-33a-3p;hsa-miR-3934-5p;hsa-miR-429;hsa-miR-452-5p;hsa-miR-454-3p;hsa-miR-576-5p;hsa-miR-589-3p;hsa-miR-590-3p;hsa-miR-629-3p;hsa-miR-7-1-3p;hsa-miR-708-5p;hsa-miR-92a-3p;hsa-miR-940 | 33 | FZD4 | Sponge network | -0.939 | 4.0E-5 | -0.816 | 0 | 0.755 |
3 | LINC00702 |
hsa-miR-130b-5p;hsa-miR-138-5p;hsa-miR-148a-3p;hsa-miR-148b-5p;hsa-miR-15b-3p;hsa-miR-19b-1-5p;hsa-miR-205-5p;hsa-miR-25-3p;hsa-miR-27b-3p;hsa-miR-30d-5p;hsa-miR-30e-5p;hsa-miR-331-3p;hsa-miR-363-3p;hsa-miR-582-3p;hsa-miR-7-1-3p;hsa-miR-92a-3p;hsa-miR-92b-3p | 17 | CAMK2A | Sponge network | -0.573 | 0.0699 | -1.032 | 0.00875 | 0.712 |
4 | MAGI2-AS3 |
hsa-let-7a-3p;hsa-miR-103a-3p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-205-5p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-26b-3p;hsa-miR-29a-5p;hsa-miR-429;hsa-miR-582-5p;hsa-miR-590-3p;hsa-miR-944 | 15 | AXIN2 | Sponge network | -0.939 | 4.0E-5 | -0.655 | 0.00118 | 0.682 |
5 | MAGI2-AS3 |
hsa-miR-193a-3p;hsa-miR-221-3p;hsa-miR-27a-3p;hsa-miR-324-5p;hsa-miR-33a-3p;hsa-miR-3607-3p;hsa-miR-455-5p;hsa-miR-576-5p;hsa-miR-590-3p;hsa-miR-944 | 10 | DKK2 | Sponge network | -0.939 | 4.0E-5 | -0.436 | 0.09649 | 0.66 |
6 | RP11-166D19.1 |
hsa-let-7a-3p;hsa-let-7g-3p;hsa-miR-141-3p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-17-3p;hsa-miR-17-5p;hsa-miR-185-5p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-20a-5p;hsa-miR-224-3p;hsa-miR-27a-3p;hsa-miR-301a-3p;hsa-miR-324-3p;hsa-miR-33a-3p;hsa-miR-3934-5p;hsa-miR-429;hsa-miR-452-5p;hsa-miR-454-3p;hsa-miR-455-3p;hsa-miR-484;hsa-miR-576-5p;hsa-miR-589-3p;hsa-miR-590-5p;hsa-miR-629-3p;hsa-miR-7-1-3p;hsa-miR-92a-3p;hsa-miR-940 | 30 | FZD4 | Sponge network | -0.882 | 5.0E-5 | -0.816 | 0 | 0.603 |
7 | LINC00702 |
hsa-let-7g-3p;hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-141-3p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-17-3p;hsa-miR-17-5p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-20a-5p;hsa-miR-224-3p;hsa-miR-25-3p;hsa-miR-301a-3p;hsa-miR-3065-3p;hsa-miR-324-3p;hsa-miR-33a-3p;hsa-miR-3934-5p;hsa-miR-454-3p;hsa-miR-484;hsa-miR-576-5p;hsa-miR-589-3p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-629-3p;hsa-miR-7-1-3p;hsa-miR-92a-3p;hsa-miR-92b-3p;hsa-miR-940 | 30 | FZD4 | Sponge network | -0.573 | 0.0699 | -0.816 | 0 | 0.568 |
8 | RP11-150O12.1 | hsa-miR-140-5p;hsa-miR-148a-3p;hsa-miR-148b-3p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-195-5p;hsa-miR-28-5p;hsa-miR-30b-3p;hsa-miR-423-5p;hsa-miR-769-5p | 10 | PPARD | Sponge network | 1.523 | 0 | 0.352 | 0.00541 | 0.565 |
9 | EMX2OS |
hsa-miR-138-5p;hsa-miR-141-5p;hsa-miR-182-5p;hsa-miR-18a-5p;hsa-miR-1976;hsa-miR-19b-3p;hsa-miR-205-5p;hsa-miR-339-5p;hsa-miR-589-3p;hsa-miR-590-3p;hsa-miR-9-5p | 11 | DAAM2 | Sponge network | -1.459 | 1.0E-5 | -0.579 | 0.01161 | 0.562 |
10 | CTD-2003C8.2 | hsa-miR-10a-5p;hsa-miR-130b-5p;hsa-miR-138-5p;hsa-miR-148a-3p;hsa-miR-148b-5p;hsa-miR-15b-3p;hsa-miR-19b-1-5p;hsa-miR-205-5p;hsa-miR-25-3p;hsa-miR-27b-3p | 10 | CAMK2A | Sponge network | -0.024 | 0.94289 | -1.032 | 0.00875 | 0.554 |
11 | RP11-389C8.2 |
hsa-let-7a-3p;hsa-miR-141-3p;hsa-miR-17-5p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-20a-5p;hsa-miR-224-3p;hsa-miR-27a-3p;hsa-miR-301a-3p;hsa-miR-3065-3p;hsa-miR-429;hsa-miR-589-3p | 12 | FZD4 | Sponge network | 0.187 | 0.31051 | -0.816 | 0 | 0.54 |
12 | RP11-815I9.4 |
hsa-let-7a-3p;hsa-miR-15a-5p;hsa-miR-16-1-3p;hsa-miR-17-5p;hsa-miR-181b-5p;hsa-miR-193a-3p;hsa-miR-205-5p;hsa-miR-20a-5p;hsa-miR-29b-3p;hsa-miR-671-5p | 10 | LRP6 | Sponge network | 0.004 | 0.98116 | -0.291 | 0.0285 | 0.54 |
13 | EMX2OS |
hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-let-7g-3p;hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-141-3p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-17-3p;hsa-miR-17-5p;hsa-miR-185-5p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-224-3p;hsa-miR-25-3p;hsa-miR-301a-3p;hsa-miR-3065-3p;hsa-miR-324-3p;hsa-miR-33a-3p;hsa-miR-3934-5p;hsa-miR-454-3p;hsa-miR-484;hsa-miR-505-5p;hsa-miR-576-5p;hsa-miR-589-3p;hsa-miR-590-3p;hsa-miR-629-3p;hsa-miR-7-1-3p;hsa-miR-708-5p;hsa-miR-92a-3p;hsa-miR-92b-3p;hsa-miR-940 | 35 | FZD4 | Sponge network | -1.459 | 1.0E-5 | -0.816 | 0 | 0.538 |
14 | RP11-58E21.3 |
hsa-miR-125a-5p;hsa-miR-125b-5p;hsa-miR-130b-3p;hsa-miR-130b-5p;hsa-miR-181c-5p;hsa-miR-182-5p;hsa-miR-194-5p;hsa-miR-218-5p;hsa-miR-335-3p;hsa-miR-335-5p;hsa-miR-500a-3p;hsa-miR-96-5p | 12 | DAAM1 | Sponge network | 0.445 | 0.04375 | -0.372 | 0.02951 | 0.537 |
15 | MAGI2-AS3 |
hsa-miR-130b-5p;hsa-miR-16-2-3p;hsa-miR-182-5p;hsa-miR-186-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-205-3p;hsa-miR-222-3p;hsa-miR-2355-3p;hsa-miR-2355-5p;hsa-miR-26b-3p;hsa-miR-27b-5p;hsa-miR-29a-5p;hsa-miR-30c-5p;hsa-miR-320a;hsa-miR-320b;hsa-miR-33a-3p;hsa-miR-3607-3p;hsa-miR-3613-5p;hsa-miR-7-1-3p | 20 | NFATC2 | Sponge network | -0.939 | 4.0E-5 | -1.255 | 0.00017 | 0.524 |
16 | RP11-193H5.1 |
hsa-miR-130b-5p;hsa-miR-16-2-3p;hsa-miR-182-5p;hsa-miR-186-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-2355-5p;hsa-miR-29a-5p;hsa-miR-320a;hsa-miR-7-1-3p | 10 | NFATC2 | Sponge network | -0.426 | 0.01062 | -1.255 | 0.00017 | 0.518 |
17 | RP11-815I9.4 |
hsa-miR-103a-3p;hsa-miR-148b-5p;hsa-miR-15a-5p;hsa-miR-16-1-3p;hsa-miR-17-5p;hsa-miR-186-5p;hsa-miR-20a-5p;hsa-miR-29b-3p;hsa-miR-30c-5p;hsa-miR-320a;hsa-miR-361-3p;hsa-miR-576-5p;hsa-miR-590-5p;hsa-miR-664a-3p | 14 | NFAT5 | Sponge network | 0.004 | 0.98116 | -0.144 | 0.16169 | 0.517 |
18 | MEG3 | hsa-let-7f-1-3p;hsa-miR-106b-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-17-3p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-224-3p;hsa-miR-27a-3p;hsa-miR-324-3p;hsa-miR-33a-3p;hsa-miR-3934-5p;hsa-miR-429;hsa-miR-452-5p;hsa-miR-455-3p;hsa-miR-629-3p;hsa-miR-7-1-3p | 17 | FZD4 | Sponge network | -0.286 | 0.30726 | -0.816 | 0 | 0.51 |
19 | RP11-594N15.3 |
hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-141-3p;hsa-miR-15a-5p;hsa-miR-17-5p;hsa-miR-185-5p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-27a-3p;hsa-miR-301a-3p;hsa-miR-484;hsa-miR-940 | 14 | FZD4 | Sponge network | -2.86 | 0 | -0.816 | 0 | 0.499 |
20 | EMX2OS |
hsa-miR-130b-5p;hsa-miR-138-5p;hsa-miR-148b-5p;hsa-miR-15b-3p;hsa-miR-19b-1-5p;hsa-miR-205-5p;hsa-miR-25-3p;hsa-miR-331-3p;hsa-miR-582-3p;hsa-miR-7-1-3p;hsa-miR-92a-3p;hsa-miR-92b-3p;hsa-miR-939-5p | 13 | CAMK2A | Sponge network | -1.459 | 1.0E-5 | -1.032 | 0.00875 | 0.496 |
21 | DNM3OS |
hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-141-3p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-17-3p;hsa-miR-17-5p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-20a-5p;hsa-miR-224-3p;hsa-miR-27a-3p;hsa-miR-33a-3p;hsa-miR-429;hsa-miR-590-5p;hsa-miR-7-1-3p | 16 | FZD4 | Sponge network | 0.932 | 0.00442 | -0.816 | 0 | 0.495 |
22 | SH3RF3-AS1 |
hsa-let-7a-3p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-205-5p;hsa-miR-222-3p;hsa-miR-26b-3p;hsa-miR-29a-5p;hsa-miR-582-5p | 10 | AXIN2 | Sponge network | -0.175 | 0.58985 | -0.655 | 0.00118 | 0.494 |
23 | MAGI2-AS3 |
hsa-miR-106a-5p;hsa-miR-130a-3p;hsa-miR-142-3p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-205-5p;hsa-miR-20a-5p;hsa-miR-26b-5p;hsa-miR-301a-3p;hsa-miR-30c-5p;hsa-miR-320a;hsa-miR-454-3p;hsa-miR-590-3p;hsa-miR-7-1-3p;hsa-miR-93-5p | 17 | PLCB1 | Sponge network | -0.939 | 4.0E-5 | -0.023 | 0.91504 | 0.484 |
24 | SH3RF3-AS1 |
hsa-let-7a-3p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-505-5p;hsa-miR-576-5p;hsa-miR-590-5p;hsa-miR-7-1-3p | 10 | FZD4 | Sponge network | -0.175 | 0.58985 | -0.816 | 0 | 0.475 |
25 | AC108142.1 |
hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-27b-5p;hsa-miR-29b-2-5p;hsa-miR-30d-3p;hsa-miR-30e-3p;hsa-miR-362-5p;hsa-miR-374a-5p;hsa-miR-429;hsa-miR-532-3p | 10 | PRKCA | Sponge network | 2.31 | 0 | 0.318 | 0.04622 | 0.474 |
26 | RP11-193H5.1 |
hsa-miR-103a-3p;hsa-miR-1301-3p;hsa-miR-130b-5p;hsa-miR-148b-5p;hsa-miR-15a-5p;hsa-miR-17-5p;hsa-miR-186-5p;hsa-miR-20a-5p;hsa-miR-25-3p;hsa-miR-29b-3p;hsa-miR-320a;hsa-miR-362-5p;hsa-miR-374a-3p;hsa-miR-500a-5p;hsa-miR-576-5p | 15 | NFAT5 | Sponge network | -0.426 | 0.01062 | -0.144 | 0.16169 | 0.472 |
27 | ZNF667-AS1 |
hsa-miR-141-3p;hsa-miR-15a-5p;hsa-miR-17-5p;hsa-miR-185-5p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-224-3p;hsa-miR-27a-3p;hsa-miR-301a-3p;hsa-miR-452-5p;hsa-miR-484;hsa-miR-589-3p;hsa-miR-590-5p;hsa-miR-629-3p | 14 | FZD4 | Sponge network | -1.395 | 0 | -0.816 | 0 | 0.471 |
28 | SNHG14 | hsa-miR-141-3p;hsa-miR-15a-5p;hsa-miR-17-5p;hsa-miR-185-5p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-27a-3p;hsa-miR-301a-3p;hsa-miR-3934-5p;hsa-miR-452-5p;hsa-miR-454-3p;hsa-miR-455-3p;hsa-miR-484;hsa-miR-576-5p;hsa-miR-589-3p;hsa-miR-629-3p;hsa-miR-92a-3p | 17 | FZD4 | Sponge network | -1.125 | 0.0001 | -0.816 | 0 | 0.469 |
29 | AC007743.1 |
hsa-let-7a-3p;hsa-miR-15a-5p;hsa-miR-17-5p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-27a-3p;hsa-miR-301a-3p;hsa-miR-589-3p;hsa-miR-590-5p;hsa-miR-629-3p;hsa-miR-7-1-3p;hsa-miR-92a-3p | 12 | FZD4 | Sponge network | -1.053 | 0.00923 | -0.816 | 0 | 0.465 |
30 | SH3RF3-AS1 |
hsa-miR-16-2-3p;hsa-miR-182-5p;hsa-miR-186-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-205-3p;hsa-miR-222-3p;hsa-miR-2355-5p;hsa-miR-26b-3p;hsa-miR-29a-5p;hsa-miR-30b-5p;hsa-miR-30c-5p;hsa-miR-320a;hsa-miR-320b;hsa-miR-7-1-3p | 15 | NFATC2 | Sponge network | -0.175 | 0.58985 | -1.255 | 0.00017 | 0.463 |
31 | RP11-166D19.1 |
hsa-let-7a-3p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-205-5p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-26b-3p;hsa-miR-429;hsa-miR-944 | 11 | AXIN2 | Sponge network | -0.882 | 5.0E-5 | -0.655 | 0.00118 | 0.459 |
32 | AC007743.1 |
hsa-miR-130a-3p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-205-5p;hsa-miR-20a-5p;hsa-miR-301a-3p;hsa-miR-590-5p;hsa-miR-7-1-3p | 10 | PLCB1 | Sponge network | -1.053 | 0.00923 | -0.023 | 0.91504 | 0.458 |
33 | AC003090.1 |
hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-141-3p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-17-5p;hsa-miR-185-5p;hsa-miR-200c-3p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-27a-3p;hsa-miR-301a-3p;hsa-miR-452-5p;hsa-miR-576-5p;hsa-miR-590-5p;hsa-miR-629-3p;hsa-miR-7-1-3p;hsa-miR-708-5p;hsa-miR-940 | 20 | FZD4 | Sponge network | -4.323 | 0 | -0.816 | 0 | 0.457 |
34 | AC007743.1 |
hsa-let-7a-3p;hsa-miR-15a-5p;hsa-miR-16-1-3p;hsa-miR-17-5p;hsa-miR-193a-3p;hsa-miR-205-5p;hsa-miR-20a-5p;hsa-miR-221-3p;hsa-miR-424-5p;hsa-miR-500a-5p;hsa-miR-671-5p | 11 | LRP6 | Sponge network | -1.053 | 0.00923 | -0.291 | 0.0285 | 0.456 |
35 | EMX2OS |
hsa-let-7a-3p;hsa-miR-103a-3p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-205-5p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-26b-3p;hsa-miR-29a-5p;hsa-miR-34a-5p;hsa-miR-590-3p;hsa-miR-944 | 14 | AXIN2 | Sponge network | -1.459 | 1.0E-5 | -0.655 | 0.00118 | 0.456 |
36 | MAGI2-AS3 |
hsa-let-7a-3p;hsa-miR-15a-5p;hsa-miR-16-1-3p;hsa-miR-17-5p;hsa-miR-193a-3p;hsa-miR-205-5p;hsa-miR-20a-5p;hsa-miR-221-3p;hsa-miR-29b-3p;hsa-miR-424-5p;hsa-miR-500a-5p;hsa-miR-671-5p | 12 | LRP6 | Sponge network | -0.939 | 4.0E-5 | -0.291 | 0.0285 | 0.454 |
37 | MIR497HG |
hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-141-3p;hsa-miR-17-5p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-20a-5p;hsa-miR-224-3p;hsa-miR-27a-3p;hsa-miR-301a-3p;hsa-miR-3065-3p;hsa-miR-33a-3p;hsa-miR-455-3p;hsa-miR-589-3p;hsa-miR-590-5p;hsa-miR-7-1-3p | 16 | FZD4 | Sponge network | -1.263 | 0.00248 | -0.816 | 0 | 0.451 |
38 | RAMP2-AS1 | hsa-let-7a-3p;hsa-miR-17-5p;hsa-miR-181b-5p;hsa-miR-193a-3p;hsa-miR-205-5p;hsa-miR-20a-5p;hsa-miR-221-3p;hsa-miR-424-5p;hsa-miR-500a-5p;hsa-miR-671-5p | 10 | LRP6 | Sponge network | -1.258 | 0.00026 | -0.291 | 0.0285 | 0.448 |
39 | RP11-58E21.3 |
hsa-miR-101-5p;hsa-miR-125a-5p;hsa-miR-181c-5p;hsa-miR-181d-5p;hsa-miR-217;hsa-miR-29b-2-5p;hsa-miR-30a-3p;hsa-miR-30a-5p;hsa-miR-30d-3p;hsa-miR-500a-3p | 10 | PPP2R5E | Sponge network | 0.445 | 0.04375 | 0.181 | 0.07679 | 0.444 |
40 | RP1-193H18.2 |
hsa-let-7a-3p;hsa-miR-130a-3p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-21-3p;hsa-miR-224-5p;hsa-miR-2355-5p;hsa-miR-27a-3p;hsa-miR-450b-5p;hsa-miR-576-5p | 10 | SMAD4 | Sponge network | -1.539 | 0 | -0.43 | 0 | 0.443 |
41 | RP11-193H5.1 |
hsa-miR-125a-5p;hsa-miR-130b-5p;hsa-miR-182-5p;hsa-miR-186-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-29b-3p;hsa-miR-301a-3p;hsa-miR-320a;hsa-miR-576-5p | 10 | DAAM1 | Sponge network | -0.426 | 0.01062 | -0.372 | 0.02951 | 0.44 |
42 | PWAR6 |
hsa-miR-141-3p;hsa-miR-15a-5p;hsa-miR-17-5p;hsa-miR-185-5p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-224-3p;hsa-miR-27a-3p;hsa-miR-301a-3p;hsa-miR-452-5p;hsa-miR-454-3p;hsa-miR-455-3p;hsa-miR-576-5p;hsa-miR-589-3p;hsa-miR-629-3p | 15 | FZD4 | Sponge network | -1.629 | 0 | -0.816 | 0 | 0.438 |
43 | TPTEP1 |
hsa-let-7a-3p;hsa-miR-15a-5p;hsa-miR-16-1-3p;hsa-miR-17-5p;hsa-miR-181b-5p;hsa-miR-193a-3p;hsa-miR-205-5p;hsa-miR-20a-5p;hsa-miR-221-3p;hsa-miR-424-5p;hsa-miR-671-5p | 11 | LRP6 | Sponge network | -2.193 | 0 | -0.291 | 0.0285 | 0.436 |
44 | TPTEP1 |
hsa-let-7a-3p;hsa-miR-15a-5p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-205-5p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-29a-5p;hsa-miR-3614-5p;hsa-miR-944 | 10 | AXIN2 | Sponge network | -2.193 | 0 | -0.655 | 0.00118 | 0.432 |
45 | CTD-2015G9.2 |
hsa-miR-130b-5p;hsa-miR-16-2-3p;hsa-miR-182-5p;hsa-miR-186-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-222-3p;hsa-miR-2355-3p;hsa-miR-2355-5p;hsa-miR-7-1-3p | 10 | NFATC2 | Sponge network | -3.112 | 5.0E-5 | -1.255 | 0.00017 | 0.432 |
46 | FZD10-AS1 |
hsa-let-7a-3p;hsa-miR-15a-5p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-205-5p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-26b-3p;hsa-miR-29a-5p;hsa-miR-3614-5p;hsa-miR-590-3p | 11 | AXIN2 | Sponge network | -0.218 | 0.34607 | -0.655 | 0.00118 | 0.414 |
47 | AF127936.7 |
hsa-miR-17-3p;hsa-miR-181c-5p;hsa-miR-19b-1-5p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-27b-5p;hsa-miR-29b-2-5p;hsa-miR-30d-3p;hsa-miR-30e-3p;hsa-miR-362-5p;hsa-miR-374a-5p;hsa-miR-532-3p | 12 | PRKCA | Sponge network | 0.453 | 0.00811 | 0.318 | 0.04622 | 0.412 |
48 | SH3RF3-AS1 |
hsa-miR-103a-2-5p;hsa-miR-183-5p;hsa-miR-186-5p;hsa-miR-1976;hsa-miR-19b-1-5p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-24-2-5p;hsa-miR-339-5p;hsa-miR-505-5p | 10 | PRKCA | Sponge network | -0.175 | 0.58985 | 0.318 | 0.04622 | 0.404 |
49 | RP11-166D19.1 |
hsa-miR-16-2-3p;hsa-miR-182-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-205-3p;hsa-miR-222-3p;hsa-miR-2355-3p;hsa-miR-2355-5p;hsa-miR-26b-3p;hsa-miR-27b-5p;hsa-miR-33a-3p;hsa-miR-3613-5p;hsa-miR-484;hsa-miR-7-1-3p | 14 | NFATC2 | Sponge network | -0.882 | 5.0E-5 | -1.255 | 0.00017 | 0.403 |
50 | NOP14-AS1 |
hsa-miR-127-3p;hsa-miR-140-5p;hsa-miR-148a-3p;hsa-miR-195-5p;hsa-miR-28-5p;hsa-miR-29a-3p;hsa-miR-29c-3p;hsa-miR-30b-3p;hsa-miR-34a-5p;hsa-miR-497-5p | 10 | PPARD | Sponge network | 0.939 | 0 | 0.352 | 0.00541 | 0.403 |
51 | TP73-AS1 | hsa-miR-141-3p;hsa-miR-17-5p;hsa-miR-185-5p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-27a-3p;hsa-miR-301a-3p;hsa-miR-452-5p;hsa-miR-455-3p;hsa-miR-589-3p;hsa-miR-92a-3p | 11 | FZD4 | Sponge network | -0.533 | 0.00643 | -0.816 | 0 | 0.402 |
52 | MAGI2-AS3 |
hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-205-3p;hsa-miR-23a-3p;hsa-miR-24-3p;hsa-miR-27a-3p;hsa-miR-429;hsa-miR-452-3p;hsa-miR-589-3p;hsa-miR-944 | 10 | PRKCB | Sponge network | -0.939 | 4.0E-5 | -0.01 | 0.96606 | 0.401 |
53 | RP11-35G9.5 |
hsa-let-7a-3p;hsa-miR-141-3p;hsa-miR-17-5p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-20a-5p;hsa-miR-224-3p;hsa-miR-27a-3p;hsa-miR-301a-3p;hsa-miR-454-3p;hsa-miR-589-3p | 11 | FZD4 | Sponge network | -0.33 | 0.08136 | -0.816 | 0 | 0.401 |
54 | LINC00639 | hsa-miR-141-3p;hsa-miR-15a-5p;hsa-miR-17-5p;hsa-miR-20a-5p;hsa-miR-27a-3p;hsa-miR-301a-3p;hsa-miR-452-5p;hsa-miR-455-3p;hsa-miR-484;hsa-miR-589-3p;hsa-miR-629-3p | 11 | FZD4 | Sponge network | -0.91 | 0.00848 | -0.816 | 0 | 0.398 |
55 | C10orf71-AS1 |
hsa-let-7g-3p;hsa-miR-130b-3p;hsa-miR-185-5p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-224-3p;hsa-miR-25-3p;hsa-miR-301a-3p;hsa-miR-3065-3p;hsa-miR-324-3p;hsa-miR-33a-3p;hsa-miR-3934-5p;hsa-miR-576-5p;hsa-miR-7-1-3p | 14 | FZD4 | Sponge network | -3.382 | 0.00013 | -0.816 | 0 | 0.397 |
56 | RP11-30P6.6 | hsa-miR-101-5p;hsa-miR-181c-5p;hsa-miR-181d-5p;hsa-miR-217;hsa-miR-29b-2-5p;hsa-miR-30a-3p;hsa-miR-30a-5p;hsa-miR-30b-5p;hsa-miR-30c-5p;hsa-miR-30d-3p;hsa-miR-30d-5p;hsa-miR-30e-3p;hsa-miR-30e-5p;hsa-miR-374a-5p | 14 | PPP2R5E | Sponge network | 2.847 | 0 | 0.181 | 0.07679 | 0.394 |
57 | KB-1732A1.1 | hsa-miR-140-5p;hsa-miR-148a-3p;hsa-miR-148b-3p;hsa-miR-15b-5p;hsa-miR-195-5p;hsa-miR-28-5p;hsa-miR-29a-3p;hsa-miR-29c-3p;hsa-miR-30b-3p;hsa-miR-497-5p;hsa-miR-625-3p | 11 | PPARD | Sponge network | 1.697 | 0 | 0.352 | 0.00541 | 0.393 |
58 | LINC00707 |
hsa-miR-125b-5p;hsa-miR-181c-5p;hsa-miR-182-5p;hsa-miR-194-5p;hsa-miR-218-5p;hsa-miR-335-3p;hsa-miR-335-5p;hsa-miR-34a-5p;hsa-miR-429;hsa-miR-500a-3p | 10 | DAAM1 | Sponge network | 2.018 | 1.0E-5 | -0.372 | 0.02951 | 0.393 |
59 | RP11-400K9.4 |
hsa-let-7a-3p;hsa-miR-141-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-200a-3p;hsa-miR-200b-3p;hsa-miR-339-5p;hsa-miR-362-5p;hsa-miR-93-5p | 13 | PRKACB | Sponge network | -0.304 | 0.38627 | -0.321 | 0.02288 | 0.393 |
60 | LINC00883 | hsa-let-7a-3p;hsa-miR-141-3p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-19b-3p;hsa-miR-200a-3p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-30d-3p;hsa-miR-532-5p;hsa-miR-944 | 11 | PRKACB | Sponge network | 0.556 | 0.00093 | -0.321 | 0.02288 | 0.392 |
61 | SH3RF3-AS1 |
hsa-miR-130a-3p;hsa-miR-16-2-3p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-205-5p;hsa-miR-26b-5p;hsa-miR-30c-5p;hsa-miR-320a;hsa-miR-590-5p;hsa-miR-7-1-3p | 10 | PLCB1 | Sponge network | -0.175 | 0.58985 | -0.023 | 0.91504 | 0.39 |
62 | LINC00707 |
hsa-miR-30a-5p;hsa-miR-30b-5p;hsa-miR-30c-5p;hsa-miR-30d-5p;hsa-miR-30e-5p;hsa-miR-335-3p;hsa-miR-340-5p;hsa-miR-491-5p;hsa-miR-664a-3p;hsa-miR-664a-5p | 10 | CSNK1A1 | Sponge network | 2.018 | 1.0E-5 | -0.068 | 0.47768 | 0.388 |
63 | MAGI2-AS3 |
hsa-let-7a-3p;hsa-let-7d-3p;hsa-miR-141-3p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-18a-5p;hsa-miR-193a-3p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-200a-3p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-339-5p;hsa-miR-362-5p;hsa-miR-429;hsa-miR-7-1-3p;hsa-miR-708-3p;hsa-miR-93-5p;hsa-miR-944 | 21 | PRKACB | Sponge network | -0.939 | 4.0E-5 | -0.321 | 0.02288 | 0.386 |
64 | AC007743.1 |
hsa-miR-16-2-3p;hsa-miR-186-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-205-3p;hsa-miR-222-3p;hsa-miR-2355-3p;hsa-miR-2355-5p;hsa-miR-29a-5p;hsa-miR-7-1-3p | 10 | NFATC2 | Sponge network | -1.053 | 0.00923 | -1.255 | 0.00017 | 0.386 |
65 | CASC15 |
hsa-miR-141-3p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-17-3p;hsa-miR-200b-3p;hsa-miR-33a-3p;hsa-miR-429;hsa-miR-452-5p;hsa-miR-590-3p;hsa-miR-7-1-3p | 10 | FZD4 | Sponge network | 1.485 | 0 | -0.816 | 0 | 0.384 |
66 | AC006116.24 |
hsa-miR-130a-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-186-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-301a-3p;hsa-miR-454-3p;hsa-miR-93-5p | 10 | FBXW11 | Sponge network | -1.832 | 1.0E-5 | -0.523 | 0 | 0.384 |
67 | CASC15 |
hsa-miR-142-3p;hsa-miR-155-5p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-205-3p;hsa-miR-26b-5p;hsa-miR-30b-5p;hsa-miR-30d-3p;hsa-miR-30e-3p;hsa-miR-30e-5p;hsa-miR-582-5p;hsa-miR-590-3p;hsa-miR-7-1-3p | 14 | WNT5A | Sponge network | 1.485 | 0 | 0.23 | 0.27604 | 0.383 |
68 | RP11-999E24.3 |
hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-let-7g-3p;hsa-miR-16-5p;hsa-miR-17-3p;hsa-miR-17-5p;hsa-miR-20a-5p;hsa-miR-27a-3p;hsa-miR-301a-3p;hsa-miR-33a-3p | 10 | FZD4 | Sponge network | -1.447 | 0.0004 | -0.816 | 0 | 0.379 |
69 | MAGI2-AS3 |
hsa-let-7a-3p;hsa-miR-130a-3p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-21-3p;hsa-miR-224-5p;hsa-miR-2355-5p;hsa-miR-27a-3p;hsa-miR-454-3p;hsa-miR-576-5p | 10 | SMAD4 | Sponge network | -0.939 | 4.0E-5 | -0.43 | 0 | 0.379 |
70 | RP11-594N15.3 |
hsa-let-7a-3p;hsa-let-7d-3p;hsa-miR-141-3p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-200a-3p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-93-5p | 14 | PRKACB | Sponge network | -2.86 | 0 | -0.321 | 0.02288 | 0.377 |
71 | HHIP-AS1 |
hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-15a-5p;hsa-miR-16-5p;hsa-miR-17-5p;hsa-miR-20a-5p;hsa-miR-301a-3p;hsa-miR-455-3p;hsa-miR-590-3p;hsa-miR-7-1-3p;hsa-miR-92a-3p | 11 | FZD4 | Sponge network | -1.293 | 0.01561 | -0.816 | 0 | 0.374 |
72 | RP11-227H15.4 |
hsa-miR-140-5p;hsa-miR-148a-3p;hsa-miR-16-5p;hsa-miR-195-5p;hsa-miR-28-5p;hsa-miR-29a-3p;hsa-miR-29c-3p;hsa-miR-30b-3p;hsa-miR-34a-5p;hsa-miR-497-5p | 10 | PPARD | Sponge network | 4.405 | 0 | 0.352 | 0.00541 | 0.371 |
73 | RP11-284N8.3 |
hsa-let-7a-3p;hsa-miR-141-3p;hsa-miR-17-5p;hsa-miR-200c-3p;hsa-miR-20a-5p;hsa-miR-224-3p;hsa-miR-27a-3p;hsa-miR-301a-3p;hsa-miR-3065-3p;hsa-miR-452-5p;hsa-miR-455-3p;hsa-miR-576-5p;hsa-miR-590-5p | 13 | FZD4 | Sponge network | 0.003 | 0.99478 | -0.816 | 0 | 0.371 |
74 | CTD-2269F5.1 |
hsa-miR-142-3p;hsa-miR-155-5p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-186-5p;hsa-miR-205-3p;hsa-miR-29a-5p;hsa-miR-576-5p;hsa-miR-7-1-3p;hsa-miR-92a-3p | 11 | WNT5A | Sponge network | -0.168 | 0.67173 | 0.23 | 0.27604 | 0.371 |
75 | CTC-297N7.7 |
hsa-miR-141-3p;hsa-miR-15b-5p;hsa-miR-17-5p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-20a-5p;hsa-miR-224-3p;hsa-miR-3065-3p;hsa-miR-33a-3p;hsa-miR-589-3p;hsa-miR-629-3p | 11 | FZD4 | Sponge network | -1.666 | 0.01558 | -0.816 | 0 | 0.366 |
76 | CTD-2015G9.2 |
hsa-miR-103a-3p;hsa-miR-1301-3p;hsa-miR-130b-5p;hsa-miR-148b-5p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-1-3p;hsa-miR-17-5p;hsa-miR-186-5p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-25-3p;hsa-miR-361-3p;hsa-miR-362-5p;hsa-miR-500a-3p;hsa-miR-576-5p;hsa-miR-93-5p | 17 | NFAT5 | Sponge network | -3.112 | 5.0E-5 | -0.144 | 0.16169 | 0.362 |
77 | RP4-798P15.3 |
hsa-miR-16-2-3p;hsa-miR-182-5p;hsa-miR-186-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-205-3p;hsa-miR-222-3p;hsa-miR-2355-3p;hsa-miR-2355-5p;hsa-miR-29a-5p;hsa-miR-31-3p;hsa-miR-484;hsa-miR-7-1-3p | 13 | NFATC2 | Sponge network | -1.213 | 0.00098 | -1.255 | 0.00017 | 0.362 |
78 | MAGI2-AS3 |
hsa-let-7a-3p;hsa-miR-142-3p;hsa-miR-17-5p;hsa-miR-200b-3p;hsa-miR-3607-3p;hsa-miR-429;hsa-miR-500a-5p;hsa-miR-582-5p;hsa-miR-589-3p;hsa-miR-590-3p | 10 | ROCK2 | Sponge network | -0.939 | 4.0E-5 | -0.315 | 0.07076 | 0.361 |
79 | AC006116.24 |
hsa-miR-130a-3p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-205-5p;hsa-miR-20a-5p;hsa-miR-301a-3p;hsa-miR-454-3p;hsa-miR-93-5p | 10 | PLCB1 | Sponge network | -1.832 | 1.0E-5 | -0.023 | 0.91504 | 0.36 |
80 | LINC00702 |
hsa-miR-17-3p;hsa-miR-183-5p;hsa-miR-19b-1-5p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-27b-5p;hsa-miR-29b-2-5p;hsa-miR-30d-3p;hsa-miR-339-5p;hsa-miR-500a-5p;hsa-miR-532-3p;hsa-miR-590-3p;hsa-miR-92a-3p;hsa-miR-93-3p | 14 | PRKCA | Sponge network | -0.573 | 0.0699 | 0.318 | 0.04622 | 0.359 |
81 | SH3RF3-AS1 |
hsa-let-7a-3p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-186-5p;hsa-miR-205-3p;hsa-miR-26b-5p;hsa-miR-29a-5p;hsa-miR-30b-5p;hsa-miR-30c-5p;hsa-miR-576-5p;hsa-miR-582-5p;hsa-miR-7-1-3p | 13 | WNT5A | Sponge network | -0.175 | 0.58985 | 0.23 | 0.27604 | 0.358 |
82 | PSMG3-AS1 | hsa-let-7a-3p;hsa-miR-141-3p;hsa-miR-17-5p;hsa-miR-200c-3p;hsa-miR-20a-5p;hsa-miR-27a-3p;hsa-miR-301a-3p;hsa-miR-324-3p;hsa-miR-3934-5p;hsa-miR-455-3p;hsa-miR-484;hsa-miR-708-5p;hsa-miR-92a-3p;hsa-miR-940 | 14 | FZD4 | Sponge network | -0.793 | 0 | -0.816 | 0 | 0.356 |
83 | RP11-757G1.6 | hsa-miR-15a-5p;hsa-miR-17-5p;hsa-miR-185-5p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-27a-3p;hsa-miR-301a-3p;hsa-miR-452-5p;hsa-miR-454-3p;hsa-miR-576-5p;hsa-miR-589-3p | 11 | FZD4 | Sponge network | -1.346 | 0.00088 | -0.816 | 0 | 0.356 |
84 | HHIP-AS1 |
hsa-miR-142-3p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-205-5p;hsa-miR-20a-5p;hsa-miR-301a-3p;hsa-miR-590-3p;hsa-miR-7-1-3p | 10 | PLCB1 | Sponge network | -1.293 | 0.01561 | -0.023 | 0.91504 | 0.355 |
85 | FZD10-AS1 |
hsa-let-7a-3p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-186-5p;hsa-miR-205-3p;hsa-miR-26b-5p;hsa-miR-29a-5p;hsa-miR-330-5p;hsa-miR-576-5p;hsa-miR-590-3p;hsa-miR-7-1-3p;hsa-miR-92a-3p | 13 | WNT5A | Sponge network | -0.218 | 0.34607 | 0.23 | 0.27604 | 0.354 |
86 | RP11-594N15.3 |
hsa-miR-130b-5p;hsa-miR-16-2-3p;hsa-miR-182-5p;hsa-miR-186-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-205-3p;hsa-miR-222-3p;hsa-miR-2355-3p;hsa-miR-2355-5p;hsa-miR-27b-5p;hsa-miR-320b;hsa-miR-3607-3p;hsa-miR-484 | 14 | NFATC2 | Sponge network | -2.86 | 0 | -1.255 | 0.00017 | 0.353 |
87 | BHLHE40-AS1 |
hsa-let-7a-3p;hsa-miR-130a-3p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-224-5p;hsa-miR-2355-5p;hsa-miR-27a-3p;hsa-miR-450b-5p;hsa-miR-576-5p;hsa-miR-590-5p | 10 | SMAD4 | Sponge network | -0.932 | 0 | -0.43 | 0 | 0.353 |
88 | RP13-379O24.2 | hsa-miR-106b-5p;hsa-miR-141-3p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-17-5p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-20a-5p;hsa-miR-324-3p;hsa-miR-940 | 10 | FZD4 | Sponge network | -2.013 | 0.02568 | -0.816 | 0 | 0.351 |
89 | RP11-166D19.1 |
hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-182-5p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-224-3p;hsa-miR-33a-3p;hsa-miR-33a-5p;hsa-miR-33b-5p;hsa-miR-429;hsa-miR-576-5p;hsa-miR-589-3p;hsa-miR-589-5p;hsa-miR-590-5p;hsa-miR-629-3p;hsa-miR-7-1-3p;hsa-miR-944 | 18 | PRICKLE2 | Sponge network | -0.882 | 5.0E-5 | -0.654 | 4.0E-5 | 0.351 |
90 | MAGI2-AS3 |
hsa-miR-103a-2-5p;hsa-miR-17-3p;hsa-miR-183-5p;hsa-miR-186-5p;hsa-miR-1976;hsa-miR-19b-1-5p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-24-2-5p;hsa-miR-27b-5p;hsa-miR-339-5p;hsa-miR-3607-3p;hsa-miR-362-5p;hsa-miR-429;hsa-miR-500a-5p;hsa-miR-501-5p;hsa-miR-532-3p;hsa-miR-590-3p;hsa-miR-92a-3p;hsa-miR-93-3p | 20 | PRKCA | Sponge network | -0.939 | 4.0E-5 | 0.318 | 0.04622 | 0.351 |
91 | AC006262.4 |
hsa-miR-148a-3p;hsa-miR-148b-3p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-195-5p;hsa-miR-28-5p;hsa-miR-29a-3p;hsa-miR-29c-3p;hsa-miR-30b-3p;hsa-miR-497-5p | 10 | PPARD | Sponge network | 1.721 | 0.01526 | 0.352 | 0.00541 | 0.348 |
92 | CTD-2015G9.2 |
hsa-miR-130a-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-186-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-301a-3p;hsa-miR-450b-5p;hsa-miR-454-3p;hsa-miR-93-5p | 11 | FBXW11 | Sponge network | -3.112 | 5.0E-5 | -0.523 | 0 | 0.348 |
93 | CTC-205M6.5 | hsa-miR-141-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-19b-3p;hsa-miR-200a-3p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-34a-5p;hsa-miR-7-1-3p;hsa-miR-96-5p | 10 | PRKACB | Sponge network | 0.381 | 0.01756 | -0.321 | 0.02288 | 0.348 |
94 | LINC00900 |
hsa-let-7a-3p;hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-141-3p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-17-5p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-25-3p;hsa-miR-27a-3p;hsa-miR-301a-3p;hsa-miR-3934-5p;hsa-miR-454-3p;hsa-miR-455-3p;hsa-miR-505-5p;hsa-miR-576-5p;hsa-miR-589-3p;hsa-miR-590-5p;hsa-miR-7-1-3p;hsa-miR-708-5p;hsa-miR-92a-3p;hsa-miR-92b-3p | 26 | FZD4 | Sponge network | -1.803 | 0 | -0.816 | 0 | 0.347 |
95 | BHLHE40-AS1 |
hsa-miR-130a-3p;hsa-miR-130b-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-301a-3p;hsa-miR-450b-5p;hsa-miR-96-5p | 10 | FBXW11 | Sponge network | -0.932 | 0 | -0.523 | 0 | 0.347 |
96 | BZRAP1-AS1 |
hsa-let-7a-3p;hsa-miR-141-3p;hsa-miR-17-5p;hsa-miR-20a-5p;hsa-miR-27a-3p;hsa-miR-301a-3p;hsa-miR-3065-3p;hsa-miR-452-5p;hsa-miR-454-3p;hsa-miR-455-3p | 10 | FZD4 | Sponge network | -0.233 | 0.50729 | -0.816 | 0 | 0.347 |
97 | RP11-693J15.4 |
hsa-let-7a-3p;hsa-miR-141-3p;hsa-miR-17-5p;hsa-miR-185-5p;hsa-miR-200c-3p;hsa-miR-20a-5p;hsa-miR-27a-3p;hsa-miR-301a-3p;hsa-miR-455-3p;hsa-miR-590-5p;hsa-miR-940 | 11 | FZD4 | Sponge network | -0.732 | 0.18487 | -0.816 | 0 | 0.346 |
98 | APCDD1L-AS1 |
hsa-miR-140-5p;hsa-miR-148a-3p;hsa-miR-148b-3p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-28-5p;hsa-miR-29a-3p;hsa-miR-29c-3p;hsa-miR-30b-3p;hsa-miR-497-5p;hsa-miR-9-5p | 11 | PPARD | Sponge network | 2.077 | 0 | 0.352 | 0.00541 | 0.345 |
99 | RP11-403I13.7 | hsa-miR-141-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-362-5p;hsa-miR-590-5p;hsa-miR-96-5p | 10 | PRKACB | Sponge network | 0.214 | 0.38819 | -0.321 | 0.02288 | 0.34 |
100 | LINC00707 |
hsa-miR-101-5p;hsa-miR-181c-5p;hsa-miR-181d-5p;hsa-miR-195-3p;hsa-miR-217;hsa-miR-29b-2-5p;hsa-miR-30a-3p;hsa-miR-30a-5p;hsa-miR-30b-5p;hsa-miR-30c-5p;hsa-miR-30d-3p;hsa-miR-30d-5p;hsa-miR-30e-3p;hsa-miR-30e-5p;hsa-miR-374a-3p;hsa-miR-500a-3p | 16 | PPP2R5E | Sponge network | 2.018 | 1.0E-5 | 0.181 | 0.07679 | 0.339 |
101 | RASSF8-AS1 | hsa-miR-141-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-200a-3p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-429;hsa-miR-944 | 11 | PRKACB | Sponge network | 0.121 | 0.52445 | -0.321 | 0.02288 | 0.338 |
102 | TPTEP1 |
hsa-let-7a-3p;hsa-miR-15a-5p;hsa-miR-16-5p;hsa-miR-17-5p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-27a-3p;hsa-miR-301a-3p;hsa-miR-3934-5p;hsa-miR-454-3p;hsa-miR-455-3p;hsa-miR-484;hsa-miR-576-5p;hsa-miR-589-3p;hsa-miR-590-5p;hsa-miR-629-3p;hsa-miR-92a-3p | 17 | FZD4 | Sponge network | -2.193 | 0 | -0.816 | 0 | 0.337 |
103 | CTA-221G9.11 | hsa-miR-17-5p;hsa-miR-185-5p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-224-3p;hsa-miR-301a-3p;hsa-miR-3934-5p;hsa-miR-484;hsa-miR-576-5p;hsa-miR-629-3p | 10 | FZD4 | Sponge network | -2.198 | 0 | -0.816 | 0 | 0.336 |
104 | RP1-193H18.2 |
hsa-let-7a-3p;hsa-miR-17-5p;hsa-miR-185-5p;hsa-miR-21-5p;hsa-miR-27a-3p;hsa-miR-301a-3p;hsa-miR-452-5p;hsa-miR-455-3p;hsa-miR-576-5p;hsa-miR-589-3p | 10 | FZD4 | Sponge network | -1.539 | 0 | -0.816 | 0 | 0.336 |
105 | RP11-411K7.1 |
hsa-miR-125a-5p;hsa-miR-130b-3p;hsa-miR-130b-5p;hsa-miR-181a-5p;hsa-miR-181b-5p;hsa-miR-186-5p;hsa-miR-194-5p;hsa-miR-218-5p;hsa-miR-301a-3p;hsa-miR-320a;hsa-miR-320b;hsa-miR-335-3p | 12 | DAAM1 | Sponge network | -0.883 | 0.003 | -0.372 | 0.02951 | 0.335 |
106 | BHLHE40-AS1 |
hsa-let-7a-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-18a-5p;hsa-miR-193a-3p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-339-5p;hsa-miR-590-5p;hsa-miR-96-5p | 11 | PRKACB | Sponge network | -0.932 | 0 | -0.321 | 0.02288 | 0.322 |
107 | AF127936.7 |
hsa-miR-155-5p;hsa-miR-15b-5p;hsa-miR-16-1-3p;hsa-miR-16-5p;hsa-miR-17-3p;hsa-miR-181c-5p;hsa-miR-25-3p;hsa-miR-27b-5p;hsa-miR-320a;hsa-miR-361-3p;hsa-miR-362-5p | 11 | NFAT5 | Sponge network | 0.453 | 0.00811 | -0.144 | 0.16169 | 0.321 |
108 | LINC00957 | hsa-miR-141-3p;hsa-miR-15a-5p;hsa-miR-17-5p;hsa-miR-185-5p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-301a-3p;hsa-miR-3934-5p;hsa-miR-455-3p;hsa-miR-484;hsa-miR-576-5p | 11 | FZD4 | Sponge network | -0.677 | 2.0E-5 | -0.816 | 0 | 0.318 |
109 | HHIP-AS1 |
hsa-let-7a-3p;hsa-miR-142-3p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-186-5p;hsa-miR-205-3p;hsa-miR-29a-5p;hsa-miR-330-5p;hsa-miR-590-3p;hsa-miR-7-1-3p;hsa-miR-92a-3p | 12 | WNT5A | Sponge network | -1.293 | 0.01561 | 0.23 | 0.27604 | 0.315 |
110 | MAGI2-AS3 |
hsa-miR-130b-5p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-182-5p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-21-5p;hsa-miR-224-3p;hsa-miR-29b-3p;hsa-miR-320a;hsa-miR-320b;hsa-miR-33a-3p;hsa-miR-33a-5p;hsa-miR-33b-5p;hsa-miR-362-5p;hsa-miR-429;hsa-miR-500a-5p;hsa-miR-576-5p;hsa-miR-589-3p;hsa-miR-589-5p;hsa-miR-629-3p;hsa-miR-7-1-3p;hsa-miR-944 | 24 | PRICKLE2 | Sponge network | -0.939 | 4.0E-5 | -0.654 | 4.0E-5 | 0.314 |
111 | RP11-35G9.5 |
hsa-let-7a-3p;hsa-miR-141-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-200a-3p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-96-5p | 12 | PRKACB | Sponge network | -0.33 | 0.08136 | -0.321 | 0.02288 | 0.312 |
112 | CTD-2135D7.5 | hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-185-5p;hsa-miR-21-5p;hsa-miR-224-3p;hsa-miR-301a-3p;hsa-miR-452-5p;hsa-miR-589-3p;hsa-miR-590-5p;hsa-miR-629-3p | 10 | FZD4 | Sponge network | -2.579 | 0.0001 | -0.816 | 0 | 0.31 |
113 | RP11-218E20.3 | hsa-miR-101-5p;hsa-miR-181c-5p;hsa-miR-195-3p;hsa-miR-217;hsa-miR-29b-2-5p;hsa-miR-30a-3p;hsa-miR-30a-5p;hsa-miR-30b-5p;hsa-miR-30d-3p;hsa-miR-30d-5p;hsa-miR-30e-3p;hsa-miR-30e-5p;hsa-miR-374a-5p;hsa-miR-374b-5p | 14 | PPP2R5E | Sponge network | 4.613 | 0 | 0.181 | 0.07679 | 0.308 |
114 | RP11-58E21.3 |
hsa-miR-106b-5p;hsa-miR-1301-3p;hsa-miR-130b-5p;hsa-miR-181c-5p;hsa-miR-194-5p;hsa-miR-25-3p;hsa-miR-362-5p;hsa-miR-500a-3p;hsa-miR-582-3p;hsa-miR-93-5p | 10 | NFAT5 | Sponge network | 0.445 | 0.04375 | -0.144 | 0.16169 | 0.308 |
115 | DNM3OS |
hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-182-5p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-224-3p;hsa-miR-33a-3p;hsa-miR-33a-5p;hsa-miR-33b-5p;hsa-miR-429;hsa-miR-590-5p;hsa-miR-7-1-3p;hsa-miR-944 | 14 | PRICKLE2 | Sponge network | 0.932 | 0.00442 | -0.654 | 4.0E-5 | 0.306 |
116 | LINC00702 |
hsa-miR-130b-5p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-182-5p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-224-3p;hsa-miR-320a;hsa-miR-320b;hsa-miR-335-3p;hsa-miR-33a-3p;hsa-miR-33a-5p;hsa-miR-33b-5p;hsa-miR-500a-5p;hsa-miR-576-5p;hsa-miR-589-3p;hsa-miR-590-5p;hsa-miR-629-3p;hsa-miR-7-1-3p | 20 | PRICKLE2 | Sponge network | -0.573 | 0.0699 | -0.654 | 4.0E-5 | 0.304 |
117 | MAGI2-AS3 |
hsa-miR-130b-5p;hsa-miR-148b-5p;hsa-miR-15b-3p;hsa-miR-19b-1-5p;hsa-miR-205-5p;hsa-miR-25-3p;hsa-miR-331-3p;hsa-miR-429;hsa-miR-582-3p;hsa-miR-7-1-3p;hsa-miR-92a-3p;hsa-miR-939-5p | 12 | CAMK2A | Sponge network | -0.939 | 4.0E-5 | -1.032 | 0.00875 | 0.303 |
118 | AC093627.10 | hsa-let-7a-3p;hsa-miR-130a-3p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-21-3p;hsa-miR-224-5p;hsa-miR-2355-5p;hsa-miR-27a-3p;hsa-miR-450b-5p;hsa-miR-454-3p | 10 | SMAD4 | Sponge network | -0.893 | 0.00123 | -0.43 | 0 | 0.301 |
119 | TPTEP1 |
hsa-miR-130a-3p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-205-5p;hsa-miR-20a-5p;hsa-miR-301a-3p;hsa-miR-454-3p;hsa-miR-590-5p;hsa-miR-93-5p | 11 | PLCB1 | Sponge network | -2.193 | 0 | -0.023 | 0.91504 | 0.3 |
120 | BZRAP1-AS1 |
hsa-let-7a-3p;hsa-miR-141-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-18a-5p;hsa-miR-193a-3p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-200a-3p;hsa-miR-339-5p;hsa-miR-944 | 12 | PRKACB | Sponge network | -0.233 | 0.50729 | -0.321 | 0.02288 | 0.299 |
121 | MAGI2-AS3 |
hsa-miR-1301-3p;hsa-miR-16-1-3p;hsa-miR-182-5p;hsa-miR-19b-1-5p;hsa-miR-205-3p;hsa-miR-429;hsa-miR-501-5p;hsa-miR-576-5p;hsa-miR-7-1-3p;hsa-miR-940 | 10 | SFRP1 | Sponge network | -0.939 | 4.0E-5 | -2.96 | 0 | 0.299 |
122 | RP11-815I9.4 |
hsa-miR-130a-3p;hsa-miR-17-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-205-5p;hsa-miR-20a-5p;hsa-miR-26b-5p;hsa-miR-301a-3p;hsa-miR-30c-5p;hsa-miR-320a;hsa-miR-34a-5p;hsa-miR-590-5p | 12 | PLCB1 | Sponge network | 0.004 | 0.98116 | -0.023 | 0.91504 | 0.298 |
123 | MAGI2-AS3 |
hsa-miR-182-5p;hsa-miR-186-5p;hsa-miR-193b-3p;hsa-miR-20a-5p;hsa-miR-2355-3p;hsa-miR-25-3p;hsa-miR-26b-5p;hsa-miR-29b-1-5p;hsa-miR-30c-5p;hsa-miR-339-5p;hsa-miR-342-3p;hsa-miR-582-3p;hsa-miR-590-3p;hsa-miR-92a-3p | 14 | EP300 | Sponge network | -0.939 | 4.0E-5 | -0.038 | 0.77828 | 0.297 |
124 | RP4-798P15.3 |
hsa-let-7a-3p;hsa-miR-15a-5p;hsa-miR-17-5p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-301a-3p;hsa-miR-3934-5p;hsa-miR-455-3p;hsa-miR-484;hsa-miR-576-5p;hsa-miR-589-3p;hsa-miR-590-5p;hsa-miR-7-1-3p;hsa-miR-708-5p | 14 | FZD4 | Sponge network | -1.213 | 0.00098 | -0.816 | 0 | 0.295 |
125 | FAM66C | hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-15a-5p;hsa-miR-17-5p;hsa-miR-21-5p;hsa-miR-27a-3p;hsa-miR-3934-5p;hsa-miR-452-5p;hsa-miR-455-3p;hsa-miR-484;hsa-miR-576-5p | 11 | FZD4 | Sponge network | -0.798 | 0.00038 | -0.816 | 0 | 0.295 |
126 | LINC00284 |
hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-17-5p;hsa-miR-185-5p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-301a-3p;hsa-miR-455-3p;hsa-miR-576-5p;hsa-miR-589-3p;hsa-miR-590-5p;hsa-miR-629-3p | 13 | FZD4 | Sponge network | -4.159 | 0 | -0.816 | 0 | 0.295 |
127 | LINC00675 |
hsa-miR-106b-5p;hsa-miR-1301-3p;hsa-miR-130b-5p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-1-3p;hsa-miR-181a-5p;hsa-miR-194-5p;hsa-miR-21-5p;hsa-miR-25-3p | 10 | NFAT5 | Sponge network | -4.584 | 0 | -0.144 | 0.16169 | 0.295 |
128 | AC007182.6 | hsa-miR-130b-3p;hsa-miR-148b-3p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-28-5p;hsa-miR-30b-3p;hsa-miR-34a-5p;hsa-miR-423-5p;hsa-miR-625-3p;hsa-miR-9-5p | 10 | PPARD | Sponge network | -1.639 | 0.05151 | 0.352 | 0.00541 | 0.293 |
129 | RP11-384L8.1 |
hsa-let-7a-3p;hsa-miR-15a-5p;hsa-miR-16-1-3p;hsa-miR-17-5p;hsa-miR-181b-5p;hsa-miR-193a-3p;hsa-miR-205-5p;hsa-miR-20a-5p;hsa-miR-221-3p;hsa-miR-424-5p;hsa-miR-671-5p | 11 | LRP6 | Sponge network | -1.152 | 0.00016 | -0.291 | 0.0285 | 0.293 |
130 | EMX2OS |
hsa-miR-130b-5p;hsa-miR-16-2-3p;hsa-miR-182-5p;hsa-miR-186-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-205-3p;hsa-miR-222-3p;hsa-miR-2355-3p;hsa-miR-2355-5p;hsa-miR-26b-3p;hsa-miR-27b-5p;hsa-miR-29a-5p;hsa-miR-335-3p;hsa-miR-33a-3p;hsa-miR-3607-3p;hsa-miR-484;hsa-miR-7-1-3p;hsa-miR-9-5p | 19 | NFATC2 | Sponge network | -1.459 | 1.0E-5 | -1.255 | 0.00017 | 0.292 |
131 | RP4-798P15.3 |
hsa-miR-130a-3p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-205-5p;hsa-miR-20a-5p;hsa-miR-26b-5p;hsa-miR-301a-3p;hsa-miR-590-5p;hsa-miR-7-1-3p | 11 | PLCB1 | Sponge network | -1.213 | 0.00098 | -0.023 | 0.91504 | 0.292 |
132 | EMX2OS |
hsa-miR-130b-5p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-182-5p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-21-5p;hsa-miR-224-3p;hsa-miR-29b-3p;hsa-miR-335-3p;hsa-miR-33a-3p;hsa-miR-33a-5p;hsa-miR-33b-5p;hsa-miR-576-5p;hsa-miR-589-3p;hsa-miR-629-3p;hsa-miR-7-1-3p;hsa-miR-944 | 19 | PRICKLE2 | Sponge network | -1.459 | 1.0E-5 | -0.654 | 4.0E-5 | 0.292 |
133 | MAGI2-AS3 |
hsa-let-7a-3p;hsa-miR-142-3p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-186-5p;hsa-miR-205-3p;hsa-miR-26b-5p;hsa-miR-29a-5p;hsa-miR-30c-5p;hsa-miR-330-5p;hsa-miR-576-5p;hsa-miR-582-5p;hsa-miR-590-3p;hsa-miR-7-1-3p;hsa-miR-92a-3p | 16 | WNT5A | Sponge network | -0.939 | 4.0E-5 | 0.23 | 0.27604 | 0.291 |
134 | RP4-798P15.3 |
hsa-miR-103a-3p;hsa-miR-148b-5p;hsa-miR-155-5p;hsa-miR-15a-5p;hsa-miR-16-1-3p;hsa-miR-17-5p;hsa-miR-186-5p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-362-5p;hsa-miR-500a-3p;hsa-miR-500a-5p;hsa-miR-576-5p;hsa-miR-590-5p | 14 | NFAT5 | Sponge network | -1.213 | 0.00098 | -0.144 | 0.16169 | 0.29 |
135 | MIR22HG |
hsa-miR-103a-3p;hsa-miR-106b-5p;hsa-miR-1301-3p;hsa-miR-130b-5p;hsa-miR-148b-5p;hsa-miR-15b-5p;hsa-miR-17-3p;hsa-miR-17-5p;hsa-miR-181c-5p;hsa-miR-186-5p;hsa-miR-194-5p;hsa-miR-20a-5p;hsa-miR-25-3p;hsa-miR-582-5p;hsa-miR-590-5p;hsa-miR-92a-3p;hsa-miR-93-5p | 17 | NFAT5 | Sponge network | -0.601 | 4.0E-5 | -0.144 | 0.16169 | 0.288 |
136 | AC003090.1 |
hsa-miR-130a-3p;hsa-miR-142-3p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-205-5p;hsa-miR-20a-5p;hsa-miR-301a-3p;hsa-miR-320a;hsa-miR-590-5p;hsa-miR-7-1-3p;hsa-miR-93-5p | 13 | PLCB1 | Sponge network | -4.323 | 0 | -0.023 | 0.91504 | 0.287 |
137 | RP11-166D19.1 |
hsa-miR-103a-2-5p;hsa-miR-17-3p;hsa-miR-183-5p;hsa-miR-19b-1-5p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-24-2-5p;hsa-miR-27b-5p;hsa-miR-339-5p;hsa-miR-429;hsa-miR-532-3p;hsa-miR-92a-3p;hsa-miR-93-3p | 13 | PRKCA | Sponge network | -0.882 | 5.0E-5 | 0.318 | 0.04622 | 0.285 |
138 | LINC00702 |
hsa-miR-103a-3p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-205-5p;hsa-miR-222-3p;hsa-miR-26b-3p;hsa-miR-34a-5p;hsa-miR-582-5p;hsa-miR-590-3p | 11 | AXIN2 | Sponge network | -0.573 | 0.0699 | -0.655 | 0.00118 | 0.284 |
139 | RP11-284N8.3 |
hsa-let-7a-3p;hsa-miR-141-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-200a-3p;hsa-miR-200c-3p;hsa-miR-590-5p;hsa-miR-93-5p;hsa-miR-944;hsa-miR-96-5p | 14 | PRKACB | Sponge network | 0.003 | 0.99478 | -0.321 | 0.02288 | 0.281 |
140 | RP11-193H5.1 |
hsa-miR-103a-2-5p;hsa-miR-186-5p;hsa-miR-24-2-5p;hsa-miR-29b-2-5p;hsa-miR-339-5p;hsa-miR-362-5p;hsa-miR-500a-5p;hsa-miR-501-5p;hsa-miR-505-5p;hsa-miR-93-3p | 10 | PRKCA | Sponge network | -0.426 | 0.01062 | 0.318 | 0.04622 | 0.281 |
141 | CTD-2008P7.9 |
hsa-miR-125a-5p;hsa-miR-130b-3p;hsa-miR-130b-5p;hsa-miR-181a-5p;hsa-miR-181b-5p;hsa-miR-186-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-21-5p;hsa-miR-301a-3p;hsa-miR-454-3p;hsa-miR-576-5p | 12 | DAAM1 | Sponge network | -1.202 | 0.00093 | -0.372 | 0.02951 | 0.28 |
142 | DIO3OS | hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-141-3p;hsa-miR-17-3p;hsa-miR-17-5p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-3065-3p;hsa-miR-324-3p;hsa-miR-3934-5p;hsa-miR-629-3p;hsa-miR-940 | 12 | FZD4 | Sponge network | -0.462 | 0.26057 | -0.816 | 0 | 0.28 |
143 | RP11-166D19.1 |
hsa-let-7a-3p;hsa-miR-141-3p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-18a-5p;hsa-miR-193a-3p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-200a-3p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-339-5p;hsa-miR-429;hsa-miR-590-5p;hsa-miR-7-1-3p;hsa-miR-944;hsa-miR-96-5p | 19 | PRKACB | Sponge network | -0.882 | 5.0E-5 | -0.321 | 0.02288 | 0.279 |
144 | RP11-244O19.1 |
hsa-miR-141-3p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-200a-3p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-30d-3p;hsa-miR-34a-5p;hsa-miR-532-5p;hsa-miR-93-5p | 10 | PRKACB | Sponge network | 0.52 | 0.05156 | -0.321 | 0.02288 | 0.278 |
145 | CTD-2554C21.3 | hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-17-5p;hsa-miR-185-5p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-301a-3p;hsa-miR-3934-5p;hsa-miR-455-3p;hsa-miR-629-3p | 11 | FZD4 | Sponge network | -2.118 | 6.0E-5 | -0.816 | 0 | 0.277 |
146 | CASC15 |
hsa-miR-17-3p;hsa-miR-1976;hsa-miR-19b-1-5p;hsa-miR-200b-3p;hsa-miR-27b-5p;hsa-miR-29b-2-5p;hsa-miR-30d-3p;hsa-miR-30e-3p;hsa-miR-429;hsa-miR-590-3p | 10 | PRKCA | Sponge network | 1.485 | 0 | 0.318 | 0.04622 | 0.269 |
147 | RP11-389C8.2 |
hsa-let-7a-3p;hsa-miR-141-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-18a-5p;hsa-miR-193a-3p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-200a-3p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-429;hsa-miR-93-5p;hsa-miR-944 | 15 | PRKACB | Sponge network | 0.187 | 0.31051 | -0.321 | 0.02288 | 0.267 |
148 | RP11-400K9.4 |
hsa-miR-130a-3p;hsa-miR-130b-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-186-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-301a-3p;hsa-miR-93-5p | 10 | FBXW11 | Sponge network | -0.304 | 0.38627 | -0.523 | 0 | 0.267 |
149 | RP11-774O3.3 |
hsa-let-7a-3p;hsa-miR-130b-3p;hsa-miR-141-3p;hsa-miR-15a-5p;hsa-miR-17-5p;hsa-miR-185-5p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-27a-3p;hsa-miR-301a-3p;hsa-miR-324-3p;hsa-miR-576-5p;hsa-miR-589-3p;hsa-miR-7-1-3p;hsa-miR-708-5p | 15 | FZD4 | Sponge network | -1.712 | 0 | -0.816 | 0 | 0.264 |
150 | RP11-166D19.1 |
hsa-let-7a-3p;hsa-miR-130a-3p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-224-5p;hsa-miR-2355-5p;hsa-miR-27a-3p;hsa-miR-454-3p;hsa-miR-576-5p;hsa-miR-590-5p | 10 | SMAD4 | Sponge network | -0.882 | 5.0E-5 | -0.43 | 0 | 0.259 |
151 | TPTEP1 |
hsa-let-7a-3p;hsa-miR-130a-3p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-21-3p;hsa-miR-224-5p;hsa-miR-2355-5p;hsa-miR-27a-3p;hsa-miR-454-3p;hsa-miR-576-5p;hsa-miR-590-5p | 11 | SMAD4 | Sponge network | -2.193 | 0 | -0.43 | 0 | 0.257 |
152 | CTD-2008P7.9 |
hsa-miR-103a-3p;hsa-miR-1301-3p;hsa-miR-130b-5p;hsa-miR-148b-5p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-1-3p;hsa-miR-16-5p;hsa-miR-17-5p;hsa-miR-181a-5p;hsa-miR-186-5p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-25-3p;hsa-miR-500a-5p;hsa-miR-576-5p | 16 | NFAT5 | Sponge network | -1.202 | 0.00093 | -0.144 | 0.16169 | 0.254 |
153 | SH3RF3-AS1 |
hsa-let-7a-3p;hsa-miR-16-2-3p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-18a-5p;hsa-miR-193a-3p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-339-5p;hsa-miR-590-5p;hsa-miR-7-1-3p | 13 | PRKACB | Sponge network | -0.175 | 0.58985 | -0.321 | 0.02288 | 0.254 |